{
  "conditions_to_closing": [
    {
      "section": "conditions_to_closing",
      "field_name": "mutual_conditions_list",
      "answer": [
        "The Company shall have obtained the Company Stockholder Approval.",
        "The Parent Share Issuance shall have been approved for listing on the NYSE, subject to official notice of issuance.",
        "The Form F-4 shall have become effective under the Securities Act and shall not be the subject of any stop order or any Proceedings by or before the SEC seeking a stop order.",
        "Any applicable waiting period (and any extension thereof) under the HSR Act relating to the consummation of the Merger shall have expired or early termination thereof shall have been granted.",
        "No Governmental Authority of competent jurisdiction shall have issued or entered any Order after the date of this Agreement, and no Law shall have been enacted or promulgated after the date of this Agreement, in each case, that (whether temporary or permanent) is then in effect and has the effect of enjoining or otherwise prohibiting the consummation of the Merger."
      ],
      "summary": "The mutual conditions for closing include obtaining stockholder approval, listing approval on NYSE, effectiveness of Form F-4, expiration of HSR Act waiting period, and absence of legal prohibitions.",
      "confidence": 0.95,
      "reason": "The conditions listed in Section 6.1 are explicitly stated as mutual conditions to closing.",
      "clause_text": "The respective obligations of each party to consummate the Merger are subject to the satisfaction or (to the extent permitted by Law) waiver by the Company and Parent at or prior to the Closing of the following conditions: (a) the Company shall have obtained the Company Stockholder Approval; (b) the Parent Share Issuance shall have been approved for listing on the NYSE, subject to official notice of issuance; (c) the Form F-4 shall have become effective under the Securities Act and shall not be the subject of any stop order or any Proceedings by or before the SEC seeking a stop order; (d) any applicable waiting period (and any extension thereof) under the HSR Act relating to the consummation of the Merger shall have expired or early termination thereof shall have been granted (the \"Required Regulatory Approval\"); and (e) no Governmental Authority of competent jurisdiction shall have issued or entered any Order after the date of this Agreement, and no Law shall have been enacted or promulgated after the date of this Agreement, in each case, that (whether temporary or permanent) is then in effect and has the effect of enjoining or otherwise prohibiting the consummation of the Merger (a \"Restraint\").",
      "reference_section": "ARTICLE VI – Conditions to the Merger > Section 6.1 – Conditions to the Obligations of Each Party"
    },
    {
      "section": "conditions_to_closing",
      "field_name": "parent_closing_conditions",
      "answer": [
        "Each of the representations and warranties of the Company contained in specified sections shall be true and correct in all respects or in all material respects as of the Closing Date.",
        "The Company shall have performed or complied in all material respects with its obligations required under the Agreement to be performed or complied with on or prior to the Closing.",
        "Since the date of the Agreement, there shall not have been any event or change that has had, or would reasonably be expected to have, a Material Adverse Effect on the Company.",
        "Parent shall have received a certificate signed by an executive officer of the Company certifying as to the matters set forth in the specified sections."
      ],
      "summary": "",
      "confidence": 1.0,
      "reason": "",
      "clause_text": "",
      "reference_section": ""
    },
    {
      "section": "conditions_to_closing",
      "field_name": "company_closing_conditions",
      "answer": [
        "Each of the representations and warranties of Parent and Merger Sub contained in specified sections shall be true and correct in all respects as of the Closing Date, except for de minimis inaccuracies.",
        "Parent and Merger Sub shall have performed or complied in all material respects with each of their respective obligations required under the Agreement to be performed or complied with on or prior to the Closing.",
        "Since the date of the Agreement, there shall not have been any event that has had, or would reasonably be expected to have, a Material Adverse Effect on Parent.",
        "The Company shall have received a certificate signed by an executive officer of Parent certifying as to the matters set forth in the specified sections."
      ],
      "summary": "The Company must ensure Parent's representations are accurate, obligations are fulfilled, no adverse effects have occurred, and a certification is received.",
      "confidence": 0.95,
      "reason": "The conditions are explicitly outlined in Section 6.3, detailing the requirements for the Company to close the transaction.",
      "clause_text": "The obligation of the Company to effect the Merger is subject to the satisfaction or (to the extent permitted by Law) waiver by the Company at or prior to the Closing of the following additional conditions: (a) each of the representations and warranties of Parent and Merger Sub (i) contained in Sections 4.2(a), 4.2(c)(i), (c)(ii), (c)(iv), 4.2(e) and 4.7(c) shall be true and correct in all respects (other than, in the case of Sections 4.2(a), 4.2(c)(i), (c)(ii) and (c)(iv), de minimis inaccuracies) as of the Closing Date as though made on and as of such date (except to the extent such representations and warranties are expressly made as of a specific date, in which case such representations and warranties shall be so true and correct as of such specific date only), (ii) contained in Section 4.2(d), Section 4.3, Section 4.4 and Section 4.23 (together with the Sections of this Agreement referred to in clause (i), the \"Parent Fundamental Representations\") shall be true and correct in all material respects, without giving effect to any materiality or \"Material Adverse Effect on Parent\" qualifications therein, as of the Closing Date as though made on and as of such date (except to the extent such representations and warranties are expressly made as of a specific date, in which case such representations and warranties shall be so true and correct as of such specific date only) and (iii) contained in this Agreement (other than the Parent Fundamental Representations), without giving effect to any materiality or \"Material Adverse Effect on Parent\" qualifications therein, shall be true and correct as of the Closing Date as though made on and as of such date (except to the extent such representations and warranties are expressly made as of a specific date, in which case such representations and warranties shall be so true and correct as of such specific date only), except where the failure of such representations and warranties to be true and correct, individually or in the aggregate, has not had, and would not reasonably be expected to have, a Material Adverse Effect on Parent; (b) Parent and Merger Sub shall have performed or complied in all material respects with each of their respective obligations required under this Agreement to be performed or complied with on or prior to the Closing; (c) since the date of this Agreement there shall not have been any event, circumstance, occurrence, effect, fact, development or change that has had, or would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect on Parent; and (d) the Company shall have received a certificate signed by an executive officer of Parent certifying as to the matters set forth in Section 6.3(a), Section 6.3(b) and Section 6.3(c).",
      "reference_section": "ARTICLE VI CONDITIONS TO THE MERGER > Section 6.3 Conditions to Obligation of the Company to Effect the Merger"
    },
    {
      "section": "conditions_to_closing",
      "field_name": "target_shareholder_approval_required",
      "answer": true,
      "summary": "The agreement requires the Company to obtain the Company Stockholder Approval as a condition to closing.",
      "confidence": 1.0,
      "reason": "The clause explicitly states that the Company shall have obtained the Company Stockholder Approval as a condition to consummate the Merger.",
      "clause_text": "The respective obligations of each party to consummate the Merger are subject to the satisfaction or (to the extent permitted by Law) waiver by the Company and Parent at or prior to the Closing of the following conditions: (a) the Company shall have obtained the Company Stockholder Approval;",
      "reference_section": "ARTICLE Article VI CONDITIONS TO THE MERGER > Section 6.1 Conditions to the Obligations of Each Party"
    },
    {
      "section": "conditions_to_closing",
      "field_name": "target_shareholder_approval_threshold",
      "answer": "majority of the outstanding shares of Company Common Stock entitled to vote thereon",
      "summary": "The adoption of the Agreement requires the affirmative vote of at least a majority of the outstanding shares of Company Common Stock entitled to vote.",
      "confidence": 0.95,
      "reason": "The document explicitly states the threshold for shareholder approval as a majority of the outstanding shares entitled to vote.",
      "clause_text": "Assuming the accuracy of Parent's and Merger Sub's representations and warranties in Section 4.24, the adoption of this Agreement by the affirmative vote of the holders of at least a majority of the outstanding shares of Company Common Stock entitled to vote thereon at the Company Stockholders' Meeting (the 'Company Stockholder Approval') is the only vote of holders of securities of the Company that is required in connection with the consummation by the Company of the transactions contemplated by this Agreement;",
      "reference_section": "ARTICLE Article III REPRESENTATIONS AND WARRANTIES OF THE COMPANY > Section 3.4 Vote Required"
    },
    {
      "section": "conditions_to_closing",
      "field_name": "hsr_clearance_required",
      "answer": true,
      "summary": "The agreement specifies that HSR Act clearance is required for the consummation of the Merger.",
      "confidence": 1.0,
      "reason": "The clause explicitly states that any applicable waiting period under the HSR Act must have expired or early termination thereof must have been granted.",
      "clause_text": "any applicable waiting period (and any extension thereof) under the HSR Act relating to the consummation of the Merger shall have expired or early termination thereof shall have been granted (the \"Required Regulatory Approval\");",
      "reference_section": "ARTICLE Article VI CONDITIONS TO THE MERGER > Section 6.1 Conditions to the Obligations of Each Party > (d)"
    },
    {
      "section": "conditions_to_closing",
      "field_name": "other_customary_conditions",
      "answer": [
        "Company Stockholder Approval obtained",
        "Parent Share Issuance approved for listing on NYSE",
        "Form F-4 effective under the Securities Act",
        "Expiration or early termination of waiting period under HSR Act",
        "No Governmental Authority issued Order prohibiting the Merger"
      ],
      "summary": "The obligations of each party to consummate the Merger are subject to customary conditions including stockholder approval, listing approval, effectiveness of registration statements, regulatory approval, and absence of prohibitive governmental orders.",
      "confidence": 0.95,
      "reason": "The conditions listed are standard requirements for closing a merger, as they include regulatory approvals and absence of legal prohibitions.",
      "clause_text": "The respective obligations of each party to consummate the Merger are subject to the satisfaction or (to the extent permitted by Law) waiver by the Company and Parent at or prior to the Closing of the following conditions: (a) the Company shall have obtained the Company Stockholder Approval; (b) the Parent Share Issuance shall have been approved for listing on the NYSE, subject to official notice of issuance; (c) the Form F-4 shall have become effective under the Securities Act and shall not be the subject of any stop order or any Proceedings by or before the SEC seeking a stop order; (d) any applicable waiting period (and any extension thereof) under the HSR Act relating to the consummation of the Merger shall have expired or early termination thereof shall have been granted (the \"Required Regulatory Approval\"); and (e) no Governmental Authority of competent jurisdiction shall have issued or entered any Order after the date of this Agreement, and no Law shall have been enacted or promulgated after the date of this Agreement, in each case, that (whether temporary or permanent) is then in effect and has the effect of enjoining or otherwise prohibiting the consummation of the Merger (a \"Restraint\").",
      "reference_section": "ARTICLE Article VI CONDITIONS TO THE MERGER > Section 6.1 Conditions to the Obligations of Each Party"
    },
    {
      "section": "conditions_to_closing",
      "field_name": "financial_conditions_minimum_cash_threshold",
      "answer": "Not found",
      "summary": "",
      "confidence": 1.0,
      "reason": "",
      "clause_text": "",
      "reference_section": ""
    },
    {
      "section": "conditions_to_closing",
      "field_name": "financial_conditions_maximum_net_debt",
      "answer": "Not found",
      "summary": "",
      "confidence": 1.0,
      "reason": "",
      "clause_text": "",
      "reference_section": ""
    },
    {
      "section": "conditions_to_closing",
      "field_name": "financial_conditions_minimum_any_condition",
      "answer": "Not found",
      "summary": "",
      "confidence": 1.0,
      "reason": "",
      "clause_text": "",
      "reference_section": ""
    },
    {
      "section": "conditions_to_closing",
      "field_name": "tax_conditions_tax_opinion_required",
      "answer": "Not found",
      "summary": "",
      "confidence": 1.0,
      "reason": "",
      "clause_text": "",
      "reference_section": ""
    }
  ],
  "material_adverse_effect": {
    "mae_carveout": [
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_general_economic_conditions_included",
        "answer": true,
        "summary": "The MAE definition excludes adverse effects resulting from actions taken by the Company at the express written request of the Parent.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that any action taken at the express written request of the Parent is excluded from constituting a Material Adverse Effect.",
        "clause_text": "any action taken or (to the extent the relevant action is expressly permitted by the terms of this Agreement) not taken at the express written request of the Company (in the case of Parent) or Parent (in the case of the Company) after the date of this Agreement;",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_general_economic_conditions_explanation",
        "answer": "Adverse effects resulting from general economic conditions are excluded from the definition of Material Adverse Effect.",
        "summary": "The clause specifies that changes in general economic, financial market, regulatory, business, financial, political, geopolitical, credit or capital market conditions, including interest or exchange rates, tariffs and trade wars, shall not be taken into account in determining whether a Material Adverse Effect has occurred.",
        "confidence": 0.95,
        "reason": "The clause explicitly lists changes in general economic conditions as exclusions from the Material Adverse Effect definition.",
        "clause_text": "Material Adverse Effect shall mean, with respect to Parent or the Company, any event, circumstance, occurrence, effect, fact, development or change that, individually or in the aggregate, has a material adverse effect on the business, financial condition or results of operations of such Person and its Subsidiaries, taken as a whole; provided that none of the following (or the results thereof) shall constitute or be taken into account in determining whether a Material Adverse Effect shall have occurred: (i) changes in general economic, financial market, regulatory, business, financial, political, geopolitical, credit or capital market conditions, including interest or exchange rates, tariffs and trade wars;",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_industry_conditions_included",
        "answer": true,
        "summary": "The MAE definition explicitly excludes general changes or developments in any of the industries or markets in which the Company operates from constituting a Material Adverse Effect.",
        "confidence": 1.0,
        "reason": "The clause explicitly states that general changes or developments in any of the industries or markets in which the Company operates shall not constitute a Material Adverse Effect.",
        "clause_text": "Material Adverse Effect shall mean, with respect to Parent or the Company, any event, circumstance, occurrence, effect, fact, development or change that, individually or in the aggregate, has a material adverse effect on the business, financial condition or results of operations of such Person and its Subsidiaries, taken as a whole; provided that none of the following (or the results thereof) shall constitute or be taken into account in determining whether a Material Adverse Effect shall have occurred: (i) changes in general economic, financial market, regulatory, business, financial, political, geopolitical, credit or capital market conditions, including interest or exchange rates, tariffs and trade wars; (ii) general changes or developments in any of the industries or markets in which such Person or any of its Subsidiaries operate;",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_industry_conditions_explanation",
        "answer": "changes in general economic, financial market, regulatory, business, financial, political, geopolitical, credit or capital market conditions, including interest or exchange rates, tariffs and trade wars; (ii) general changes or developments in any of the industries or markets in which such Person or any of its Subsidiaries operate;",
        "summary": "The MAE definition excludes changes in general economic conditions and developments in the industries where the Company operates.",
        "confidence": 0.9,
        "reason": "The clause explicitly excludes general industry changes from constituting a Material Adverse Effect.",
        "clause_text": "Material Adverse Effect shall mean, with respect to Parent or the Company, any event, circumstance, occurrence, effect, fact, development or change that, individually or in the aggregate, has a material adverse effect on the business, financial condition or results of operations of such Person and its Subsidiaries, taken as a whole; provided that none of the following (or the results thereof) shall constitute or be taken into account in determining whether a Material Adverse Effect shall have occurred: (i) changes in general economic, financial market, regulatory, business, financial, political, geopolitical, credit or capital market conditions, including interest or exchange rates, tariffs and trade wars; (ii) general changes or developments in any of the industries or markets in which such Person or any of its Subsidiaries operate;",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_stock_price_changes_included",
        "answer": true,
        "summary": "The MAE definition explicitly excludes changes in the price or trading volume of the Company's securities from constituting a Material Adverse Effect.",
        "confidence": 1.0,
        "reason": "The clause explicitly states that changes in the price or trading volume of the Company's securities shall not constitute a Material Adverse Effect.",
        "clause_text": "any change in the price or trading volume of such Person's securities or other financial instruments or change in such Person's credit rating, in and of itself (provided that the facts or occurrences giving rise to or contributing to such change that are not otherwise excluded from the definition of 'Material Adverse Effect' may constitute or be taken into account in determining whether a Material Adverse Effect has occurred);",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_stock_price_changes_explanation",
        "answer": "changes in the price or trading volume of such Person's securities or other financial instruments or change in such Person's credit rating, in and of itself (provided that the facts or occurrences giving rise to or contributing to such change that are not otherwise excluded from the definition of 'Material Adverse Effect' may constitute or be taken into account in determining whether a Material Adverse Effect has occurred)",
        "summary": "The clause excludes changes in the price or trading volume of a company's securities or credit rating from being considered a Material Adverse Effect, unless the underlying facts causing these changes are not otherwise excluded.",
        "confidence": 0.95,
        "reason": "The clause explicitly states that changes in stock price or trading volume are not considered a Material Adverse Effect unless the underlying causes are not excluded.",
        "clause_text": "changes in the price or trading volume of such Person's securities or other financial instruments or change in such Person's credit rating, in and of itself (provided that the facts or occurrences giving rise to or contributing to such change that are not otherwise excluded from the definition of 'Material Adverse Effect' may constitute or be taken into account in determining whether a Material Adverse Effect has occurred)",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_credit_rating_changes_included",
        "answer": true,
        "summary": "The MAE definition explicitly excludes changes in credit ratings from constituting a Material Adverse Effect.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that a change in credit rating, in and of itself, shall not constitute a Material Adverse Effect.",
        "clause_text": "Material Adverse Effect shall mean, with respect to Parent or the Company, any event, circumstance, occurrence, effect, fact, development or change that, individually or in the aggregate, has a material adverse effect on the business, financial condition or results of operations of such Person and its Subsidiaries, taken as a whole; provided that none of the following (or the results thereof) shall constitute or be taken into account in determining whether a Material Adverse Effect shall have occurred: ... (iv) any change in the price or trading volume of such Person's securities or other financial instruments or change in such Person's credit rating, in and of itself (provided that the facts or occurrences giving rise to or contributing to such change that are not otherwise excluded from the definition of 'Material Adverse Effect' may constitute or be taken into account in determining whether a Material Adverse Effect has occurred);",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_credit_rating_changes_explanation",
        "answer": "Changes in credit ratings are excluded from the definition of Material Adverse Effect.",
        "summary": "The clause specifies that changes in a person's credit rating, in and of itself, shall not constitute a Material Adverse Effect.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that changes in credit rating are excluded from being considered a Material Adverse Effect.",
        "clause_text": "any change in the price or trading volume of such Person's securities or other financial instruments or change in such Person's credit rating, in and of itself (provided that the facts or occurrences giving rise to or contributing to such change that are not otherwise excluded from the definition of 'Material Adverse Effect' may constitute or be taken into account in determining whether a Material Adverse Effect has occurred);",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_legal_or_regulatory_changes_included",
        "answer": true,
        "summary": "The MAE definition explicitly excludes changes in laws, regulations, GAAP, or accounting principles from constituting a Material Adverse Effect.",
        "confidence": 1.0,
        "reason": "The clause explicitly states that changes in laws or GAAP shall not constitute a Material Adverse Effect.",
        "clause_text": "Material Adverse Effect shall mean, with respect to Parent or the Company, any event, circumstance, occurrence, effect, fact, development or change that, individually or in the aggregate, has a material adverse effect on the business, financial condition or results of operations of such Person and its Subsidiaries, taken as a whole; provided that none of the following (or the results thereof) shall constitute or be taken into account in determining whether a Material Adverse Effect shall have occurred: (i) changes in general economic, financial market, regulatory, business, financial, political, geopolitical, credit or capital market conditions, including interest or exchange rates, tariffs and trade wars; (ii) general changes or developments in any of the industries or markets in which such Person or any of its Subsidiaries operate; (iii) (A) adoption, implementation, repeal, modification or amendment of any applicable Laws or (B) changes in GAAP, or in the case of each of clause (A) and (B), any proposal therefor or change in interpretations or enforcement thereof;",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_legal_or_regulatory_changes_explanation",
        "answer": "changes in general economic, financial market, regulatory, business, financial, political, geopolitical, credit or capital market conditions, including interest or exchange rates, tariffs and trade wars; (ii) general changes or developments in any of the industries or markets in which such Person or any of its Subsidiaries operate; (iii) (A) adoption, implementation, repeal, modification or amendment of any applicable Laws or (B) changes in GAAP, or in the case of each of clause (A) and (B), any proposal therefor or change in interpretations or enforcement thereof;",
        "summary": "The clause excludes changes in laws, regulations, GAAP, or accounting principles from the definition of Material Adverse Effect.",
        "confidence": 0.95,
        "reason": "The clause explicitly states that changes in laws, regulations, GAAP, or accounting principles are excluded from the definition of Material Adverse Effect.",
        "clause_text": "Material Adverse Effect shall mean, with respect to Parent or the Company, any event, circumstance, occurrence, effect, fact, development or change that, individually or in the aggregate, has a material adverse effect on the business, financial condition or results of operations of such Person and its Subsidiaries, taken as a whole; provided that none of the following (or the results thereof) shall constitute or be taken into account in determining whether a Material Adverse Effect shall have occurred: (i) changes in general economic, financial market, regulatory, business, financial, political, geopolitical, credit or capital market conditions, including interest or exchange rates, tariffs and trade wars; (ii) general changes or developments in any of the industries or markets in which such Person or any of its Subsidiaries operate; (iii) (A) adoption, implementation, repeal, modification or amendment of any applicable Laws or (B) changes in GAAP, or in the case of each of clause (A) and (B), any proposal therefor or change in interpretations or enforcement thereof;",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_force_majeure_events_included",
        "answer": true,
        "summary": "The MAE definition explicitly excludes acts of God, natural disasters, and weather events from constituting a Material Adverse Effect.",
        "confidence": 1.0,
        "reason": "The clause explicitly states that weather-related events, natural disasters, and acts of God shall not constitute a Material Adverse Effect.",
        "clause_text": "Material Adverse Effect shall mean, with respect to Parent or the Company, any event, circumstance, occurrence, effect, fact, development or change that, individually or in the aggregate, has a material adverse effect on the business, financial condition or results of operations of such Person and its Subsidiaries, taken as a whole; provided that none of the following (or the results thereof) shall constitute or be taken into account in determining whether a Material Adverse Effect shall have occurred: ... (vi) acts of war (whether or not declared), hostilities, military actions or acts of terrorism, cyberterrorism (to the extent not specifically targeting such Person), or any escalation or worsening of the foregoing, weather related events, fires, natural disasters, epidemics, pandemics, plagues or other outbreaks of illness or disease or public health events (including COVID-19) or any other acts of God;",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_force_majeure_events_explanation",
        "answer": "acts of war (whether or not declared), hostilities, military actions or acts of terrorism, cyberterrorism (to the extent not specifically targeting such Person), or any escalation or worsening of the foregoing, weather related events, fires, natural disasters, epidemics, pandemics, plagues or other outbreaks of illness or disease or public health events (including COVID-19) or any other acts of God",
        "summary": "The definition of Material Adverse Effect excludes acts of God, natural disasters, weather-related events, and similar occurrences.",
        "confidence": 0.95,
        "reason": "The clause explicitly lists acts of God, natural disasters, and weather-related events as exclusions from the definition of Material Adverse Effect.",
        "clause_text": "acts of war (whether or not declared), hostilities, military actions or acts of terrorism, cyberterrorism (to the extent not specifically targeting such Person), or any escalation or worsening of the foregoing, weather related events, fires, natural disasters, epidemics, pandemics, plagues or other outbreaks of illness or disease or public health events (including COVID-19) or any other acts of God",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_political_events_or_war_included",
        "answer": true,
        "summary": "The MAE definition explicitly excludes acts of war, terrorism, military conflict, or geopolitical instability from constituting a Material Adverse Effect.",
        "confidence": 1.0,
        "reason": "The clause explicitly states that acts of war, hostilities, military actions, or acts of terrorism shall not constitute a Material Adverse Effect.",
        "clause_text": "Material Adverse Effect shall mean, with respect to Parent or the Company, any event, circumstance, occurrence, effect, fact, development or change that, individually or in the aggregate, has a material adverse effect on the business, financial condition or results of operations of such Person and its Subsidiaries, taken as a whole; provided that none of the following (or the results thereof) shall constitute or be taken into account in determining whether a Material Adverse Effect shall have occurred: (vi) acts of war (whether or not declared), hostilities, military actions or acts of terrorism, cyberterrorism (to the extent not specifically targeting such Person), or any escalation or worsening of the foregoing...",
        "reference_section": "Definition > Material Adverse Effect > (vi)"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_political_events_or_war_explanation",
        "answer": "acts of war (whether or not declared), hostilities, military actions or acts of terrorism, cyberterrorism (to the extent not specifically targeting such Person), or any escalation or worsening of the foregoing",
        "summary": "The clause excludes acts of war, terrorism, armed conflict, or political instability from the Material Adverse Effect definition.",
        "confidence": 0.95,
        "reason": "The clause explicitly lists acts of war, terrorism, and related events as exclusions from the Material Adverse Effect definition.",
        "clause_text": "acts of war (whether or not declared), hostilities, military actions or acts of terrorism, cyberterrorism (to the extent not specifically targeting such Person), or any escalation or worsening of the foregoing",
        "reference_section": "Definition > Material Adverse Effect > (vi)"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_pandemic_health_events_included",
        "answer": true,
        "summary": "The MAE definition explicitly excludes pandemics, epidemics, or public health emergencies, including COVID-19, from constituting a Material Adverse Effect.",
        "confidence": 1.0,
        "reason": "The clause explicitly lists epidemics, pandemics, plagues, or other outbreaks of illness or disease or public health events (including COVID-19) as exceptions to the Material Adverse Effect.",
        "clause_text": "Material Adverse Effect shall mean, with respect to Parent or the Company, any event, circumstance, occurrence, effect, fact, development or change that, individually or in the aggregate, has a material adverse effect on the business, financial condition or results of operations of such Person and its Subsidiaries, taken as a whole; provided that none of the following (or the results thereof) shall constitute or be taken into account in determining whether a Material Adverse Effect shall have occurred: ... (vi) acts of war (whether or not declared), hostilities, military actions or acts of terrorism, cyberterrorism (to the extent not specifically targeting such Person), or any escalation or worsening of the foregoing, weather related events, fires, natural disasters, epidemics, pandemics, plagues or other outbreaks of illness or disease or public health events (including COVID-19) or any other acts of God; ...",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_pandemic_health_events_explanation",
        "answer": "epidemics, pandemics, plagues or other outbreaks of illness or disease or public health events (including COVID-19) shall not constitute or be taken into account in determining whether a Material Adverse Effect shall have occurred",
        "summary": "Pandemics, epidemics, and public health emergencies, including COVID-19, are excluded from the definition of a Material Adverse Effect.",
        "confidence": 1.0,
        "reason": "The clause explicitly states that epidemics, pandemics, and public health events, including COVID-19, shall not constitute or be taken into account in determining a Material Adverse Effect.",
        "clause_text": "Material Adverse Effect shall mean, with respect to Parent or the Company, any event, circumstance, occurrence, effect, fact, development or change that, individually or in the aggregate, has a material adverse effect on the business, financial condition or results of operations of such Person and its Subsidiaries, taken as a whole; provided that none of the following (or the results thereof) shall constitute or be taken into account in determining whether a Material Adverse Effect shall have occurred: ... (vi) acts of war (whether or not declared), hostilities, military actions or acts of terrorism, cyberterrorism (to the extent not specifically targeting such Person), or any escalation or worsening of the foregoing, weather related events, fires, natural disasters, epidemics, pandemics, plagues or other outbreaks of illness or disease or public health events (including COVID-19) or any other acts of God;",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_agreement_compliance_effects_included",
        "answer": true,
        "summary": "The MAE definition explicitly excludes effects resulting from the execution, announcement, or consummation of the merger agreement from constituting a Material Adverse Effect.",
        "confidence": 0.95,
        "reason": "The clause explicitly states that the execution of the Agreement, the public announcement, pendency or consummation of the Merger shall not constitute a Material Adverse Effect.",
        "clause_text": "the execution of this Agreement, the public announcement, pendency or consummation of the Merger or the other transactions contemplated by this Agreement (including, to the extent resulting from the foregoing, any effect on any of such Person’s or any of its Subsidiaries’ relationships with their respective customers, suppliers or employees);",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_agreement_compliance_effects_explanation",
        "answer": "The execution of this Agreement, the public announcement, pendency or consummation of the Merger or the other transactions contemplated by this Agreement shall not constitute or be taken into account in determining whether a Material Adverse Effect has occurred.",
        "summary": "The effects resulting from the execution, announcement, or consummation of the merger agreement are excluded from the Material Adverse Effect definition.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that the execution and announcement of the merger agreement are excluded from the MAE definition.",
        "clause_text": "the execution of this Agreement, the public announcement, pendency or consummation of the Merger or the other transactions contemplated by this Agreement (including, to the extent resulting from the foregoing, any effect on any of such Person’s or any of its Subsidiaries’ relationships with their respective customers, suppliers or employees);",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_parent_actions_included",
        "answer": true,
        "summary": "The MAE definition excludes adverse effects caused by actions or omissions of the Parent or its Affiliates if taken at the express written request of the Company.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that any action taken or not taken at the express written request of the Company shall not constitute a Material Adverse Effect.",
        "clause_text": "any action taken or (to the extent the relevant action is expressly permitted by the terms of this Agreement) not taken at the express written request of the Company (in the case of Parent) or Parent (in the case of the Company) after the date of this Agreement;",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_parent_actions_explanation",
        "answer": "Adverse effects resulting from actions taken by the Company at the direction, request, or with the consent of the Parent or its Affiliates are excluded from the definition of Material Adverse Effect.",
        "summary": "The definition of Material Adverse Effect excludes any action taken or not taken at the express written request of the Parent.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that actions taken at the express written request of the Parent are excluded from being considered a Material Adverse Effect.",
        "clause_text": "any action taken or (to the extent the relevant action is expressly permitted by the terms of this Agreement) not taken at the express written request of the Company (in the case of Parent) or Parent (in the case of the Company) after the date of this Agreement;",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_projections_miss_included",
        "answer": true,
        "summary": "The MAE definition explicitly excludes failures to meet projections, forecasts, estimates, or internal budgets from constituting a Material Adverse Effect.",
        "confidence": 1.0,
        "reason": "The clause explicitly states that any failure to meet projections, budgets, plans, or forecasts shall not constitute a Material Adverse Effect.",
        "clause_text": "any failure by such Person to meet its internal or published projections, budgets, plans or forecasts of its revenues, earnings or other financial performance or results of operation or any published analyst or other third-party estimates or expectations of such Person's revenue, earnings or other financial performance or results of operations for any period, in and of itself (provided that the facts or occurrences giving rise to or contributing to such failure that are not otherwise excluded from the definition of 'Material Adverse Effect' may constitute or be taken into account in determining whether a Material Adverse Effect has occurred);",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_projections_miss_explanation",
        "answer": "changes in such Person's credit rating, in and of itself (provided that the facts or occurrences giving rise to or contributing to such change that are not otherwise excluded from the definition of 'Material Adverse Effect' may constitute or be taken into account in determining whether a Material Adverse Effect has occurred); (v) any failure by such Person to meet its internal or published projections, budgets, plans or forecasts of its revenues, earnings or other financial performance or results of operation or any published analyst or other third-party estimates or expectations of such Person's revenue, earnings or other financial performance or results of operations for any period, in and of itself (provided that the facts or occurrences giving rise to or contributing to such failure that are not otherwise excluded from the definition of 'Material Adverse Effect' may constitute or be taken into account in determining whether a Material Adverse Effect has occurred);",
        "summary": "The clause excludes failures to meet projections, forecasts, estimates, or internal budgets from constituting a Material Adverse Effect, unless the underlying facts or occurrences are not otherwise excluded.",
        "confidence": 0.95,
        "reason": "The clause explicitly states that failures to meet projections or forecasts do not constitute a Material Adverse Effect unless the underlying facts are not excluded.",
        "clause_text": "any failure by such Person to meet its internal or published projections, budgets, plans or forecasts of its revenues, earnings or other financial performance or results of operation or any published analyst or other third-party estimates or expectations of such Person's revenue, earnings or other financial performance or results of operations for any period, in and of itself (provided that the facts or occurrences giving rise to or contributing to such failure that are not otherwise excluded from the definition of 'Material Adverse Effect' may constitute or be taken into account in determining whether a Material Adverse Effect has occurred);",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_other_custom_items_present",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveout_other_custom_items",
        "answer": [
          {
            "label": "Identity of Company or Parent",
            "excerpt": "the identity of Company (in the case of Parent) or Parent (in the case of the Company) and, other than with respect to a representation or warranty contained in this Agreement to the extent that the purpose of such representation or warranty is to address the consequences resulting from the execution and delivery of this Agreement or the consummation of the Merger or the performance of obligations under this Agreement, the execution of this Agreement, the public announcement, pendency or consummation of the Merger or the other transactions contemplated by this Agreement (including, to the extent resulting from the foregoing, any effect on any of such Person’s or any of its Subsidiaries’ relationships with their respective customers, suppliers or employees)"
          },
          {
            "label": "Disclosed Matters",
            "excerpt": "any matter disclosed against a representation or warranty set forth in Article III in the Company Disclosure Letter (as it relates to the Company) or Article IV in the Parent Disclosure Letter in (as it relates to Parent)"
          }
        ],
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "mae_carveback": [
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveback_disproportionate_effects_included",
        "answer": true,
        "summary": "The MAE clause specifies that carve-outs are reintroduced if the Company is disproportionately affected compared to others in its industry.",
        "confidence": 0.95,
        "reason": "The clause explicitly states that exceptions do not apply if the events have a disproportionate impact on the Company relative to its industry.",
        "clause_text": "provided, further, that, the exceptions in clauses (i) through (iii) and (vi) shall not apply to the extent the events, circumstances, occurrences, effects, facts, developments or changes set forth in such clauses have a disproportionate impact on such Person and its Subsidiaries, taken as a whole, relative to the other participants in the industries in which such Person and its Subsidiaries operate.",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveback_disproportionate_effects_explanation",
        "answer": "The MAE definition includes a carve-back stating that carve-outs do not apply if such events disproportionately affect the Company or Parent relative to others in its industry.",
        "summary": "The MAE definition includes a carve-back for disproportionate impacts on the Company or Parent relative to industry participants.",
        "confidence": 0.95,
        "reason": "The clause explicitly states that exceptions do not apply if events have a disproportionate impact on the Company or Parent relative to industry participants.",
        "clause_text": "provided, further, that, the exceptions in clauses (i) through (iii) and (vi) shall not apply to the extent the events, circumstances, occurrences, effects, facts, developments or changes set forth in such clauses have a disproportionate impact on such Person and its Subsidiaries, taken as a whole, relative to the other participants in the industries in which such Person and its Subsidiaries operate.",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveback_additional_exceptions_included",
        "answer": true,
        "summary": "The MAE clause specifies carve-outs are reintroduced under specific conditions, such as when events have a disproportionate impact on the company relative to industry participants.",
        "confidence": 0.9,
        "reason": "The clause includes language that exceptions do not apply if events have a disproportionate impact on the company.",
        "clause_text": "provided, further, that, the exceptions in clauses (i) through (iii) and (vi) shall not apply to the extent the events, circumstances, occurrences, effects, facts, developments or changes set forth in such clauses have a disproportionate impact on such Person and its Subsidiaries, taken as a whole, relative to the other participants in the industries in which such Person and its Subsidiaries operate.",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveback_additional_exceptions_explanation",
        "answer": [
          "The exceptions in clauses (i) through (iii) and (vi) shall not apply to the extent the events, circumstances, occurrences, effects, facts, developments or changes set forth in such clauses have a disproportionate impact on such Person and its Subsidiaries, taken as a whole, relative to the other participants in the industries in which such Person and its Subsidiaries operate."
        ],
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveback_causation_based_analysis_included",
        "answer": true,
        "summary": "The MAE definition includes language indicating that underlying facts or occurrences contributing to certain excluded outcomes may be considered in determining a Material Adverse Effect.",
        "confidence": 1.0,
        "reason": "The clause explicitly states that facts or occurrences contributing to changes in stock price or failure to meet projections may be considered in determining an MAE.",
        "clause_text": "provided that the facts or occurrences giving rise to or contributing to such change that are not otherwise excluded from the definition of 'Material Adverse Effect' may constitute or be taken into account in determining whether a Material Adverse Effect has occurred",
        "reference_section": "Definition > Material Adverse Effect"
      },
      {
        "section": "material_adverse_effect",
        "field_name": "mae_carveback_causation_based_analysis_explanation",
        "answer": "The facts or occurrences giving rise to an excluded event may still be taken into account in determining whether a Material Adverse Effect has occurred, specifically for clauses (iv) and (v).",
        "summary": "The carve-back applies to changes in the price or trading volume of securities and failures to meet financial projections, allowing underlying facts to be considered for Material Adverse Effect.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that facts or occurrences contributing to changes in securities price or financial performance failures can be considered.",
        "clause_text": "provided that the facts or occurrences giving rise to or contributing to such change that are not otherwise excluded from the definition of 'Material Adverse Effect' may constitute or be taken into account in determining whether a Material Adverse Effect has occurred",
        "reference_section": "Definition > Material Adverse Effect"
      }
    ]
  },
  "non_solicitation": {
    "no_shop_clause": [
      {
        "section": "non_solicitation",
        "field_name": "no_shop_clause_included",
        "answer": true,
        "summary": "The agreement includes a 'No-Shop' clause that restricts the Company from soliciting or engaging in discussions regarding alternative acquisition proposals.",
        "confidence": 0.95,
        "reason": "The clause explicitly states that the Company shall not solicit or engage in discussions with third parties regarding any Acquisition Proposal.",
        "clause_text": "(i) the Company shall, and shall cause its Subsidiaries, and its and their respective officers and directors to, immediately cease, and shall instruct and use its reasonable best efforts to cause its and their respective other Representatives to immediately cease, and cause to be terminated all existing discussions, negotiations and communications with any Persons or entities with respect to any Acquisition Proposal (other than the transactions contemplated by this Agreement), (ii) the Company shall not, and shall not authorize, and shall use its reasonable best efforts not to permit, any of its Representatives to, directly or indirectly through another Person, (A) initiate, seek, solicit, knowingly facilitate, knowingly encourage (including by way of furnishing any non-public information) or knowingly induce or knowingly take any other action which would reasonably be expected to lead to an Acquisition Proposal, (B) engage in negotiations or discussions with, or provide any non-public information or non-public data to, any Person (other than Parent or any of its Representatives) relating to or for the purpose of encouraging or facilitating, any Acquisition Proposal or grant any waiver or release under any standstill, confidentiality or other similar agreement...",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.6 – No Solicitation by the Company > (a)"
      },
      {
        "section": "non_solicitation",
        "field_name": "no_shop_claus_explanation",
        "answer": "The Company is restricted from soliciting, initiating, or encouraging competing acquisition proposals and must cease all existing discussions and negotiations with third parties regarding any Acquisition Proposal, except as provided in specific sections. The Company must also terminate third-party access to any data rooms and demand the return or destruction of confidential information.",
        "summary": "The Company is prohibited from soliciting or engaging in discussions regarding competing acquisition proposals and must cease existing negotiations with third parties.",
        "confidence": 0.95,
        "reason": "The clause explicitly outlines restrictions on the Company's ability to engage with third parties regarding acquisition proposals.",
        "clause_text": "(a) From the date of this Agreement until the earlier of the Effective Time and the termination of this Agreement in accordance with Section 7.1, except as provided in Section 5.6(b) or Section 5.6(d), (i) the Company shall, and shall cause its Subsidiaries, and its and their respective officers and directors to, immediately cease, and shall instruct and use its reasonable best efforts to cause its and their respective other Representatives to immediately cease, and cause to be terminated all existing discussions, negotiations and communications with any Persons or entities with respect to any Acquisition Proposal (other than the transactions contemplated by this Agreement), (ii) the Company shall not, and shall not authorize, and shall use its reasonable best efforts not to permit, any of its Representatives to, directly or indirectly through another Person, (A) initiate, seek, solicit, knowingly facilitate, knowingly encourage (including by way of furnishing any non-public information) or knowingly induce or knowingly take any other action which would reasonably be expected to lead to an Acquisition Proposal, (B) engage in negotiations or discussions with, or provide any non-public information or non-public data to, any Person (other than Parent or any of its Representatives) relating to or for the purpose of encouraging or facilitating, any Acquisition Proposal or grant any waiver or release under any standstill, confidentiality or other similar agreement (except that if the Company Board determines in good faith that the failure to grant any waiver or release would be inconsistent with its fiduciary duties under applicable Law, the Company may waive any such standstill provision in order to permit a third party to make and pursue an Acquisition Proposal) or (C) resolve to do any of the foregoing, (iii) the Company shall not provide and shall, within one (1) Business Day of the date of this Agreement, terminate access of any third party to any data room (virtual or actual) which has been set up in the context of a possible Acquisition Proposal containing any information of the Company or any of its Subsidiaries and (iv) within one (1) Business Day of the date of this Agreement, the Company shall demand the return or destruction of all confidential, non-public information and materials that have been provided to third parties that have entered into confidentiality agreements relating to a possible Acquisition Proposal with the Company or any of its Subsidiaries.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.6 – No Solicitation by the Company > (a)"
      }
    ],
    "notice_of_competing_offer": [
      {
        "section": "non_solicitation",
        "field_name": "notice_of_competing_offer_included",
        "answer": true,
        "summary": "The agreement requires the Company to promptly notify the Parent of the receipt of any Acquisition Proposal, including providing a complete, unredacted copy of all related materials within twenty-four hours.",
        "confidence": 1.0,
        "reason": "The clause explicitly states that the Company shall promptly provide notice to Parent of the receipt of any Acquisition Proposal within twenty-four hours.",
        "clause_text": "The Company shall (A) promptly (and in any case within twenty-four (24) hours) provide Parent notice (I) of the receipt of any Acquisition Proposal, which notice shall include a complete, unredacted copy of all written proposals, written indications of interest or draft agreements relating to, or other written materials that describe any of the material terms and conditions of, such Acquisition Proposal.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.6 – No Solicitation by the Company > (b)"
      },
      {
        "section": "non_solicitation",
        "field_name": "notice_of_competing_offer_explanation",
        "answer": "The Company is required to notify the Parent of any Acquisition Proposal within twenty-four (24) hours, including providing a complete, unredacted copy of all written proposals and disclosing the identity of the other party and material terms.",
        "summary": "The Company must notify the Parent of any Acquisition Proposal within 24 hours, including providing copies of written proposals and disclosing party identities and material terms.",
        "confidence": 0.95,
        "reason": "The clause explicitly requires the Company to notify the Parent of any Acquisition Proposal within 24 hours, including sharing written proposals and party identities.",
        "clause_text": "The Company shall (A) promptly (and in any case within twenty-four (24) hours) provide Parent notice (I) of the receipt of any Acquisition Proposal, which notice shall include a complete, unredacted copy of all written proposals, written indications of interest or draft agreements relating to, or other written materials that describe any of the material terms and conditions of, such Acquisition Proposal, and (II) of any inquiries, proposals or offers received by, any requests for non-public information from, or any discussions or negotiations initiated or continued (or sought to be initiated or continued) with, the Company or any of its Representatives concerning an Acquisition Proposal, and disclose the identity of the other party (or parties) and the material terms of such inquiry, offer, proposal or request and, in the case of written materials that describe any of the material terms and conditions of such inquiry, offer, proposal or request, provide copies of such materials.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.6 – No Solicitation by the Company > (b)"
      }
    ],
    "ongoing_update": [
      {
        "section": "non_solicitation",
        "field_name": "ongoing_update_included",
        "answer": true,
        "summary": "The agreement requires the Company to keep Parent informed on a reasonably prompt basis of the status and material details of any Acquisition Proposal.",
        "confidence": 0.95,
        "reason": "The clause explicitly states that the Company shall keep Parent informed on a reasonably prompt basis of the status and material details of any Acquisition Proposal.",
        "clause_text": "The Company shall (A) promptly (and in any case within twenty-four (24) hours) provide Parent notice (I) of the receipt of any Acquisition Proposal, which notice shall include a complete, unredacted copy of all written proposals, written indications of interest or draft agreements relating to, or other written materials that describe any of the material terms and conditions of, such Acquisition Proposal, and (II) of any inquiries, proposals or offers received by, any requests for non-public information from, or any discussions or negotiations initiated or continued (or sought to be initiated or continued) with, the Company or any of its Representatives concerning an Acquisition Proposal, and disclose the identity of the other party (or parties) and the material terms of such inquiry, offer, proposal or request and, in the case of written materials that describe any of the material terms and conditions of such inquiry, offer, proposal or request, provide copies of such materials, (B) promptly (and in any case within twenty-four (24) hours) make available to Parent all material non-public information, including copies of all written materials relating to the Company and its Subsidiaries, made available by the Company to such party but not previously made available to Parent and (C) keep Parent informed on a reasonably prompt basis (and, in any case, within twenty-four (24) hours of any significant development) of the status and material details (including amendments and proposed amendments) of any such Acquisition Proposal or other inquiry, offer, proposal or request and providing to Parent copies of any additional or revised written proposals or written indications of interest or draft agreements relating to such Acquisition Proposal or other inquiry, offer, proposal or request, or other written materials that describe any of the material terms and conditions of such Acquisition Proposal or other inquiry, offer, proposal or request.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.6 – No Solicitation by the Company > (b)"
      },
      {
        "section": "non_solicitation",
        "field_name": "ongoing_update_explanation",
        "answer": "The Company is obligated to promptly provide updates to the Parent within twenty-four (24) hours regarding any Acquisition Proposal, including copies of all relevant written materials, and keep the Parent informed of any significant developments.",
        "summary": "The Company must promptly update the Parent within 24 hours of receiving any Acquisition Proposal, including providing copies of relevant documents and informing the Parent of significant developments.",
        "confidence": 0.9,
        "reason": "The clause specifies a 24-hour timeframe for notifying the Parent about Acquisition Proposals and significant developments.",
        "clause_text": "The Company shall (A) promptly (and in any case within twenty-four (24) hours) provide Parent notice (I) of the receipt of any Acquisition Proposal, which notice shall include a complete, unredacted copy of all written proposals, written indications of interest or draft agreements relating to, or other written materials that describe any of the material terms and conditions of, such Acquisition Proposal, and (II) of any inquiries, proposals or offers received by, any requests for non-public information from, or any discussions or negotiations initiated or continued (or sought to be initiated or continued) with, the Company or any of its Representatives concerning an Acquisition Proposal, and disclose the identity of the other party (or parties) and the material terms of such inquiry, offer, proposal or request and, in the case of written materials that describe any of the material terms and conditions of such inquiry, offer, proposal or request, provide copies of such materials, (B) promptly (and in any case within twenty-four (24) hours) make available to Parent all material non-public information, including copies of all written materials relating to the Company and its Subsidiaries, made available by the Company to such party but not previously made available to Parent and (C) keep Parent informed on a reasonably prompt basis (and, in any case, within twenty-four (24) hours of any significant development) of the status and material details (including amendments and proposed amendments) of any such Acquisition Proposal or other inquiry, offer, proposal or request and providing to Parent copies of any additional or revised written proposals or written indications of interest or draft agreements relating to such Acquisition Proposal or other inquiry, offer, proposal or request, or other written materials that describe any of the material terms and conditions of such Acquisition Proposal or other inquiry, offer, proposal or request.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.6 – No Solicitation by the Company > (b)"
      }
    ],
    "superior_proposal_engagement": [
      {
        "section": "non_solicitation",
        "field_name": "superior_proposal_engagement_included",
        "answer": true,
        "summary": "The agreement permits the Company to engage in discussions or negotiations with a third party that submits a Superior Proposal, under certain conditions.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that the Company may negotiate and participate in discussions with a third party if the Company Board determines in good faith that the Acquisition Proposal is likely to constitute a Superior Proposal.",
        "clause_text": "Notwithstanding Section 5.6(a), at any time prior to obtaining the Company Stockholder Approval, if, after the date of this Agreement, the Company receives a bona fide written Acquisition Proposal from a third party that was not initiated, sought, solicited, knowingly facilitated, knowingly encouraged, knowingly induced or otherwise procured in violation, in any non-de minimis respect, of this Agreement, then the Company may (i) contact the Person or any of its Representatives who has made such Acquisition Proposal solely to clarify the terms of such Acquisition Proposal so that the Company Board (or any committee thereof) may inform itself about such Acquisition Proposal, (ii) furnish information concerning its business, properties or assets to such Person or any of its Representatives pursuant to a confidentiality agreement with confidentiality terms that, taken as a whole, are not materially less favorable to the Company than those contained in the Confidentiality Agreement ... and (iii) negotiate and participate in discussions and negotiations with such Person or any of its Representatives concerning such Acquisition Proposal, in the case of clauses (ii) and (iii), if the Company Board determines in good faith, after consultation with outside financial advisors and outside legal counsel, that such Acquisition Proposal constitutes or is reasonably likely to constitute or result in a Superior Proposal.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.6 – No Solicitation by the Company > (b)"
      },
      {
        "section": "non_solicitation",
        "field_name": "superior_proposal_engagement_explanation",
        "answer": "The Company is authorized to engage with third parties if a Superior Proposal is received, provided the Company Board determines in good faith that such proposal constitutes or is reasonably likely to constitute a Superior Proposal.",
        "summary": "The Company may negotiate or share information with third parties if a Superior Proposal is received, based on the Company Board's good faith determination.",
        "confidence": 0.9,
        "reason": "The clause explicitly allows the Company to engage with third parties if the Company Board determines in good faith that an Acquisition Proposal is or is likely to be a Superior Proposal.",
        "clause_text": "Notwithstanding Section 5.6(a), at any time prior to obtaining the Company Stockholder Approval, if, after the date of this Agreement, the Company receives a bona fide written Acquisition Proposal from a third party that was not initiated, sought, solicited, knowingly facilitated, knowingly encouraged, knowingly induced or otherwise procured in violation, in any non-de minimis respect, of this Agreement, then the Company may (i) contact the Person or any of its Representatives who has made such Acquisition Proposal solely to clarify the terms of such Acquisition Proposal so that the Company Board (or any committee thereof) may inform itself about such Acquisition Proposal, (ii) furnish information concerning its business, properties or assets to such Person or any of its Representatives pursuant to a confidentiality agreement with confidentiality terms that, taken as a whole, are not materially less favorable to the Company than those contained in the Confidentiality Agreement... and (iii) negotiate and participate in discussions and negotiations with such Person or any of its Representatives concerning such Acquisition Proposal, in the case of clauses (ii) and (iii), if the Company Board determines in good faith, after consultation with outside financial advisors and outside legal counsel, that such Acquisition Proposal constitutes or is reasonably likely to constitute or result in a Superior Proposal.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.6 – No Solicitation by the Company > (b)"
      }
    ],
    "match_right": [
      {
        "section": "non_solicitation",
        "field_name": "match_right_initial_included",
        "answer": true,
        "summary": "The agreement grants the buyer a right to match an initial Superior Proposal received by the target.",
        "confidence": 0.9,
        "reason": "The agreement provides a negotiation period for the buyer to propose modifications to the terms in response to a Superior Proposal.",
        "clause_text": "for a period of four (4) Business Days following the notice delivered pursuant to clause (A) of this Section 5.6(d), the Company shall have discussed and negotiated in good faith (in each case only if Parent desires to negotiate) with Parent's Representatives any proposed modifications to the terms and conditions of this Agreement or the transactions contemplated by this Agreement so that the Acquisition Proposal is no longer a Superior Proposal",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.6 – No Solicitation by the Company > (d)"
      },
      {
        "section": "non_solicitation",
        "field_name": "match_right_initial_explanation",
        "answer": "The Company has provided Parent a copy of the proposed definitive agreements and other proposed transaction documentation between the Company and the Person making such Superior Proposal, if any, (C) for a period of four (4) Business Days following the notice delivered pursuant to clause (A) of this Section 5.6(d), the Company shall have discussed and negotiated in good faith (in each case only if Parent desires to negotiate) with Parent's Representatives any proposed modifications to the terms and conditions of this Agreement or the transactions contemplated by this Agreement so that the Acquisition Proposal is no longer a Superior Proposal.",
        "summary": "The Company must provide Parent with proposed agreements and negotiate in good faith for four business days to modify the terms so the Acquisition Proposal is no longer superior.",
        "confidence": 0.95,
        "reason": "The clause explicitly outlines the negotiation period and conditions for modifying the agreement after receiving a Superior Proposal.",
        "clause_text": "The Company has provided Parent a copy of the proposed definitive agreements and other proposed transaction documentation between the Company and the Person making such Superior Proposal, if any, (C) for a period of four (4) Business Days following the notice delivered pursuant to clause (A) of this Section 5.6(d), the Company shall have discussed and negotiated in good faith (in each case only if Parent desires to negotiate) with Parent's Representatives any proposed modifications to the terms and conditions of this Agreement or the transactions contemplated by this Agreement so that the Acquisition Proposal is no longer a Superior Proposal.",
        "reference_section": "ARTICLE Article V COVENANTS AND AGREEMENTS > Section 5.6 No Solicitation by the Company > (d)"
      },
      {
        "section": "non_solicitation",
        "field_name": "match_right_amended_included",
        "answer": true,
        "summary": "The agreement explicitly provides the buyer a renewed right to match if the third party modifies or improves its Superior Proposal after the initial match notice.",
        "confidence": 0.9,
        "reason": "The clause states that any amendment to any material term or condition of any Superior Proposal shall require a new notice and a new negotiation period.",
        "clause_text": "it being understood and agreed that any amendment to any material term or condition of any Superior Proposal shall require a new notice and a new negotiation period that shall expire on the later to occur of (I) two (2) Business Days following delivery of such new notice from the Company to Parent and (II) the expiration of the original four (4)-Business Day period described in this clause (C)",
        "reference_section": "ARTICLE Article V COVENANTS AND AGREEMENTS > Section 5.6 No Solicitation by the Company > (d)"
      },
      {
        "section": "non_solicitation",
        "field_name": "match_right_amended_explanation",
        "answer": "The agreement permits the Buyer to respond to a modified or revised Superior Proposal by providing a new notice and a new negotiation period that shall expire on the later to occur of two (2) Business Days following delivery of such new notice from the Company to Parent and the expiration of the original four (4)-Business Day period.",
        "summary": "The Buyer is allowed to respond to a modified Superior Proposal with a new notice and negotiation period, extending up to two additional business days.",
        "confidence": 0.9,
        "reason": "The clause explicitly mentions the requirement for a new notice and negotiation period if there is an amendment to a Superior Proposal.",
        "clause_text": "it being understood and agreed that any amendment to any material term or condition of any Superior Proposal shall require a new notice and a new negotiation period that shall expire on the later to occur of (I) two (2) Business Days following delivery of such new notice from the Company to Parent and (II) the expiration of the original four (4)-Business Day period described in this clause (C)",
        "reference_section": "ARTICLE Article V COVENANTS AND AGREEMENTS > Section 5.6 No Solicitation by the Company > (d)"
      }
    ],
    "adverse_recommendation_change": [
      {
        "section": "non_solicitation",
        "field_name": "adverse_recommendation_change_superior_proposal_included",
        "answer": true,
        "summary": "The board of directors is permitted to change its recommendation in response to a Superior Proposal.",
        "confidence": 1.0,
        "reason": "The document explicitly states that the Company Board may effect an Adverse Recommendation Change if it receives a bona fide written Acquisition Proposal that constitutes a Superior Proposal.",
        "clause_text": "If, after the date of this Agreement and prior to the receipt of the Company Stockholder Approval, the Company Board receives a bona fide written Acquisition Proposal that the Company Board determines in good faith, after consultation with its outside financial advisors and outside legal counsel, constitutes a Superior Proposal... the Company Board may (i) effect an Adverse Recommendation Change...",
        "reference_section": "ARTICLE Article V COVENANTS AND AGREEMENTS > Section 5.6 No Solicitation by the Company > (d)"
      },
      {
        "section": "non_solicitation",
        "field_name": "adverse_recommendation_change_superior_proposal_explanation",
        "answer": "The Company Board is permitted to change its recommendation in response to a Superior Proposal.",
        "summary": "The Company Board may effect an Adverse Recommendation Change if it receives a bona fide written Acquisition Proposal that constitutes a Superior Proposal, determined in good faith after consultation with financial and legal advisors.",
        "confidence": 0.95,
        "reason": "The clause explicitly allows the Company Board to change its recommendation in response to a Superior Proposal, subject to good faith determination and consultation with advisors.",
        "clause_text": "If, after the date of this Agreement and prior to the receipt of the Company Stockholder Approval, the Company Board receives a bona fide written Acquisition Proposal that the Company Board determines in good faith, after consultation with its outside financial advisors and outside legal counsel, constitutes a Superior Proposal that was not initiated, sought, solicited, knowingly facilitated, knowingly encouraged, knowingly induced or otherwise procured in violation, in any non-de minimis respect, of this Agreement, the Company Board may (i) effect an Adverse Recommendation Change or (ii) cause the Company to terminate this Agreement pursuant to Section 7.1(c)(ii) in order to enter into a definitive agreement providing for such Superior Proposal...",
        "reference_section": "ARTICLE Article V COVENANTS AND AGREEMENTS > Section 5.6 No Solicitation by the Company > (d)"
      },
      {
        "section": "non_solicitation",
        "field_name": "adverse_recommendation_change_intervening_event_included",
        "answer": true,
        "summary": "The Company Board is permitted to change its recommendation in response to an Intervening Event, provided certain conditions are met.",
        "confidence": 0.9,
        "reason": "The agreement explicitly allows the Company Board to make an Adverse Recommendation Change in response to an Intervening Event.",
        "clause_text": "Other than in connection with a Superior Proposal (which shall be subject to Section 5.6(d) and shall not be subject to this Section 5.6(e)), prior to obtaining the Company Stockholder Approval, the Company Board may, in response to an Intervening Event, take any action prohibited by clause (i) of Section 5.6(c), only if (i) the Company Board determines in good faith, after consultation with its outside financial advisors and outside legal counsel, that the failure to take such action would be inconsistent with its fiduciary duties under applicable Law...",
        "reference_section": "ARTICLE Article V COVENANTS AND AGREEMENTS > Section 5.6 No Solicitation by the Company > (e)"
      },
      {
        "section": "non_solicitation",
        "field_name": "adverse_recommendation_change_intervening_event_explanation",
        "answer": "The Company Board may, in response to an Intervening Event, take any action prohibited by clause (i) of Section 5.6(c), only if (i) the Company Board determines in good faith, after consultation with its outside financial advisors and outside legal counsel, that the failure to take such action would be inconsistent with its fiduciary duties under applicable Law, (ii) the Company has notified Parent in writing that the Company Board intends to effect such an Adverse Recommendation Change pursuant to this Section 5.6(e) (which notice shall specify the facts and circumstances providing the basis of the Intervening Event and for the Company Board's determination to effect such an Adverse Recommendation Change in reasonable detail), (iii) for a period of four (4) Business Days following the notice delivered pursuant to clause (ii) of this Section 5.6(e), the Company shall have discussed and negotiated in good faith (in each case only if Parent desires to negotiate) with Parent's Representatives any proposed modifications to the terms and conditions of this Agreement or the transactions contemplated by this Agreement so that the failure to take such action would no longer be inconsistent with the Company Board's fiduciary duties under applicable Law (it being understood and agreed that any material change to the relevant facts and circumstances shall require a new notice and a new negotiation period that shall expire on the later to occur of (A) two (2) Business Days following delivery of such new notice from the Company to Parent and (B) the expiration of the original four (4) Business Day period described above in this clause (iii)), and (iv) no earlier than the end of such negotiation period, the Company Board shall have determined in good faith, after consultation with its outside financial advisors and outside legal counsel, and after considering the terms of any proposed amendment or modification to this Agreement, that the failure to take such action would still be inconsistent with its fiduciary duties under applicable Law.",
        "summary": "The Company Board may change its recommendation due to an Intervening Event if it determines in good faith that not doing so would be inconsistent with its fiduciary duties, after notifying the Parent and negotiating potential modifications to the agreement.",
        "confidence": 0.95,
        "reason": "The clause explicitly allows for an Adverse Recommendation Change in response to an Intervening Event, subject to specific conditions and procedures.",
        "clause_text": "The Company Board may, in response to an Intervening Event, take any action prohibited by clause (i) of Section 5.6(c), only if (i) the Company Board determines in good faith, after consultation with its outside financial advisors and outside legal counsel, that the failure to take such action would be inconsistent with its fiduciary duties under applicable Law, (ii) the Company has notified Parent in writing that the Company Board intends to effect such an Adverse Recommendation Change pursuant to this Section 5.6(e) (which notice shall specify the facts and circumstances providing the basis of the Intervening Event and for the Company Board's determination to effect such an Adverse Recommendation Change in reasonable detail), (iii) for a period of four (4) Business Days following the notice delivered pursuant to clause (ii) of this Section 5.6(e), the Company shall have discussed and negotiated in good faith (in each case only if Parent desires to negotiate) with Parent's Representatives any proposed modifications to the terms and conditions of this Agreement or the transactions contemplated by this Agreement so that the failure to take such action would no longer be inconsistent with the Company Board's fiduciary duties under applicable Law (it being understood and agreed that any material change to the relevant facts and circumstances shall require a new notice and a new negotiation period that shall expire on the later to occur of (A) two (2) Business Days following delivery of such new notice from the Company to Parent and (B) the expiration of the original four (4) Business Day period described above in this clause (iii)), and (iv) no earlier than the end of such negotiation period, the Company Board shall have determined in good faith, after consultation with its outside financial advisors and outside legal counsel, and after considering the terms of any proposed amendment or modification to this Agreement, that the failure to take such action would still be inconsistent with its fiduciary duties under applicable Law.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.6 – No Solicitation by the Company > (e)"
      },
      {
        "section": "non_solicitation",
        "field_name": "adverse_recommendation_change_timing",
        "answer": "The Company must provide Parent with a written notice of its intent to make an Adverse Recommendation Change and engage in good faith negotiations for four (4) Business Days before making such a change.",
        "summary": "The Company must notify Parent in writing of its intent to make an Adverse Recommendation Change and engage in good faith negotiations for four (4) Business Days before proceeding.",
        "confidence": 0.95,
        "reason": "The clause specifies a four (4) Business Day negotiation period following written notice to Parent before an Adverse Recommendation Change can be made.",
        "clause_text": "If, after the date of this Agreement and prior to the receipt of the Company Stockholder Approval, the Company Board receives a bona fide written Acquisition Proposal that the Company Board determines in good faith, after consultation with its outside financial advisors and outside legal counsel, constitutes a Superior Proposal that was not initiated, sought, solicited, knowingly facilitated, knowingly encouraged, knowingly induced or otherwise procured in violation, in any non-de minimis respect, of this Agreement, the Company Board may (i) effect an Adverse Recommendation Change or (ii) cause the Company to terminate this Agreement pursuant to Section 7.1(c)(ii) in order to enter into a definitive agreement providing for such Superior Proposal if, in each case, (A) the Company has notified Parent in writing that the Company Board intends to effect an Adverse Recommendation Change pursuant to this Section 5.6(d) or terminate this Agreement pursuant to Section 7.1(c)(ii), (B) the Company has provided Parent a copy of the proposed definitive agreements and other proposed transaction documentation between the Company and the Person making such Superior Proposal, if any, (C) for a period of four (4) Business Days following the notice delivered pursuant to clause (A) of this Section 5.6(d), the Company shall have discussed and negotiated in good faith (in each case only if Parent desires to negotiate) with Parent's Representatives any proposed modifications to the terms and conditions of this Agreement or the transactions contemplated by this Agreement so that the Acquisition Proposal is no longer a Superior Proposal (it being understood and agreed that any amendment to any material term or condition of any Superior Proposal shall require a new notice and a new negotiation period that shall expire on the later to occur of (I) two (2) Business Days following delivery of such new notice from the Company to Parent and (II) the expiration of the original four (4)-Business Day period described in this clause (C)), and (D) no earlier than the end of such negotiation period, the Company Board shall have determined in good faith, after consultation with its outside financial advisors and outside legal counsel, and after considering the terms of any proposed amendment or modification to this Agreement, that the Acquisition Proposal that is the subject of the notice described in clause (B) above still constitutes a Superior Proposal; provided that any purported termination of this Agreement pursuant to this sentence shall be void and of no force and effect unless the Company shall have paid Merger Sub (or a United States Affiliate of Merger Sub as Merger Sub may designate) the Termination Amount in accordance with Section 7.3(a) prior to or substantially concurrently with such termination.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.6 – No Solicitation by the Company > (d)"
      }
    ],
    "go_shop": [
      {
        "section": "non_solicitation",
        "field_name": "go_shop_included",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "non_solicitation",
        "field_name": "go_shop_explanation",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "standstill_waiver_restriction": [
      {
        "section": "non_solicitation",
        "field_name": "standstill_waiver_restriction_included",
        "answer": false,
        "summary": "The agreement permits the Company to waive standstill provisions if the Company Board determines in good faith that not doing so would be inconsistent with its fiduciary duties.",
        "confidence": 0.9,
        "reason": "The clause explicitly allows the Company to waive standstill provisions under certain fiduciary duty considerations.",
        "clause_text": "except that if the Company Board determines in good faith that the failure to grant any waiver or release would be inconsistent with its fiduciary duties under applicable Law, the Company may waive any such standstill provision in order to permit a third party to make and pursue an Acquisition Proposal",
        "reference_section": "ARTICLE Article V COVENANTS AND AGREEMENTS > Section 5.6 No Solicitation by the Company > (a) > (ii) > (B)"
      },
      {
        "section": "non_solicitation",
        "field_name": "standstill_waiver_restriction_explanation",
        "answer": "The Company may waive any standstill provision if the Company Board determines in good faith that the failure to grant any waiver or release would be inconsistent with its fiduciary duties under applicable Law.",
        "summary": "The Company is restricted from waiving standstill agreements unless the Company Board determines in good faith that not doing so would breach its fiduciary duties.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that the Company can waive standstill provisions if the Board determines it is necessary to fulfill fiduciary duties.",
        "clause_text": "except that if the Company Board determines in good faith that the failure to grant any waiver or release would be inconsistent with its fiduciary duties under applicable Law, the Company may waive any such standstill provision in order to permit a third party to make and pursue an Acquisition Proposal",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.6 – No Solicitation by the Company > (a) > (ii) > (B)"
      }
    ],
    "superior_proposal": [
      {
        "section": "non_solicitation",
        "field_name": "superior_proposal_definition",
        "answer": "Superior Proposal shall mean a bona fide written Acquisition Proposal (provided that for purposes of this definition, references to 'twenty percent (20%) or more' in the definition of 'Acquisition Proposal' shall be deemed to be references to 'more than fifty percent (50%)'), which the Company Board determines in good faith (i) to be reasonably likely to be consummated if accepted and (ii) to be more favorable to the Company's stockholders than the Merger and the other transactions contemplated by this Agreement, in each case, taking into account at the time of determination all relevant circumstances, including the various legal, financial and regulatory aspects of the proposal, all the terms and conditions of such proposal and this Agreement, and any changes to the terms of this Agreement offered by Parent in response to such Acquisition Proposal.",
        "summary": "A 'Superior Proposal' is a bona fide written Acquisition Proposal deemed by the Company Board to be more favorable to stockholders than the current Merger, considering legal, financial, and regulatory aspects.",
        "confidence": 1.0,
        "reason": "The definition explicitly outlines the criteria for a 'Superior Proposal', including financial and non-financial elements.",
        "clause_text": "Superior Proposal shall mean a bona fide written Acquisition Proposal (provided that for purposes of this definition, references to 'twenty percent (20%) or more' in the definition of 'Acquisition Proposal' shall be deemed to be references to 'more than fifty percent (50%)'), which the Company Board determines in good faith (i) to be reasonably likely to be consummated if accepted and (ii) to be more favorable to the Company's stockholders than the Merger and the other transactions contemplated by this Agreement, in each case, taking into account at the time of determination all relevant circumstances, including the various legal, financial and regulatory aspects of the proposal, all the terms and conditions of such proposal and this Agreement, and any changes to the terms of this Agreement offered by Parent in response to such Acquisition Proposal.",
        "reference_section": "Definition > Superior Proposal"
      }
    ],
    "buyer_diligence_access": [
      {
        "section": "non_solicitation",
        "field_name": "buyer_diligence_access_included",
        "answer": true,
        "summary": "The agreement grants the buyer the right to receive any diligence materials, data, or information that the target provides to a third party.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that the Company shall promptly make available to Parent all material non-public information made available to a third party.",
        "clause_text": "The Company shall (A) promptly (and in any case within twenty-four (24) hours) provide Parent notice (I) of the receipt of any Acquisition Proposal, which notice shall include a complete, unredacted copy of all written proposals, written indications of interest or draft agreements relating to, or other written materials that describe any of the material terms and conditions of, such Acquisition Proposal, and (II) of any inquiries, proposals or offers received by, any requests for non-public information from, or any discussions or negotiations initiated or continued (or sought to be initiated or continued) with, the Company or any of its Representatives concerning an Acquisition Proposal, and disclose the identity of the other party (or parties) and the material terms of such inquiry, offer, proposal or request and, in the case of written materials that describe any of the material terms and conditions of such inquiry, offer, proposal or request, provide copies of such materials, (B) promptly (and in any case within twenty-four (24) hours) make available to Parent all material non-public information, including copies of all written materials relating to the Company and its Subsidiaries, made available by the Company to such party but not previously made available to Parent.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.6 – No Solicitation by the Company > (b)"
      },
      {
        "section": "non_solicitation",
        "field_name": "buyer_diligence_access_explanation",
        "answer": "The Company shall promptly (and in any case within twenty-four (24) hours) make available to Parent all material non-public information, including copies of all written materials relating to the Company and its Subsidiaries, made available by the Company to such party but not previously made available to Parent.",
        "summary": "The Company is obligated to provide Parent with all material non-public information shared with a third party in connection with an Acquisition Proposal within 24 hours.",
        "confidence": 0.95,
        "reason": "The clause explicitly states the Company's obligation to make available to Parent all material non-public information shared with a third party.",
        "clause_text": "The Company shall (A) promptly (and in any case within twenty-four (24) hours) provide Parent notice (I) of the receipt of any Acquisition Proposal, which notice shall include a complete, unredacted copy of all written proposals, written indications of interest or draft agreements relating to, or other written materials that describe any of the material terms and conditions of, such Acquisition Proposal, and (II) of any inquiries, proposals or offers received by, any requests for non-public information from, or any discussions or negotiations initiated or continued (or sought to be initiated or continued) with, the Company or any of its Representatives concerning an Acquisition Proposal, and disclose the identity of the other party (or parties) and the material terms of such inquiry, offer, proposal or request and, in the case of written materials that describe any of the material terms and conditions of such inquiry, offer, proposal or request, provide copies of such materials, (B) promptly (and in any case within twenty-four (24) hours) make available to Parent all material non-public information, including copies of all written materials relating to the Company and its Subsidiaries, made available by the Company to such party but not previously made available to Parent and (C) keep Parent informed on a reasonably prompt basis (and, in any case, within twenty-four (24) hours of any significant development) of the status and material details (including amendments and proposed amendments) of any such Acquisition Proposal or other inquiry, offer, proposal or request and providing to Parent copies of any additional or revised written proposals or written indications of interest or draft agreements relating to such Acquisition Proposal or other inquiry, offer, proposal or request, or other written materials that describe any of the material terms and conditions of such Acquisition Proposal or other inquiry, offer, proposal or request.",
        "reference_section": "ARTICLE V COVENANTS AND AGREEMENTS > Section 5.6 No Solicitation by the Company > (b)"
      }
    ],
    "recommendation_change_restriction": [
      {
        "section": "non_solicitation",
        "field_name": "recommendation_change_restriction_included",
        "answer": true,
        "summary": "The agreement imposes restrictions on the board's ability to change its recommendation, requiring prior notice to the Parent and a negotiation period.",
        "confidence": 0.9,
        "reason": "The agreement specifies that the Company Board must notify Parent in writing of its intent to change its recommendation and engage in a negotiation period before making an Adverse Recommendation Change.",
        "clause_text": "If, after the date of this Agreement and prior to the receipt of the Company Stockholder Approval, the Company Board receives a bona fide written Acquisition Proposal that the Company Board determines in good faith, after consultation with its outside financial advisors and outside legal counsel, constitutes a Superior Proposal that was not initiated, sought, solicited, knowingly facilitated, knowingly encouraged, knowingly induced or otherwise procured in violation, in any non-de minimis respect, of this Agreement, the Company Board may (i) effect an Adverse Recommendation Change or (ii) cause the Company to terminate this Agreement pursuant to Section 7.1(c)(ii) in order to enter into a definitive agreement providing for such Superior Proposal if, in each case, (A) the Company has notified Parent in writing that the Company Board intends to effect an Adverse Recommendation Change pursuant to this Section 5.6(d) or terminate this Agreement pursuant to Section 7.1(c)(ii), (B) the Company has provided Parent a copy of the proposed definitive agreements and other proposed transaction documentation between the Company and the Person making such Superior Proposal, if any, (C) for a period of four (4) Business Days following the notice delivered pursuant to clause (A) of this Section 5.6(d), the Company shall have discussed and negotiated in good faith (in each case only if Parent desires to negotiate) with Parent's Representatives any proposed modifications to the terms and conditions of this Agreement or the transactions contemplated by this Agreement so that the Acquisition Proposal is no longer a Superior Proposal (it being understood and agreed that any amendment to any material term or condition of any Superior Proposal shall require a new notice and a new negotiation period that shall expire on the later to occur of (I) two (2) Business Days following delivery of such new notice from the Company to Parent and (II) the expiration of the original four (4)-Business Day period described in this clause (C)), and (D) no earlier than the end of such negotiation period, the Company Board shall have determined in good faith, after consultation with its outside financial advisors and outside legal counsel, and after considering the terms of any proposed amendment or modification to this Agreement, that the Acquisition Proposal that is the subject of the notice described in clause (B) above still constitutes a Superior Proposal.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.6 – No Solicitation by the Company > (d)"
      },
      {
        "section": "non_solicitation",
        "field_name": "recommendation_change_restriction_explanation",
        "answer": "The agreement imposes procedural and timing-based restrictions on how the Company may change its recommendation. Before making an Adverse Recommendation Change, the Company must notify Parent in writing, provide a copy of the proposed definitive agreements, and engage in good faith negotiations with Parent for a period of four (4) Business Days. If there is a material amendment to the Superior Proposal, a new notice and negotiation period is required.",
        "summary": "The Company must notify Parent and engage in good faith negotiations for four Business Days before changing its recommendation.",
        "confidence": 0.9,
        "reason": "The clause outlines specific procedural steps and timing requirements before an Adverse Recommendation Change can occur.",
        "clause_text": "If, after the date of this Agreement and prior to the receipt of the Company Stockholder Approval, the Company Board receives a bona fide written Acquisition Proposal that the Company Board determines in good faith, after consultation with its outside financial advisors and outside legal counsel, constitutes a Superior Proposal... (A) the Company has notified Parent in writing that the Company Board intends to effect an Adverse Recommendation Change... (C) for a period of four (4) Business Days following the notice delivered pursuant to clause (A)...",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.6 – No Solicitation by the Company > (d)"
      }
    ]
  },
  "best_efforts": {
    "regulatory_efforts": [
      {
        "section": "best_efforts",
        "field_name": "effort_standard",
        "answer": "Reasonable Best Efforts",
        "summary": "The parties are required to use their reasonable best efforts to consummate the transactions and obtain necessary regulatory approvals.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that the parties will use their 'reasonable best efforts' to achieve the necessary regulatory approvals.",
        "clause_text": "Subject to the terms and conditions of this Agreement, the parties hereto will cooperate with each other and use (and will cause their respective Subsidiaries to use) their respective reasonable best efforts to consummate the transactions contemplated by this Agreement and to cause the conditions to the Merger set forth in Article VI to be satisfied as promptly as reasonably practicable, including using reasonable best efforts to accomplish the following as promptly as reasonably practicable...",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (a)"
      },
      {
        "section": "best_efforts",
        "field_name": "effort_scope",
        "answer": "RBE for HSR and other applicable Antitrust Laws",
        "summary": "The effort standard applies to HSR and other applicable Antitrust Laws for the consummation of the transactions.",
        "confidence": 0.9,
        "reason": "The clause explicitly mentions the HSR Act and other applicable Antitrust Laws in the context of regulatory efforts.",
        "clause_text": "Each of the parties hereto shall, in consultation and cooperation with the other parties and as promptly as reasonably practicable, but in any event no later than twenty-five (25) Business Days following the date of this Agreement, make its respective filings under the HSR Act, and make any other applications and filings as reasonably determined by the Company and Parent under other applicable Antitrust Laws with respect to the transactions contemplated by this Agreement, as promptly as practicable, but in no event later than as required by Law.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (a)"
      }
    ],
    "regulatory_fillings_hsr": [
      {
        "section": "best_efforts",
        "field_name": "hsr_required",
        "answer": true,
        "summary": "The expiration or early termination of the HSR waiting period is a condition to closing the Merger.",
        "confidence": 0.95,
        "reason": "The document explicitly states that the expiration or early termination of the HSR waiting period is a condition to the obligations of each party to consummate the Merger.",
        "clause_text": "The respective obligations of each party to consummate the Merger are subject to the satisfaction or (to the extent permitted by Law) waiver by the Company and Parent at or prior to the Closing of the following conditions: ... (d) any applicable waiting period (and any extension thereof) under the HSR Act relating to the consummation of the Merger shall have expired or early termination thereof shall have been granted (the 'Required Regulatory Approval');",
        "reference_section": "ARTICLE Article VI CONDITIONS TO THE MERGER > Section 6.1 Conditions to the Obligations of Each Party"
      },
      {
        "section": "best_efforts",
        "field_name": "hsr_filing_deadline_days",
        "answer": "25",
        "summary": "The parties are required to make their HSR filing no later than twenty-five (25) Business Days following the date of the Agreement.",
        "confidence": 0.95,
        "reason": "The clause explicitly states the deadline for HSR filings as twenty-five (25) Business Days from the date of the Agreement.",
        "clause_text": "Each of the parties hereto shall, in consultation and cooperation with the other parties and as promptly as reasonably practicable, but in any event no later than twenty-five (25) Business Days following the date of this Agreement, make its respective filings under the HSR Act.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (a)"
      },
      {
        "section": "best_efforts",
        "field_name": "hsr_notes",
        "answer": "Must file within 25 business days of signing; filing required under HSR Act as a condition to closing.",
        "summary": "Must file within 25 business days of signing; filing required under HSR Act as a condition to closing.",
        "confidence": 0.95,
        "reason": "The document specifies a 25 business day deadline for HSR filings and states that the expiration or early termination of the HSR waiting period is a condition to closing.",
        "clause_text": "Each of the parties hereto shall, in consultation and cooperation with the other parties and as promptly as reasonably practicable, but in any event no later than twenty-five (25) Business Days following the date of this Agreement, make its respective filings under the HSR Act, and make any other applications and filings as reasonably determined by the Company and Parent under other applicable Antitrust Laws with respect to the transactions contemplated by this Agreement, as promptly as practicable, but in no event later than as required by Law.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (a)"
      }
    ],
    "regulatory_fillings_cfiius": [
      {
        "section": "best_efforts",
        "field_name": "cfiius_required",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "cfiius_filing_deadline_days",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "cfiius_notes",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "regulatory_fillings_foreign": [
      {
        "section": "best_efforts",
        "field_name": "foreign_filling_notes",
        "answer": "Foreign filings may be required under applicable non-U.S. laws",
        "summary": "The agreement implies that foreign filings may be necessary under other applicable Antitrust Laws in connection with the transactions contemplated by the Agreement.",
        "confidence": 0.9,
        "reason": "The language in Section 5.4(a) suggests that filings under 'other applicable Antitrust Laws' may be required, which typically includes foreign jurisdictions.",
        "clause_text": "Each of the parties hereto shall, in consultation and cooperation with the other parties and as promptly as reasonably practicable, but in any event no later than twenty-five (25) Business Days following the date of this Agreement, make its respective filings under the HSR Act, and make any other applications and filings as reasonably determined by the Company and Parent under other applicable Antitrust Laws with respect to the transactions contemplated by this Agreement, as promptly as practicable, but in no event later than as required by Law.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (a)"
      },
      {
        "section": "best_efforts",
        "field_name": "foreign_filling_required",
        "answer": true,
        "summary": "The agreement requires filings under other applicable Antitrust Laws, which implies that foreign filings are required.",
        "confidence": 0.9,
        "reason": "The clause mentions making filings under 'other applicable Antitrust Laws,' which typically includes foreign regulatory requirements.",
        "clause_text": "Each of the parties hereto shall, in consultation and cooperation with the other parties and as promptly as reasonably practicable, but in any event no later than twenty-five (25) Business Days following the date of this Agreement, make its respective filings under the HSR Act, and make any other applications and filings as reasonably determined by the Company and Parent under other applicable Antitrust Laws with respect to the transactions contemplated by this Agreement, as promptly as practicable, but in no event later than as required by Law.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (a)"
      },
      {
        "section": "best_efforts",
        "field_name": "foreign_filling_deadline_days",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "divestiture_commitments": [
      {
        "section": "best_efforts",
        "field_name": "divestiture_required",
        "answer": true,
        "summary": "The agreement conditionally requires Remedy Actions, such as divestiture or other commitments, to secure regulatory approval, provided they do not exceed certain financial thresholds.",
        "confidence": 0.9,
        "reason": "The clause explicitly mentions Remedy Actions and sets conditions under which they are required.",
        "clause_text": "Parent, Merger Sub and Parent's Subsidiaries shall take, and shall cause to be taken, all actions, and shall do, or cause to be done, all things necessary, proper or advisable to eliminate each and every impediment under any Antitrust Law and to obtain the consent or cooperation of any other Person, and to permit and cause the satisfaction of the conditions set forth in Article VI, in each case, to permit the Closing to occur as promptly as reasonably practicable and in any event prior to the Termination Date, including (i) defending through litigation on the merits or otherwise, including appeals, any Proceeding asserted by any Person or Governmental Authority with respect to this Agreement or the Merger or the other transactions contemplated by this Agreement that seeks or would reasonably be expected to prevent, prohibit, interfere with or delay the Closing and (ii) agreeing to, committing to, proffering, proposing or taking any action required to sell, divest, hold separate, lease, license, transfer, dispose of or otherwise encumber or impair or take any other action with respect to the Company's or any of their respective Affiliate's assets, properties, businesses or product lines (including, for the avoidance of doubt, any equity or other interests in the Company), or its or their ability to own or operate any of the foregoing, or any other restriction, limitation or condition on or with respect to the foregoing or with respect to the Company's or any of their respective Affiliate's freedom to operate (any of the foregoing in this clause (ii), a 'Remedy Action'); provided, however, that with respect to this clause (ii), (A) Parent and its Subsidiaries shall not be required to agree to, commit to, proffer, propose or take any Remedy Actions with respect to any businesses and products (I) of the Company and its Subsidiaries that individually or in the aggregate, generated net sales in excess of $140,000,000 during the Company's 2024 fiscal year or (II) of Parent and its Subsidiaries (other than, following the Closing, and subject to the preceding clause (I), the Company and its Subsidiaries); (B) the Company shall not, without Parent's prior written consent, agree to, commit to, proffer, propose or take Remedy Actions; and (C) no party shall be required to agree to, commit to, proffer, propose or take Remedy Actions unless they are conditioned upon the consummation of the transactions contemplated by this Agreement.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (d)"
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_cap_target_value",
        "answer": 140,
        "summary": "The agreement specifies a divestiture cap based on net sales, limiting Remedy Actions to businesses and products of the Company and its Subsidiaries that generated net sales not exceeding $140,000,000 during the Company's 2024 fiscal year.",
        "confidence": 0.9,
        "reason": "The clause explicitly mentions a threshold of $140,000,000 in net sales for divestiture actions.",
        "clause_text": "Parent and its Subsidiaries shall not be required to agree to, commit to, proffer, propose or take any Remedy Actions with respect to any businesses and products (I) of the Company and its Subsidiaries that individually or in the aggregate, generated net sales in excess of $140,000,000 during the Company's 2024 fiscal year.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (d) > (ii) > (A)"
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_cap_target_unit",
        "answer": "USD_millions",
        "summary": "The agreement specifies a divestiture cap based on financial measures, limiting Remedy Actions to businesses and products of the Company and its Subsidiaries that generated net sales in excess of $140,000,000 during the Company's 2024 fiscal year.",
        "confidence": 0.9,
        "reason": "The clause explicitly mentions a financial threshold of $140,000,000 in net sales as a limitation for divestiture actions.",
        "clause_text": "Parent and its Subsidiaries shall not be required to agree to, commit to, proffer, propose or take any Remedy Actions with respect to any businesses and products (I) of the Company and its Subsidiaries that individually or in the aggregate, generated net sales in excess of $140,000,000 during the Company's 2024 fiscal year.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (d)"
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_cap_target_basis",
        "answer": "revenue",
        "summary": "The divestiture cap is measured against 'net sales', which is equivalent to 'revenue'.",
        "confidence": 0.9,
        "reason": "The clause specifies 'net sales' as the basis for the divestiture cap, which is commonly understood as 'revenue' in financial terms.",
        "clause_text": "Parent and its Subsidiaries shall not be required to agree to, commit to, proffer, propose or take any Remedy Actions with respect to any businesses and products (I) of the Company and its Subsidiaries that individually or in the aggregate, generated net sales in excess of $140,000,000 during the Company's 2024 fiscal year.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (d)"
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_cap_target_basis_scope",
        "answer": "Target",
        "summary": "The divestiture cap is applied to the businesses and products of the Company and its Subsidiaries, as indicated by the reference to net sales generated by the Company and its Subsidiaries.",
        "confidence": 0.9,
        "reason": "The clause specifies a divestiture cap based on the net sales of the Company and its Subsidiaries, indicating the scope is the Target.",
        "clause_text": "Parent and its Subsidiaries shall not be required to agree to, commit to, proffer, propose or take any Remedy Actions with respect to any businesses and products (I) of the Company and its Subsidiaries that individually or in the aggregate, generated net sales in excess of $140,000,000 during the Company's 2024 fiscal year.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (d)"
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_cap_target_notes",
        "answer": "Cap applies to Target units generating more than $140,000,000 in net sales during the Company's 2024 fiscal year.",
        "summary": "Cap applies to Target units generating more than $140,000,000 in net sales during the Company's 2024 fiscal year.",
        "confidence": 0.9,
        "reason": "The clause specifies a divestiture cap based on net sales exceeding $140 million during the fiscal year 2024.",
        "clause_text": "Parent and its Subsidiaries shall not be required to agree to, commit to, proffer, propose or take any Remedy Actions with respect to any businesses and products (I) of the Company and its Subsidiaries that individually or in the aggregate, generated net sales in excess of $140,000,000 during the Company's 2024 fiscal year.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (d)"
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_cap_target_clause_reference",
        "answer": "Section 5.4(d)",
        "summary": "The divestiture cap for the Target is implied in Section 5.4(d), which outlines the obligations of Parent, Merger Sub, and Parent's Subsidiaries to take necessary actions to eliminate impediments under Antitrust Law, including divestitures, with a cap on divestitures of businesses generating net sales in excess of $140,000,000.",
        "confidence": 0.9,
        "reason": "The clause specifies a cap on divestitures related to businesses generating net sales over a certain amount, which implies a divestiture cap for the Target.",
        "clause_text": "Parent and its Subsidiaries shall not be required to agree to, commit to, proffer, propose or take any Remedy Actions with respect to any businesses and products (I) of the Company and its Subsidiaries that individually or in the aggregate, generated net sales in excess of $140,000,000 during the Company's 2024 fiscal year.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (d)"
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_cap_buyer_value",
        "answer": "ARTICLE Article V COVENANTS AND AGREEMENTS > Section 5.4 Appropriate Action; Consents; Filings > (d)",
        "summary": "The divestiture cap for the buyer is implied in the clause that limits the Remedy Actions required of Parent and its Subsidiaries to businesses and products of the Company and its Subsidiaries that generated net sales not exceeding $140,000,000 during the Company's 2024 fiscal year.",
        "confidence": 0.9,
        "reason": "The clause specifies a financial threshold for divestitures, which implies a cap on the buyer's obligations.",
        "clause_text": "provided, however, that with respect to this clause (ii), (A) Parent and its Subsidiaries shall not be required to agree to, commit to, proffer, propose or take any Remedy Actions with respect to any businesses and products (I) of the Company and its Subsidiaries that individually or in the aggregate, generated net sales in excess of $140,000,000 during the Company's 2024 fiscal year",
        "reference_section": "ARTICLE Article V COVENANTS AND AGREEMENTS > Section 5.4 Appropriate Action; Consents; Filings > (d)"
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_cap_buyer_unit",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_cap_buyer_basis",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_cap_buyer_basis_scope",
        "answer": "Parent",
        "summary": "The divestiture cap applies to the operations or assets of Parent and its Subsidiaries, as indicated by the reference to Parent and its Affiliates.",
        "confidence": 0.9,
        "reason": "The clause specifies that Parent and its Subsidiaries are involved in the divestiture commitments, implying their operations or assets are within the scope.",
        "clause_text": "Parent and its Subsidiaries shall not be required to agree to, commit to, proffer, propose or take any Remedy Actions with respect to any businesses and products (I) of the Company and its Subsidiaries that individually or in the aggregate, generated net sales in excess of $140,000,000 during the Company's 2024 fiscal year or (II) of Parent and its Subsidiaries.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (d)"
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_cap_buyer_notes",
        "answer": "Parent and its Subsidiaries shall not be required to agree to, commit to, proffer, propose or take any Remedy Actions with respect to any businesses and products of Parent and its Subsidiaries.",
        "summary": "Parent is not required to take Remedy Actions with respect to its own businesses and products.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that Parent and its Subsidiaries are not required to take Remedy Actions with respect to their own businesses and products.",
        "clause_text": "Parent and its Subsidiaries shall not be required to agree to, commit to, proffer, propose or take any Remedy Actions with respect to any businesses and products (I) of the Company and its Subsidiaries that individually or in the aggregate, generated net sales in excess of $140,000,000 during the Company's 2024 fiscal year or (II) of Parent and its Subsidiaries (other than, following the Closing, and subject to the preceding clause (I), the Company and its Subsidiaries);",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (d)"
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_cap_buyer_clause_reference",
        "answer": "Section 5.4(d)",
        "summary": "The clause outlines the obligations of Parent, Merger Sub, and Parent's Subsidiaries to take all necessary actions to eliminate impediments under Antitrust Law and obtain necessary consents for the transaction.",
        "confidence": 0.9,
        "reason": "The clause explicitly mentions actions related to divestiture commitments under Antitrust Law, which implies divestiture obligations for the Buyer.",
        "clause_text": "Notwithstanding anything in this Agreement to the contrary and in furtherance of and consistent with Parent's reasonable best efforts obligations under this Section 5.4, Parent, Merger Sub and Parent's Subsidiaries shall take, and shall cause to be taken, all actions, and shall do, or cause to be done, all things necessary, proper or advisable to eliminate each and every impediment under any Antitrust Law and to obtain the consent or cooperation of any other Person, and to permit and cause the satisfaction of the conditions set forth in Article VI, in each case, to permit the Closing to occur as promptly as reasonably practicable and in any event prior to the Termination Date, including (i) defending through litigation on the merits or otherwise, including appeals, any Proceeding asserted by any Person or Governmental Authority with respect to this Agreement or the Merger or the other transactions contemplated by this Agreement that seeks or would reasonably be expected to prevent, prohibit, interfere with or delay the Closing and (ii) agreeing to, committing to, proffering, proposing or taking any action required to sell, divest, hold separate, lease, license, transfer, dispose of or otherwise encumber or impair or take any other action with respect to the Company's or any of their respective Affiliate's assets, properties, businesses or product lines (including, for the avoidance of doubt, any equity or other interests in the Company), or its or their ability to own or operate any of the foregoing, or any other restriction, limitation or condition on or with respect to the foregoing or with respect to the Company's or any of their respective Affiliate's freedom to operate (any of the foregoing in this clause (ii), a 'Remedy Action'); provided, however, that with respect to this clause (ii), (A) Parent and its Subsidiaries shall not be required to agree to, commit to, proffer, propose or take any Remedy Actions with respect to any businesses and products (I) of the Company and its Subsidiaries that individually or in the aggregate, generated net sales in excess of $140,000,000 during the Company's 2024 fiscal year or (II) of Parent and its Subsidiaries (other than, following the Closing, and subject to the preceding clause (I), the Company and its Subsidiaries); (B) the Company shall not, without Parent's prior written consent, agree to, commit to, proffer, propose or take Remedy Actions; and (C) no party shall be required to agree to, commit to, proffer, propose or take Remedy Actions unless they are conditioned upon the consummation of the transactions contemplated by this Agreement.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (d)"
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_scope_exclusions",
        "answer": [
          "businesses and products of the Company and its Subsidiaries that individually or in the aggregate, generated net sales in excess of $140,000,000 during the Company's 2024 fiscal year",
          "businesses and products of Parent and its Subsidiaries (other than, following the Closing, and subject to the preceding clause, the Company and its Subsidiaries)"
        ],
        "summary": "The agreement excludes from divestiture any businesses and products of the Company and its Subsidiaries with net sales exceeding $140 million during the 2024 fiscal year, as well as businesses and products of Parent and its Subsidiaries.",
        "confidence": 0.9,
        "reason": "The clause specifies exclusions based on sales thresholds and entity ownership.",
        "clause_text": "provided, however, that with respect to this clause (ii), (A) Parent and its Subsidiaries shall not be required to agree to, commit to, proffer, propose or take any Remedy Actions with respect to any businesses and products (I) of the Company and its Subsidiaries that individually or in the aggregate, generated net sales in excess of $140,000,000 during the Company's 2024 fiscal year or (II) of Parent and its Subsidiaries (other than, following the Closing, and subject to the preceding clause (I), the Company and its Subsidiaries);",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (d)"
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_clause_summary",
        "answer": "Parent, Merger Sub, and Parent's Subsidiaries are obligated to take all necessary actions to eliminate impediments under any Antitrust Law and obtain necessary consents, including divesting assets, but are not required to divest businesses that generated net sales in excess of $140,000,000 during the Company's 2024 fiscal year.",
        "summary": "The agreement obligates Parent and its affiliates to take necessary actions, including divestitures, to obtain regulatory approval, with a threshold that excludes divestitures of businesses generating over $140 million in sales.",
        "confidence": 0.9,
        "reason": "The clause explicitly outlines the obligations of Parent and its affiliates to take actions, including divestitures, to comply with Antitrust Laws, with specific thresholds.",
        "clause_text": "Parent, Merger Sub and Parent's Subsidiaries shall take, and shall cause to be taken, all actions, and shall do, or cause to be done, all things necessary, proper or advisable to eliminate each and every impediment under any Antitrust Law... including... divest, hold separate, lease, license, transfer, dispose of or otherwise encumber or impair... provided, however, that... Parent and its Subsidiaries shall not be required to agree to... Remedy Actions with respect to any businesses and products... generated net sales in excess of $140,000,000 during the Company's 2024 fiscal year...",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (d)"
      },
      {
        "section": "best_efforts",
        "field_name": "divestiture_clause_summary_clause_reference",
        "answer": "Section 5.4(d)",
        "summary": "The divestiture clause is located in Section 5.4(d), which outlines the obligations of Parent, Merger Sub, and Parent's Subsidiaries to take necessary actions to eliminate impediments under Antitrust Law and obtain consents for the transaction.",
        "confidence": 0.9,
        "reason": "The clause explicitly mentions actions related to divestiture commitments under Antitrust Law.",
        "clause_text": "Notwithstanding anything in this Agreement to the contrary and in furtherance of and consistent with Parent's reasonable best efforts obligations under this Section 5.4, Parent, Merger Sub and Parent's Subsidiaries shall take, and shall cause to be taken, all actions, and shall do, or cause to be done, all things necessary, proper or advisable to eliminate each and every impediment under any Antitrust Law and to obtain the consent or cooperation of any other Person, and to permit and cause the satisfaction of the conditions set forth in Article VI, in each case, to permit the Closing to occur as promptly as reasonably practicable and in any event prior to the Termination Date, including (i) defending through litigation on the merits or otherwise, including appeals, any Proceeding asserted by any Person or Governmental Authority with respect to this Agreement or the Merger or the other transactions contemplated by this Agreement that seeks or would reasonably be expected to prevent, prohibit, interfere with or delay the Closing and (ii) agreeing to, committing to, proffering, proposing or taking any action required to sell, divest, hold separate, lease, license, transfer, dispose of or otherwise encumber or impair or take any other action with respect to the Company's or any of their respective Affiliate's assets, properties, businesses or product lines (including, for the avoidance of doubt, any equity or other interests in the Company), or its or their ability to own or operate any of the foregoing, or any other restriction, limitation or condition on or with respect to the foregoing or with respect to the Company's or any of their respective Affiliate's freedom to operate (any of the foregoing in this clause (ii), a 'Remedy Action'); provided, however, that with respect to this clause (ii), (A) Parent and its Subsidiaries shall not be required to agree to, commit to, proffer, propose or take any Remedy Actions with respect to any businesses and products (I) of the Company and its Subsidiaries that individually or in the aggregate, generated net sales in excess of $140,000,000 during the Company's 2024 fiscal year or (II) of Parent and its Subsidiaries (other than, following the Closing, and subject to the preceding clause (I), the Company and its Subsidiaries); (B) the Company shall not, without Parent's prior written consent, agree to, commit to, proffer, propose or take Remedy Actions; and (C) no party shall be required to agree to, commit to, proffer, propose or take Remedy Actions unless they are conditioned upon the consummation of the transactions contemplated by this Agreement.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (d)"
      }
    ],
    "litigation_commitments": [
      {
        "section": "best_efforts",
        "field_name": "litigation_requirement_status",
        "answer": "Explicit Requirement to Litigate",
        "summary": "The agreement requires the Buyer to defend through litigation any Proceeding asserted by any Person or Governmental Authority that seeks to prevent, prohibit, interfere with or delay the Closing.",
        "confidence": 0.9,
        "reason": "The clause explicitly states the obligation to defend through litigation, including appeals, any Proceeding that would delay the Closing.",
        "clause_text": "Parent, Merger Sub and Parent's Subsidiaries shall take, and shall cause to be taken, all actions, and shall do, or cause to be done, all things necessary, proper or advisable to eliminate each and every impediment under any Antitrust Law and to obtain the consent or cooperation of any other Person, and to permit and cause the satisfaction of the conditions set forth in Article VI, in each case, to permit the Closing to occur as promptly as reasonably practicable and in any event prior to the Termination Date, including (i) defending through litigation on the merits or otherwise, including appeals, any Proceeding asserted by any Person or Governmental Authority with respect to this Agreement or the Merger or the other transactions contemplated by this Agreement that seeks or would reasonably be expected to prevent, prohibit, interfere with or delay the Closing",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (d)"
      },
      {
        "section": "best_efforts",
        "field_name": "litigation_clause_scope",
        "answer": "Litigate through appeals unless Remedy Actions exceed $140,000,000 in net sales.",
        "summary": "The Buyer is obligated to defend the merger through litigation, including appeals, unless Remedy Actions involve businesses generating net sales exceeding $140,000,000.",
        "confidence": 0.9,
        "reason": "The clause specifies that litigation, including appeals, is required unless Remedy Actions exceed a specified financial threshold.",
        "clause_text": "Parent, Merger Sub and Parent's Subsidiaries shall take, and shall cause to be taken, all actions, and shall do, or cause to be done, all things necessary, proper or advisable to eliminate each and every impediment under any Antitrust Law and to obtain the consent or cooperation of any other Person, and to permit and cause the satisfaction of the conditions set forth in Article VI, in each case, to permit the Closing to occur as promptly as reasonably practicable and in any event prior to the Termination Date, including (i) defending through litigation on the merits or otherwise, including appeals, any Proceeding asserted by any Person or Governmental Authority with respect to this Agreement or the Merger or the other transactions contemplated by this Agreement that seeks or would reasonably be expected to prevent, prohibit, interfere with or delay the Closing and (ii) agreeing to, committing to, proffering, proposing or taking any action required to sell, divest, hold separate, lease, license, transfer, dispose of or otherwise encumber or impair or take any other action with respect to the Company's or any of their respective Affiliate's assets, properties, businesses or product lines (including, for the avoidance of doubt, any equity or other interests in the Company), or its or their ability to own or operate any of the foregoing, or any other restriction, limitation or condition on or with respect to the foregoing or with respect to the Company's or any of their respective Affiliate's freedom to operate (any of the foregoing in this clause (ii), a \"Remedy Action\"); provided, however, that with respect to this clause (ii), (A) Parent and its Subsidiaries shall not be required to agree to, commit to, proffer, propose or take any Remedy Actions with respect to any businesses and products (I) of the Company and its Subsidiaries that individually or in the aggregate, generated net sales in excess of $140,000,000 during the Company's 2024 fiscal year or (II) of Parent and its Subsidiaries (other than, following the Closing, and subject to the preceding clause (I), the Company and its Subsidiaries);",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (d)"
      },
      {
        "section": "best_efforts",
        "field_name": "required_to_litigate_notes",
        "answer": "Parent must litigate regulatory challenges through appeals unless conditions to closing are impossible.",
        "summary": "Parent is required to defend through litigation on the merits or otherwise, including appeals, any Proceeding that seeks to prevent, prohibit, interfere with or delay the Closing.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that Parent must defend through litigation, including appeals, against any Proceeding that could delay or prevent the Closing.",
        "clause_text": "Parent, Merger Sub and Parent's Subsidiaries shall take, and shall cause to be taken, all actions, and shall do, or cause to be done, all things necessary, proper or advisable to eliminate each and every impediment under any Antitrust Law and to obtain the consent or cooperation of any other Person, and to permit and cause the satisfaction of the conditions set forth in Article VI, in each case, to permit the Closing to occur as promptly as reasonably practicable and in any event prior to the Termination Date, including (i) defending through litigation on the merits or otherwise, including appeals, any Proceeding asserted by any Person or Governmental Authority with respect to this Agreement or the Merger or the other transactions contemplated by this Agreement that seeks or would reasonably be expected to prevent, prohibit, interfere with or delay the Closing.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (d)"
      }
    ],
    "withdrawal_and_timing_controls_withdrawal": [
      {
        "section": "best_efforts",
        "field_name": "withdrawal_control_type",
        "answer": "mutual_consent_required",
        "summary": "The withdrawal of regulatory filings requires the prior written consent of both the Company and Parent.",
        "confidence": 0.9,
        "reason": "The agreement specifies that neither the Company nor Parent will withdraw any filings or applications without the prior written consent of the other party.",
        "clause_text": "Neither the Company nor Parent will withdraw any such filings or applications without the prior written consent of the other party, such consent not to be unreasonably withheld, conditioned or delayed.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (a)"
      },
      {
        "section": "best_efforts",
        "field_name": "withdrawal_control_type_notes",
        "answer": "Neither the Company nor Parent will withdraw any such filings or applications without the prior written consent of the other party, such consent not to be unreasonably withheld, conditioned or delayed.",
        "summary": "The withdrawal of regulatory filings requires prior written consent from the other party, which cannot be unreasonably withheld, conditioned, or delayed.",
        "confidence": 0.9,
        "reason": "The clause explicitly states the condition for withdrawal of filings, requiring mutual consent that cannot be unreasonably withheld.",
        "clause_text": "Neither the Company nor Parent will withdraw any such filings or applications without the prior written consent of the other party, such consent not to be unreasonably withheld, conditioned or delayed.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (a)"
      }
    ],
    "withdrawal_and_timing_controls_timing": [
      {
        "section": "best_efforts",
        "field_name": "timing_agreement_restriction",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "timing_agreement_restriction_notes",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "remedy_actions_other": [
      {
        "section": "best_efforts",
        "field_name": "remedy_definitions_provided",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "remedy_definition_text",
        "answer": "sell, divest, hold separate, lease, license, transfer, dispose of or otherwise encumber or impair or take any other action with respect to the Company's or any of their respective Affiliate's assets, properties, businesses or product lines",
        "summary": "A 'Remedy Action' involves actions such as selling, divesting, or otherwise altering the ownership or control of assets to satisfy regulatory conditions.",
        "confidence": 0.9,
        "reason": "The clause explicitly defines 'Remedy Action' in the context of regulatory compliance.",
        "clause_text": "agreeing to, committing to, proffering, proposing or taking any action required to sell, divest, hold separate, lease, license, transfer, dispose of or otherwise encumber or impair or take any other action with respect to the Company's or any of their respective Affiliate's assets, properties, businesses or product lines",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (d)"
      },
      {
        "section": "best_efforts",
        "field_name": "remedy_definition_text_clause_reference",
        "answer": "Section 5.4(d)",
        "summary": "The term 'Remedy Action' is introduced and defined in the context of actions necessary to eliminate impediments under Antitrust Law and obtain necessary consents.",
        "confidence": 0.9,
        "reason": "The clause explicitly uses the phrase 'Remedy Action' to define a set of actions.",
        "clause_text": "Parent, Merger Sub and Parent's Subsidiaries shall take, and shall cause to be taken, all actions, and shall do, or cause to be done, all things necessary, proper or advisable to eliminate each and every impediment under any Antitrust Law and to obtain the consent or cooperation of any other Person, and to permit and cause the satisfaction of the conditions set forth in Article VI, in each case, to permit the Closing to occur as promptly as reasonably practicable and in any event prior to the Termination Date, including (i) defending through litigation on the merits or otherwise, including appeals, any Proceeding asserted by any Person or Governmental Authority with respect to this Agreement or the Merger or the other transactions contemplated by this Agreement that seeks or would reasonably be expected to prevent, prohibit, interfere with or delay the Closing and (ii) agreeing to, committing to, proffering, proposing or taking any action required to sell, divest, hold separate, lease, license, transfer, dispose of or otherwise encumber or impair or take any other action with respect to the Company's or any of their respective Affiliate's assets, properties, businesses or product lines (including, for the avoidance of doubt, any equity or other interests in the Company), or its or their ability to own or operate any of the foregoing, or any other restriction, limitation or condition on or with respect to the foregoing or with respect to the Company's or any of their respective Affiliate's freedom to operate (any of the foregoing in this clause (ii), a 'Remedy Action');",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (d)"
      }
    ],
    "transaction_interference": [
      {
        "section": "best_efforts",
        "field_name": "restriction_on_other_transactions",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "interference_clause_text",
        "answer": "sell, divest, hold separate, lease, license, transfer, dispose of or otherwise encumber or impair or take any other action with respect to the Company's or any of their respective Affiliate's assets, properties, businesses or product lines",
        "summary": "A 'Remedy Action' includes actions such as selling, divesting, or otherwise altering the Company's assets or business lines to comply with antitrust laws.",
        "confidence": 0.9,
        "reason": "The clause explicitly defines 'Remedy Action' in the context of antitrust compliance.",
        "clause_text": "agreeing to, committing to, proffering, proposing or taking any action required to sell, divest, hold separate, lease, license, transfer, dispose of or otherwise encumber or impair or take any other action with respect to the Company's or any of their respective Affiliate's assets, properties, businesses or product lines (including, for the avoidance of doubt, any equity or other interests in the Company), or its or their ability to own or operate any of the foregoing, or any other restriction, limitation or condition on or with respect to the foregoing or with respect to the Company's or any of their respective Affiliate's freedom to operate (any of the foregoing in this clause (ii), a 'Remedy Action')",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (d)"
      },
      {
        "section": "best_efforts",
        "field_name": "interference_clause_text_clause_reference",
        "answer": "Section 5.4",
        "summary": "Section 5.4 outlines obligations to use reasonable best efforts to avoid actions that delay or obstruct regulatory review or merger clearance.",
        "confidence": 0.9,
        "reason": "The section explicitly mentions obligations to cooperate and use reasonable best efforts to consummate the transactions and avoid delays in regulatory approvals.",
        "clause_text": "Subject to the terms and conditions of this Agreement, the parties hereto will cooperate with each other and use (and will cause their respective Subsidiaries to use) their respective reasonable best efforts to consummate the transactions contemplated by this Agreement and to cause the conditions to the Merger set forth in Article VI to be satisfied as promptly as reasonably practicable, including using reasonable best efforts to accomplish the following as promptly as reasonably practicable: (i) the obtaining of all actions or non-actions, consents, approvals, registrations, waivers, permits, authorizations, orders, expirations or terminations of waiting periods and other confirmations from any Governmental Authority or other Person that are or may become necessary, proper or advisable in connection with the consummation of the transactions contemplated by this Agreement, including the Merger;",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (a)"
      }
    ],
    "second_request_certification": [
      {
        "section": "best_efforts",
        "field_name": "second_request_certification_deadline_specified",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "second_request_certification_certification_timeline_notes",
        "answer": "as promptly as reasonably practicable, but in any event no later than twenty-five (25) Business Days following the date of this Agreement",
        "summary": "The parties are required to make their respective filings under the HSR Act as promptly as reasonably practicable, but no later than 25 business days following the date of the Agreement.",
        "confidence": 0.9,
        "reason": "The clause specifies a timeline for making HSR-related filings, which implies a timeline for certifying compliance with a Second Request.",
        "clause_text": "Each of the parties hereto shall, in consultation and cooperation with the other parties and as promptly as reasonably practicable, but in any event no later than twenty-five (25) Business Days following the date of this Agreement, make its respective filings under the HSR Act.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (a)"
      },
      {
        "section": "best_efforts",
        "field_name": "second_request_certification_responsibility_party",
        "answer": "Both",
        "summary": "The agreement requires both parties to cooperate and use their reasonable best efforts to make filings under the HSR Act, implying joint responsibility for certifying compliance with the Second Request.",
        "confidence": 0.9,
        "reason": "The language specifies that each party must make its respective filings under the HSR Act in consultation and cooperation with the other party.",
        "clause_text": "Each of the parties hereto shall, in consultation and cooperation with the other parties and as promptly as reasonably practicable, but in any event no later than twenty-five (25) Business Days following the date of this Agreement, make its respective filings under the HSR Act.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (a)"
      }
    ],
    "ftc_warning_letter_handling": [
      {
        "section": "best_efforts",
        "field_name": "ftc_warning_letter_handling_addressed",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "ftc_warning_letter_handling_notes",
        "answer": "Not addressed",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "ftc_warning_letter_handling_effect_on_closing_condition",
        "answer": "Silent",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "ftc_warning_letter_handling_addressed_notes",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "other_timing_controls": [
      {
        "section": "best_efforts",
        "field_name": "other_timing_controls_deadlines_specified",
        "answer": [
          "Company Stockholders' Meeting to occur within 50 days of Form F-4 effectiveness",
          "Adjournments or postponements of the Company Stockholders' Meeting for insufficient votes shall be for a period of no more than 25 Business Days in the aggregate"
        ],
        "summary": "The agreement specifies that the Company Stockholders' Meeting must occur within 50 days of the Form F-4 effectiveness, and any adjournments or postponements due to insufficient votes are limited to 25 Business Days in total.",
        "confidence": 0.95,
        "reason": "The document explicitly states the timing for the Company Stockholders' Meeting and limits on adjournments or postponements.",
        "clause_text": "Subject to the earlier termination of this Agreement in accordance with Section 7.1, the Company shall, as soon as reasonably practicable following the effectiveness of the Form F-4, duly call, give notice of, convene (on a date selected by the Company in consultation with Parent, which date shall be within, subject to adjournment or postponement as provided below, fifty (50) days of the effectiveness of the Form F-4) and hold a meeting of its stockholders (the \"Company Stockholders' Meeting\") for the purpose of seeking the Company Stockholder Approval... provided, however, that unless agreed to in writing by Parent, any such adjournments or postponements under this clause (ii) shall be for a period of no more than twenty-five (25) Business Days in the aggregate;",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.3 – Preparation of the Form F-4 and the Proxy Statement; Company Stockholders’ Meeting > (b)"
      }
    ],
    "novel_or_unstructured_regulatory_clauses": [
      {
        "section": "best_efforts",
        "field_name": "novel_or_unstructured_regulatory_clauses_items",
        "answer": [
          {
            "summary": "Neither the Company nor Parent will withdraw any filings or applications without the prior written consent of the other party, such consent not to be unreasonably withheld, conditioned or delayed.",
            "section_or_clause_reference": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (a)",
            "review_required": true
          },
          {
            "summary": "None of Parent, Merger Sub or the Company shall, without the other party's prior written consent, enter into any timing or similar agreement that would extend, suspend, lengthen or toll the expiration or termination of any waiting period under the HSR Act.",
            "section_or_clause_reference": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (a)",
            "review_required": true
          },
          {
            "summary": "Neither Parent nor any of its Affiliates shall be required to grant or offer any accommodation or concession to any third party in connection with seeking or obtaining consent to the transactions.",
            "section_or_clause_reference": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (a)",
            "review_required": true
          },
          {
            "summary": "Parent and its Subsidiaries shall not be required to take any Remedy Actions with respect to businesses and products of the Company that generated net sales in excess of $140,000,000 during the Company's 2024 fiscal year.",
            "section_or_clause_reference": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (d)",
            "review_required": true
          }
        ],
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "prior_approval_commitment": [
      {
        "section": "best_efforts",
        "field_name": "prior_approval_commitment_addressed",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "prior_approval_commitment_obligations_summary",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "prior_approval_commitment_clause_reference",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "regulatory_process_control_discretion": [
      {
        "section": "best_efforts",
        "field_name": "regulatory_process_control_discretion",
        "answer": "Joint, mutual consent required",
        "summary": "Neither the Company nor Parent will withdraw any such filings or applications without the prior written consent of the other party, such consent not to be unreasonably withheld, conditioned or delayed.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that both parties must consent to the withdrawal of filings or applications.",
        "clause_text": "Neither the Company nor Parent will withdraw any such filings or applications without the prior written consent of the other party, such consent not to be unreasonably withheld, conditioned or delayed.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (a)"
      },
      {
        "section": "best_efforts",
        "field_name": "parent_has_sole_discretion_excluding_remedies",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "no_limitations_on_buyer_remedies": [
      {
        "section": "best_efforts",
        "field_name": "no_limitations_on_buyer_remedies_value",
        "answer": false,
        "summary": "The agreement places express limitations on the Buyer's obligation to take Remedy Actions, including not requiring Parent to take actions with respect to businesses and products generating net sales over $140,000,000.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that Parent is not required to take Remedy Actions for businesses and products exceeding a specified sales threshold.",
        "clause_text": "Parent and its Subsidiaries shall not be required to agree to, commit to, proffer, propose or take any Remedy Actions with respect to any businesses and products (I) of the Company and its Subsidiaries that individually or in the aggregate, generated net sales in excess of $140,000,000 during the Company's 2024 fiscal year.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (d)"
      },
      {
        "section": "best_efforts",
        "field_name": "no_limitations_on_buyer_remedies_inferred_hohw",
        "answer": false,
        "summary": "The presence of material carveouts and qualifications in the obligations of the Buyer indicates that there is no Hell-or-High-Water obligation.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that Parent and its Subsidiaries are not required to take Remedy Actions with respect to businesses and products generating net sales in excess of $140,000,000, indicating a material carveout.",
        "clause_text": "provided, however, that with respect to this clause (ii), (A) Parent and its Subsidiaries shall not be required to agree to, commit to, proffer, propose or take any Remedy Actions with respect to any businesses and products (I) of the Company and its Subsidiaries that individually or in the aggregate, generated net sales in excess of $140,000,000 during the Company's 2024 fiscal year",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (d)"
      },
      {
        "section": "best_efforts",
        "field_name": "no_limitations_on_buyer_remedies_explanation",
        "answer": "Buyer must take all actions without limitation",
        "summary": "Parent, Merger Sub and Parent's Subsidiaries shall take all actions necessary to eliminate impediments under any Antitrust Law and obtain consents to permit the Closing to occur as promptly as reasonably practicable.",
        "confidence": 0.9,
        "reason": "The clause requires Parent and its subsidiaries to take all necessary actions to eliminate impediments and obtain consents, indicating a Hell-or-High-Water obligation.",
        "clause_text": "Parent, Merger Sub and Parent's Subsidiaries shall take, and shall cause to be taken, all actions, and shall do, or cause to be done, all things necessary, proper or advisable to eliminate each and every impediment under any Antitrust Law and to obtain the consent or cooperation of any other Person, and to permit and cause the satisfaction of the conditions set forth in Article VI, in each case, to permit the Closing to occur as promptly as reasonably practicable and in any event prior to the Termination Date.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (d)"
      },
      {
        "section": "best_efforts",
        "field_name": "no_limitations_on_buyer_remedies_notes",
        "answer": "Parent and its Subsidiaries shall not be required to agree to, commit to, proffer, propose or take any Remedy Actions with respect to any businesses and products of the Company and its Subsidiaries that individually or in the aggregate, generated net sales in excess of $140,000,000 during the Company's 2024 fiscal year.",
        "summary": "There is a limitation on Parent's obligation to take Remedy Actions, specifically not requiring actions for businesses and products generating net sales over $140,000,000.",
        "confidence": 0.9,
        "reason": "The clause explicitly states a sales threshold for Remedy Actions, which is a standard limitation in M&A agreements.",
        "clause_text": "Parent and its Subsidiaries shall not be required to agree to, commit to, proffer, propose or take any Remedy Actions with respect to any businesses and products (I) of the Company and its Subsidiaries that individually or in the aggregate, generated net sales in excess of $140,000,000 during the Company's 2024 fiscal year.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (d)"
      },
      {
        "section": "best_efforts",
        "field_name": "no_limitations_on_buyer_remedies_inferred_hohw_notes",
        "answer": "Parent and Merger Sub are required to use reasonable best efforts to consummate the transactions, including taking actions to eliminate impediments under Antitrust Law, but are not required to divest assets generating over $140 million.",
        "summary": "The agreement imposes a reasonable best efforts obligation on Parent and Merger Sub to consummate the transactions, including taking actions to eliminate impediments under Antitrust Law, but limits the requirement to divest assets generating over $140 million.",
        "confidence": 0.9,
        "reason": "The clause specifies reasonable best efforts and outlines limitations on divestitures, implying a Hell-or-High-Water obligation with specific exceptions.",
        "clause_text": "Parent, Merger Sub and Parent's Subsidiaries shall take, and shall cause to be taken, all actions, and shall do, or cause to be done, all things necessary, proper or advisable to eliminate each and every impediment under any Antitrust Law... provided, however, that with respect to this clause (ii), (A) Parent and its Subsidiaries shall not be required to agree to, commit to, proffer, propose or take any Remedy Actions with respect to any businesses and products (I) of the Company and its Subsidiaries that individually or in the aggregate, generated net sales in excess of $140,000,000 during the Company's 2024 fiscal year...",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (d)"
      },
      {
        "section": "best_efforts",
        "field_name": "no_limitations_on_buyer_remedies_materiality_basis",
        "answer": "relative to combined company",
        "summary": "The agreement specifies that Parent and its Subsidiaries are not required to take Remedy Actions with respect to businesses and products of the Company and its Subsidiaries that generated net sales in excess of $140,000,000 during the Company's 2024 fiscal year, indicating a materiality threshold relative to the combined company.",
        "confidence": 0.9,
        "reason": "The clause sets a specific financial threshold for Remedy Actions, implying materiality is assessed relative to the combined company.",
        "clause_text": "Parent and its Subsidiaries shall not be required to agree to, commit to, proffer, propose or take any Remedy Actions with respect to any businesses and products (I) of the Company and its Subsidiaries that individually or in the aggregate, generated net sales in excess of $140,000,000 during the Company's 2024 fiscal year.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (d)"
      },
      {
        "section": "best_efforts",
        "field_name": "materiality_definition_text",
        "answer": "Parent and its Subsidiaries shall not be required to agree to, commit to, proffer, propose or take any Remedy Actions with respect to any businesses and products of the Company and its Subsidiaries that individually or in the aggregate, generated net sales in excess of $140,000,000 during the Company's 2024 fiscal year.",
        "summary": "The Buyer is not required to take Remedy Actions affecting businesses with net sales exceeding $140 million during the Company's 2024 fiscal year.",
        "confidence": 0.95,
        "reason": "The clause explicitly states a financial threshold for Remedy Actions, indicating a limitation based on business revenue.",
        "clause_text": "Parent and its Subsidiaries shall not be required to agree to, commit to, proffer, propose or take any Remedy Actions with respect to any businesses and products (I) of the Company and its Subsidiaries that individually or in the aggregate, generated net sales in excess of $140,000,000 during the Company's 2024 fiscal year.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (d)"
      }
    ],
    "refiling_commitment": [
      {
        "section": "best_efforts",
        "field_name": "refiling_commitment_required",
        "answer": true,
        "summary": "The parties are obligated not to withdraw any filings under the HSR Act without the prior written consent of the other party.",
        "confidence": 0.9,
        "reason": "The document explicitly states that neither the Company nor Parent will withdraw any such filings or applications without the prior written consent of the other party.",
        "clause_text": "Neither the Company nor Parent will withdraw any such filings or applications without the prior written consent of the other party, such consent not to be unreasonably withheld, conditioned or delayed.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (a)"
      },
      {
        "section": "best_efforts",
        "field_name": "refiling_commitment_required_notes",
        "answer": "Neither the Company nor Parent will withdraw any such filings or applications without the prior written consent of the other party, such consent not to be unreasonably withheld, conditioned or delayed.",
        "summary": "The parties agree not to withdraw HSR Act filings without the prior written consent of the other party, ensuring mutual cooperation in regulatory processes.",
        "confidence": 0.9,
        "reason": "The clause explicitly states the requirement for mutual consent before withdrawing filings, which implies a commitment to refile if necessary.",
        "clause_text": "Neither the Company nor Parent will withdraw any such filings or applications without the prior written consent of the other party, such consent not to be unreasonably withheld, conditioned or delayed.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (a)"
      },
      {
        "section": "best_efforts",
        "field_name": "refiling_commitment_max_refiles",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "refiling_commitment_max_refiles_notes",
        "answer": "Not Specified",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "refiling_commitment_max_refiles_specification_status",
        "answer": "Not Specified",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "best_efforts",
        "field_name": "refiling_commitment_clause_reference",
        "answer": "Section 5.4",
        "summary": "The section outlines the mutual obligations for filing under the HSR Act, including timelines and conditions for such filings.",
        "confidence": 0.9,
        "reason": "The section explicitly mentions the requirement for each party to make its respective filings under the HSR Act within twenty-five (25) Business Days following the date of the Agreement.",
        "clause_text": "Each of the parties hereto shall, in consultation and cooperation with the other parties and as promptly as reasonably practicable, but in any event no later than twenty-five (25) Business Days following the date of this Agreement, make its respective filings under the HSR Act, and make any other applications and filings as reasonably determined by the Company and Parent under other applicable Antitrust Laws with respect to the transactions contemplated by this Agreement, as promptly as practicable, but in no event later than as required by Law.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (a)"
      }
    ]
  },
  "termination": {
    "outside_date": [
      {
        "section": "termination",
        "field_name": "primary_date",
        "answer": "the twelve (12)-month anniversary of the date of this Agreement",
        "summary": "The initial Outside Date specified in the agreement is the twelve-month anniversary of the date of the Agreement.",
        "confidence": 0.9,
        "reason": "The agreement explicitly states that the Merger must be consummated on or before the twelve-month anniversary of the date of the Agreement, which serves as the initial Outside Date.",
        "clause_text": "the Merger shall not have been consummated on or before 5:00 p.m. (Chicago, Illinois, United States time) on the twelve (12)-month anniversary of the date of this Agreement (the 'Termination Date');",
        "reference_section": "ARTICLE Article VII TERMINATION, AMENDMENT AND WAIVER > Section 7.1 Termination > (b) > (i)"
      }
    ],
    "extension": [
      {
        "section": "termination",
        "field_name": "extension_list",
        "answer": [
          {
            "Extension Length": "3 months",
            "Who Grants the Extension": "automatic",
            "Conditions to Extend": "any of the conditions to Closing set forth in Section 6.1(d) or Section 6.1(e) (if the Restraint is in respect of an Antitrust Law) shall not have been satisfied, but all other conditions set forth in Section 6.1 through Section 6.3 shall have been satisfied or waived",
            "Termination Restrictions Due to Breach": "Yes, the right to terminate is not available to any party if a material breach by such party has been the principal cause of or principally resulted in the failure of the Closing to have occurred on or before the Termination Date"
          }
        ],
        "summary": "The Termination Date may be automatically extended for 3 months if certain conditions related to regulatory approval are unmet, provided all other conditions are satisfied or waived.",
        "confidence": 0.95,
        "reason": "The clause specifies an automatic extension if certain conditions are unmet, with restrictions on termination rights due to breach.",
        "clause_text": "provided that if, on the Termination Date, any of the conditions to Closing set forth in Section 6.1(d) or Section 6.1(e) (if the Restraint is in respect of an Antitrust Law) shall not have been satisfied, but all other conditions set forth in Section 6.1 through Section 6.3 shall have been satisfied or waived... the Termination Date shall automatically, without any action on the part of the parties hereto, be extended for three (3) months...",
        "reference_section": "ARTICLE Article VII TERMINATION, AMENDMENT AND WAIVER > Section 7.1 Termination > (b)(i)"
      }
    ],
    "termination_fee": [
      {
        "section": "termination",
        "field_name": "termination_fee",
        "answer": "$272,000,000",
        "summary": "The Termination Amount payable by the Target to the Parent is explicitly defined as $272,000,000.",
        "confidence": 1.0,
        "reason": "The document explicitly defines 'Termination Amount' as $272,000,000 in the Definitions section.",
        "clause_text": "Termination Amount shall mean $272,000,000.",
        "reference_section": "Definition > Termination Amount"
      }
    ],
    "reverse_termination_fee": [
      {
        "section": "termination",
        "field_name": "reverse_termination_fee",
        "answer": 272000000,
        "summary": "The Termination Amount, which functions as a reverse termination fee, is explicitly stated as $272,000,000.",
        "confidence": 1.0,
        "reason": "The document explicitly defines the Termination Amount as $272,000,000, which is payable under certain termination conditions.",
        "clause_text": "Termination Amount shall mean $272,000,000.",
        "reference_section": "Definition > Termination Amount"
      }
    ],
    "reverse_termination_fee_exist": [
      {
        "section": "termination",
        "field_name": "reverse_termination_fee_exist",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ]
  },
  "ordinary_course": {
    "ordinary_course_covenant": [
      {
        "section": "ordinary_course",
        "field_name": "concise_standard_summary",
        "answer": "Parent and the Company must use commercially reasonable efforts to conduct business in the ordinary course and preserve assets and relationships between signing and closing.",
        "summary": "The Parent and the Company are required to use commercially reasonable efforts to conduct their business in the ordinary course and preserve their assets and business relationships between the signing and closing of the merger.",
        "confidence": 0.95,
        "reason": "The document explicitly states that both the Parent and the Company must use commercially reasonable efforts to conduct business in the ordinary course and preserve assets and relationships.",
        "clause_text": "Parent shall use commercially reasonable efforts to conduct its business in the ordinary course of business and, to the extent consistent therewith, use commercially reasonable efforts to preserve its assets and business organization and maintain its existing relationships with material customers, suppliers, distributors, Governmental Authorities and business partners.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.2 – Conduct of Business by Parent Pending the Merger"
      }
    ]
  },
  "board_approval": {
    "board_approval": [
      {
        "section": "board_approval",
        "field_name": "target_board_approval",
        "answer": true,
        "summary": "The Company Board has approved the Agreement and the transactions contemplated by it.",
        "confidence": 1.0,
        "reason": "The document explicitly states that the Company Board has approved the Agreement and the transactions contemplated by it.",
        "clause_text": "The Company Board has, by resolutions unanimously adopted by the Company Board, (i) approved this Agreement and the transactions contemplated by this Agreement, (ii) determined that this Agreement and the transactions contemplated by this Agreement are advisable and in the best interests of the Company and the Company's stockholders, (iii) directed that the adoption of this Agreement be submitted to a vote at the Company Stockholders' Meeting and (iv) resolved to make the Company Recommendation;",
        "reference_section": "ARTICLE Article III REPRESENTATIONS AND WARRANTIES OF THE COMPANY > Section 3.3 Authority Relative to Agreement > (b)"
      },
      {
        "section": "board_approval",
        "field_name": "target_board_unanimous",
        "answer": true,
        "summary": "The Company Board has unanimously approved the Agreement and the transactions contemplated by it.",
        "confidence": 1.0,
        "reason": "The clause explicitly states that the Company Board's resolutions were unanimously adopted.",
        "clause_text": "The Company Board has, by resolutions unanimously adopted by the Company Board, (i) approved this Agreement and the transactions contemplated by this Agreement, (ii) determined that this Agreement and the transactions contemplated by this Agreement are advisable and in the best interests of the Company and the Company's stockholders, (iii) directed that the adoption of this Agreement be submitted to a vote at the Company Stockholders' Meeting and (iv) resolved to make the Company Recommendation;",
        "reference_section": "ARTICLE Article III REPRESENTATIONS AND WARRANTIES OF THE COMPANY > Section 3.3 Authority Relative to Agreement > (b)"
      },
      {
        "section": "board_approval",
        "field_name": "acquirer_board_approval",
        "answer": true,
        "summary": "The Parent Board and the Merger Sub Board have approved the Agreement and the transactions contemplated by this Agreement.",
        "confidence": 1.0,
        "reason": "The document explicitly states that the Parent Board and the Merger Sub Board have approved the Agreement and the transactions contemplated by this Agreement.",
        "clause_text": "The Parent Board and the Merger Sub Board have, by resolutions unanimously adopted thereby, approved this Agreement and the transactions contemplated by this Agreement.",
        "reference_section": "ARTICLE Article IV REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB > Section 4.3 Authority Relative to Agreement > (b)"
      },
      {
        "section": "board_approval",
        "field_name": "acquirer_board_unanimous",
        "answer": true,
        "summary": "The Parent Board and the Merger Sub Board have, by resolutions unanimously adopted, approved the Agreement and the transactions contemplated by it.",
        "confidence": 1.0,
        "reason": "The document explicitly states that the Parent Board and the Merger Sub Board have unanimously adopted resolutions approving the Agreement.",
        "clause_text": "The Parent Board and the Merger Sub Board have, by resolutions unanimously adopted thereby, approved this Agreement and the transactions contemplated by this Agreement.",
        "reference_section": "ARTICLE Article IV REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB > Section 4.3 Authority Relative to Agreement > (b)"
      }
    ]
  },
  "party_details": {
    "acquirer": [
      {
        "section": "party_details",
        "field_name": "acquirer",
        "answer": "James Hardie Industries plc",
        "summary": "The acquiring entity in the merger agreement is James Hardie Industries plc, an Irish public limited company.",
        "confidence": 0.95,
        "reason": "The preamble of the agreement explicitly names James Hardie Industries plc as the 'Parent,' which is the acquiring entity.",
        "clause_text": "THIS AGREEMENT AND PLAN OF MERGER (this \"Agreement\"), dated as of March 23, 2025, is made by and among James Hardie Industries plc, an Irish public limited company (\"Parent\"), Juno Merger Sub Inc., a Delaware corporation and a direct or indirect wholly owned Subsidiary of Parent (\"Merger Sub\"), and The AZEK Company Inc., a Delaware corporation (the \"Company\").",
        "reference_section": "ARTICLE Preamble"
      },
      {
        "section": "party_details",
        "field_name": "parent_entity_details",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "target": [
      {
        "section": "party_details",
        "field_name": "target",
        "answer": "The AZEK Company Inc.",
        "summary": "The full legal name of the target company being acquired is The AZEK Company Inc., as defined in the agreement.",
        "confidence": 1.0,
        "reason": "The agreement explicitly defines 'the Company' as The AZEK Company Inc., which is the entity being merged into the Merger Sub.",
        "clause_text": "THIS AGREEMENT AND PLAN OF MERGER (this \"Agreement\"), dated as of March 23, 2025, is made by and among James Hardie Industries plc, an Irish public limited company (\"Parent\"), Juno Merger Sub Inc., a Delaware corporation and a direct or indirect wholly owned Subsidiary of Parent (\"Merger Sub\"), and The AZEK Company Inc., a Delaware corporation (the \"Company\").",
        "reference_section": "ARTICLE Preamble"
      }
    ],
    "guarantor": [
      {
        "section": "party_details",
        "field_name": "guarantor_present",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "party_details",
        "field_name": "guarantor_details",
        "answer": "JH North America Holdings Inc., a Delaware corporation and a wholly owned indirect Subsidiary of Parent, is identified as the Borrower in the commitment letter related to the Financing.",
        "summary": "JH North America Holdings Inc., a wholly owned indirect Subsidiary of Parent, is the Borrower under the commitment letter for the Financing.",
        "confidence": 0.9,
        "reason": "The clause specifies JH North America Holdings Inc. as the Borrower in the commitment letter for the Financing.",
        "clause_text": "Parent has delivered to the Company true and complete fully executed copies of (a) the commitment letter, dated as of the date hereof, among JH North America Holdings Inc., a Delaware corporation and a wholly owned indirect Subsidiary of Parent (the \"Borrower\"), and Bank of America, N.A. and Jeffries Finance LLC (together, the \"Initial Lenders\")...",
        "reference_section": "ARTICLE Article IV REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB > Section 4.25 Financing"
      }
    ],
    "subsidiaries": [
      {
        "section": "party_details",
        "field_name": "target_subsidiaries_present",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "party_details",
        "field_name": "target_subsidiaries",
        "answer": "No target subsidiaries explicitly involved in the merger structure are mentioned.",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "party_details",
        "field_name": "acquirer_subsidiaries_present",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "party_details",
        "field_name": "acquirer_subsidiaries",
        "answer": "[{ \"name\": \"Juno Merger Sub Inc.\", \"clause_reference\": \"ARTICLE Article I THE MERGER > Section 1.1 The Merger\", \"role\": \"Wholly owned merger vehicle used to merge with the target\" }]",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "transaction": [
      {
        "section": "party_details",
        "field_name": "transaction_type",
        "answer": "Reverse Triangular Merger",
        "summary": "The transaction is structured as a Reverse Triangular Merger where Merger Sub merges into the Company, and the Company continues as the surviving corporation.",
        "confidence": 0.95,
        "reason": "The structure described involves Merger Sub merging into the Company, with the Company surviving, which is characteristic of a Reverse Triangular Merger.",
        "clause_text": "Upon the terms and subject to the conditions of this Agreement, and in accordance with the DGCL, at the Effective Time, Merger Sub shall be merged with and into the Company, whereupon the separate existence of Merger Sub shall cease and the Surviving Corporation shall continue as the surviving corporation of the Merger and a direct or indirect wholly owned Subsidiary of Parent.",
        "reference_section": "ARTICLE Article I THE MERGER > Section 1.1 The Merger"
      },
      {
        "section": "party_details",
        "field_name": "transaction_structure_notes",
        "answer": "The transaction is structured as a merger where Merger Sub will merge with and into the Company, with the Company continuing as the Surviving Corporation and becoming a wholly owned subsidiary of Parent.",
        "summary": "The transaction involves Merger Sub merging into the Company, resulting in the Company becoming the Surviving Corporation and a wholly owned subsidiary of Parent.",
        "confidence": 0.95,
        "reason": "The structure is explicitly described as a merger with Merger Sub merging into the Company, which will continue as the Surviving Corporation.",
        "clause_text": "Upon the terms and subject to the conditions of this Agreement, and in accordance with the DGCL, at the Effective Time, Merger Sub shall be merged with and into the Company, whereupon the separate existence of Merger Sub shall cease and the Surviving Corporation shall continue as the surviving corporation of the Merger and a direct or indirect wholly owned Subsidiary of Parent.",
        "reference_section": "ARTICLE Article I THE MERGER > Section 1.1 The Merger"
      }
    ],
    "merger_sub_details": [
      {
        "section": "party_details",
        "field_name": "merger_sub_details",
        "answer": "Juno Merger Sub Inc., a Delaware corporation and a direct or indirect wholly owned Subsidiary of Parent",
        "summary": "Juno Merger Sub Inc. is a Delaware corporation and a direct or indirect wholly owned subsidiary of the Parent.",
        "confidence": 1.0,
        "reason": "The clause explicitly states the full legal name, jurisdiction of incorporation, and ownership relationship of the Merger Sub to the Parent.",
        "clause_text": "Juno Merger Sub Inc., a Delaware corporation and a direct or indirect wholly owned Subsidiary of Parent",
        "reference_section": "ARTICLE Preamble"
      }
    ]
  },
  "closing_mechanics": {
    "target_date": [
      {
        "section": "closing_mechanics",
        "field_name": "target_date",
        "answer": "3rd Business Day after satisfaction or waiver of conditions in Article VI",
        "summary": "The closing of the Merger shall occur no later than the third Business Day after the satisfaction or waiver of the conditions set forth in Article VI, unless otherwise agreed in writing by the parties.",
        "confidence": 0.9,
        "reason": "The clause specifies the closing date relative to the satisfaction or waiver of conditions.",
        "clause_text": "Subject to the provisions of Article VI, the closing of the Merger (the \"Closing\") shall take place at 9:00 a.m. (Chicago, Illinois, United States time) on a date to be specified by the parties hereto, but no later than the third (3rd) Business Day after the satisfaction or waiver of the conditions set forth in Article VI (other than those conditions that by their terms are to be satisfied at the Closing, but subject to the satisfaction or waiver of such conditions), unless another time, date or place is agreed to in writing by the parties hereto (such date being the \"Closing Date\").",
        "reference_section": "ARTICLE Article I THE MERGER > Section 1.2 The Closing"
      }
    ],
    "marketing_period": [
      {
        "section": "closing_mechanics",
        "field_name": "has_marketing_period",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "closing_mechanics",
        "field_name": "marketing_period_details",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "inside_date": [
      {
        "section": "closing_mechanics",
        "field_name": "has_inside_date",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "closing_mechanics",
        "field_name": "inside_date_details",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ]
  },
  "specific_performance": {
    "specific_performance": [
      {
        "section": "specific_performance",
        "field_name": "specific_performance_available",
        "answer": true,
        "summary": "The agreement expressly states that the parties are entitled to specific performance as a remedy to prevent breaches and enforce the terms of the agreement.",
        "confidence": 1.0,
        "reason": "The clause explicitly mentions that the parties shall be entitled to specific performance and other equitable relief to prevent breaches of the agreement.",
        "clause_text": "Accordingly, the parties acknowledge and agree that, prior to any termination of this Agreement in accordance with Section 7.1, the parties shall be entitled to an injunction, specific performance and other equitable relief to prevent breaches of this Agreement and to enforce specifically the terms and provisions hereof, in addition to any other remedy to which they are entitled at law or in equity.",
        "reference_section": "ARTICLE Article VIII GENERAL PROVISIONS > Section 8.11 Specific Performance"
      },
      {
        "section": "specific_performance",
        "field_name": "specific_performance_parties",
        "answer": "the parties",
        "summary": "The parties to the agreement are entitled to seek specific performance to prevent breaches and enforce the terms of the agreement.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that 'the parties shall be entitled to an injunction, specific performance and other equitable relief.'",
        "clause_text": "Accordingly, the parties acknowledge and agree that, prior to any termination of this Agreement in accordance with Section 7.1, the parties shall be entitled to an injunction, specific performance and other equitable relief to prevent breaches of this Agreement and to enforce specifically the terms and provisions hereof, in addition to any other remedy to which they are entitled at law or in equity.",
        "reference_section": "ARTICLE Article VIII GENERAL PROVISIONS > Section 8.11 Specific Performance"
      },
      {
        "section": "specific_performance",
        "field_name": "specific_performance_limitations",
        "answer": "Prior to any termination of this Agreement, the parties are entitled to seek specific performance without the need to provide any bond or other security.",
        "summary": "The right to seek specific performance is available prior to termination of the Agreement, without the requirement to provide a bond or other security.",
        "confidence": 0.9,
        "reason": "The clause explicitly states the entitlement to specific performance prior to termination and waives the requirement for a bond.",
        "clause_text": "Accordingly, the parties acknowledge and agree that, prior to any termination of this Agreement in accordance with Section 7.1, the parties shall be entitled to an injunction, specific performance and other equitable relief to prevent breaches of this Agreement and to enforce specifically the terms and provisions hereof, in addition to any other remedy to which they are entitled at law or in equity. Each of the parties agrees that it will not oppose the granting of an injunction, specific performance and other equitable relief on the basis that any other party has an adequate remedy at law or that any award of specific performance is not an appropriate remedy for any reason at law or in equity. Any party seeking an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement shall not be required to provide any bond or other security in connection with any such order or injunction.",
        "reference_section": "ARTICLE Article VIII GENERAL PROVISIONS > Section 8.11 Specific Performance"
      },
      {
        "section": "specific_performance",
        "field_name": "specific_performance_financing_condition",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "specific_performance",
        "field_name": "specific_performance_financing_details",
        "answer": "The obligations of Parent and Merger Sub hereunder are not subject to any condition regarding Parent's, Merger Sub's or any other Person's ability to obtain financing (including the Financing) for the Merger and the other transactions contemplated by this Agreement.",
        "summary": "Specific performance is not conditioned on obtaining financing, as the obligations of Parent and Merger Sub are not subject to any condition regarding their ability to obtain financing.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that the obligations are not contingent on financing, implying specific performance is not conditioned on it.",
        "clause_text": "The obligations of Parent and Merger Sub hereunder are not subject to any condition regarding Parent's, Merger Sub's or any other Person's ability to obtain financing (including the Financing) for the Merger and the other transactions contemplated by this Agreement.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.15 – Financing and Financing Cooperation > (c)"
      }
    ]
  },
  "confidentiality_and_clean_room": {
    "confidentiality": [
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "confidentiality_exists",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "confidentiality_agreement_date",
        "answer": "January 23, 2025",
        "summary": "The confidentiality agreement was signed on January 23, 2025, between Parent and the Company.",
        "confidence": 1.0,
        "reason": "The date is explicitly stated in the definition of the Confidentiality Agreement.",
        "clause_text": "Confidentiality Agreement shall mean the confidentiality agreement, dated January 23, 2025, between Parent and the Company.",
        "reference_section": "Definition > Confidentiality Agreement"
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "confidentiality_obligation_termination_date",
        "answer": "The confidentiality obligations are perpetual and survive any termination of the Agreement.",
        "summary": "The Confidentiality Agreement survives any termination of the Agreement, indicating perpetual confidentiality obligations.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that the Confidentiality Agreement survives termination, implying perpetual obligations.",
        "clause_text": "provided, further, that the Confidentiality Agreement, the penultimate sentence of Section 5.15(c), this Section 7.2, Section 7.3, Section 7.4, Section 7.5 and Article VIII shall survive any termination of this Agreement pursuant to Section 7.1.",
        "reference_section": "ARTICLE Article VII TERMINATION, AMENDMENT AND WAIVER > Section 7.2 Effect of Termination"
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "confidentiality_breach_consequences",
        "answer": "In the event of a confidentiality breach, the parties are entitled to seek an injunction, specific performance, and other equitable relief to prevent breaches and enforce the agreement's terms, in addition to any other legal or equitable remedies.",
        "summary": "The agreement allows for injunctions, specific performance, and other equitable relief to prevent breaches and enforce terms in case of a confidentiality breach.",
        "confidence": 0.9,
        "reason": "The clause explicitly states the availability of equitable remedies for breaches of the agreement, which includes confidentiality breaches.",
        "clause_text": "Accordingly, the parties acknowledge and agree that, prior to any termination of this Agreement in accordance with Section 7.1, the parties shall be entitled to an injunction, specific performance and other equitable relief to prevent breaches of this Agreement and to enforce specifically the terms and provisions hereof, in addition to any other remedy to which they are entitled at law or in equity.",
        "reference_section": "ARTICLE Article VIII GENERAL PROVISIONS > Section 8.11 Specific Performance"
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "confidentiality_post_termination_use",
        "answer": "The agreement prohibits the use of confidential information after termination.",
        "summary": "The Confidentiality Agreement survives termination, indicating that the use of confidential information is prohibited post-termination.",
        "confidence": 0.9,
        "reason": "The survival of the Confidentiality Agreement implies continued confidentiality obligations.",
        "clause_text": "provided, further, that the Confidentiality Agreement, the penultimate sentence of Section 5.15(c), this Section 7.2, Section 7.3, Section 7.4, Section 7.5 and Article VIII shall survive any termination of this Agreement pursuant to Section 7.1.",
        "reference_section": "ARTICLE Article VII TERMINATION, AMENDMENT AND WAIVER > Section 7.2 Effect of Termination"
      }
    ],
    "clean_room": [
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "clean_room_exists",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "clean_room_start_date",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "clean_room_end_date",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "clean_room_scope_restrictions",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "clean_room_breach_consequences",
        "answer": "In the event of a Clean Room protocol breach, the parties are entitled to seek an injunction, specific performance, and other equitable relief to prevent breaches and enforce the terms of the Agreement.",
        "summary": "The parties agree that irreparable damage would occur if any party does not perform the provisions of the Agreement, and they are entitled to an injunction, specific performance, and other equitable relief to prevent breaches.",
        "confidence": 0.9,
        "reason": "The clause specifies that equitable relief is available to prevent breaches, which implies consequences for a Clean Room breach.",
        "clause_text": "Accordingly, the parties acknowledge and agree that, prior to any termination of this Agreement in accordance with Section 7.1, the parties shall be entitled to an injunction, specific performance and other equitable relief to prevent breaches of this Agreement and to enforce specifically the terms and provisions hereof, in addition to any other remedy to which they are entitled at law or in equity.",
        "reference_section": "ARTICLE Article VIII GENERAL PROVISIONS > Section 8.11 Specific Performance"
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "clean_room_post_termination_use",
        "answer": "The agreement prohibits the use of Clean Room information after termination.",
        "summary": "The agreement specifies that all rights and obligations cease upon termination, except for certain provisions that survive, including the Confidentiality Agreement, which implies that Clean Room information cannot be used post-termination.",
        "confidence": 0.9,
        "reason": "The survival of the Confidentiality Agreement upon termination implies that Clean Room information must remain confidential and cannot be used after termination.",
        "clause_text": "In the event that this Agreement is terminated and the Merger abandoned pursuant to Section 7.1, written notice thereof shall be given by the terminating party to the other party, specifying the provisions hereof pursuant to which such termination is made, and this Agreement shall forthwith become null and void and of no effect without liability on the part of any party hereto, and all rights and obligations of any party hereto shall cease; provided that, except as otherwise provided in Section 7.3, no such termination shall relieve any party hereto of any liability or damages...",
        "reference_section": "ARTICLE Article VII TERMINATION, AMENDMENT AND WAIVER > Section 7.2 Effect of Termination"
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "clean_room_protection_clause_present",
        "answer": true,
        "summary": "The agreement includes a clause that results in the termination of access to any data room containing information of the Company or its Subsidiaries in connection with an Acquisition Proposal.",
        "confidence": 0.9,
        "reason": "The clause explicitly requires the termination of access to any data room set up for a possible Acquisition Proposal.",
        "clause_text": "the Company shall not provide and shall, within one (1) Business Day of the date of this Agreement, terminate access of any third party to any data room (virtual or actual) which has been set up in the context of a possible Acquisition Proposal containing any information of the Company or any of its Subsidiaries",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.6 – No Solicitation by the Company > (a) > (iii)"
      },
      {
        "section": "confidentiality_and_clean_room",
        "field_name": "clean_room_protection_clause_summary",
        "answer": "The agreement contains a provision that results in the suspension of the Company's access to clean room or confidential information in connection with a Superior Proposal.",
        "summary": "The Company must terminate access to any data room set up for a possible Acquisition Proposal and demand the return or destruction of all confidential information provided to third parties within one business day of the agreement date.",
        "confidence": 0.9,
        "reason": "The clause specifies actions to be taken regarding data room access and confidential information upon receiving an Acquisition Proposal.",
        "clause_text": "The Company shall not provide and shall, within one (1) Business Day of the date of this Agreement, terminate access of any third party to any data room (virtual or actual) which has been set up in the context of a possible Acquisition Proposal containing any information of the Company or any of its Subsidiaries and (iv) within one (1) Business Day of the date of this Agreement, the Company shall demand the return or destruction of all confidential, non-public information and materials that have been provided to third parties that have entered into confidentiality agreements relating to a possible Acquisition Proposal with the Company or any of its Subsidiaries.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.6 – No Solicitation by the Company > (a)"
      }
    ]
  },
  "complex_consideration_and_dividends": {
    "deal_consideration": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "deal_consideration_overview",
        "answer": "$26.45 per share in cash and a number of Parent Shares equal to the Exchange Ratio",
        "summary": "The total consideration offered to target shareholders includes $26.45 per share in cash and a number of Parent Shares equal to the Exchange Ratio.",
        "confidence": 0.95,
        "reason": "The document explicitly states the cash amount and the stock component of the Merger Consideration.",
        "clause_text": "Each share of Company Common Stock issued and outstanding immediately prior to the Effective Time (other than Canceled Shares and Dissenting Shares) shall be automatically canceled and converted into the right to receive, in accordance with the terms of this Agreement (A) $26.45 per share in cash, without interest, from Parent (such amount of cash, the 'Cash Consideration'), and (B) a number of validly issued, fully paid and nonassessable shares, par value EUR 0.59 per share, of Parent (the 'Parent Shares') equal to the Exchange Ratio.",
        "reference_section": "ARTICLE Article II EFFECT OF THE MERGER ON CAPITAL STOCK; EXCHANGE OF CERTIFICATES > Section 2.1 Effect on Securities > (a) > (ii)"
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "deal_consideration_details",
        "answer": "$26.45 per share in cash and a number of Parent Shares equal to the Exchange Ratio",
        "summary": "The merger consideration includes $26.45 per share in cash and a number of Parent Shares equal to the Exchange Ratio, with cash in lieu of fractional shares.",
        "confidence": 0.95,
        "reason": "The document explicitly states the components of the merger consideration, including cash per share and stock exchange ratio.",
        "clause_text": "Each share of Company Common Stock issued and outstanding immediately prior to the Effective Time (other than Canceled Shares and Dissenting Shares) shall be automatically canceled and converted into the right to receive, in accordance with the terms of this Agreement (A) $26.45 per share in cash, without interest, from Parent (such amount of cash, the 'Cash Consideration'), and (B) a number of validly issued, fully paid and nonassessable shares, par value EUR 0.59 per share, of Parent (the 'Parent Shares') equal to the Exchange Ratio (and, if applicable, cash in lieu of fractional Parent Shares payable in accordance with Section 2.1(c)).",
        "reference_section": "ARTICLE Article II EFFECT OF THE MERGER ON CAPITAL STOCK; EXCHANGE OF CERTIFICATES > Section 2.1 Effect on Securities > (a) > (ii)"
      }
    ],
    "proration": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "proration_exists",
        "answer": true,
        "summary": "The agreement provides for proration between different types of consideration, specifically between cash and stock.",
        "confidence": 0.9,
        "reason": "The agreement specifies that each share of Company Common Stock will be converted into the right to receive both cash and Parent Shares, indicating proration between cash and stock consideration.",
        "clause_text": "Each share of Company Common Stock issued and outstanding immediately prior to the Effective Time (other than Canceled Shares and Dissenting Shares) shall be automatically canceled and converted into the right to receive, in accordance with the terms of this Agreement (A) $26.45 per share in cash, without interest, from Parent (such amount of cash, the 'Cash Consideration'), and (B) a number of validly issued, fully paid and nonassessable shares, par value EUR 0.59 per share, of Parent (the 'Parent Shares') equal to the Exchange Ratio.",
        "reference_section": "ARTICLE Article II EFFECT OF THE MERGER ON CAPITAL STOCK; EXCHANGE OF CERTIFICATES > Section 2.1 Effect on Securities > (a) > (ii)"
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "proration_details",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "election": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "election_exists",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "election_details",
        "answer": "No election is permitted and consideration is fixed.",
        "summary": "Shareholders are not allowed to choose the form of consideration; each share of Company Common Stock is automatically canceled and converted into the right to receive a fixed combination of cash and Parent Shares.",
        "confidence": 0.95,
        "reason": "The agreement specifies that each share of Company Common Stock is converted into a fixed combination of cash and Parent Shares, with no mention of an election process for shareholders.",
        "clause_text": "Each share of Company Common Stock issued and outstanding immediately prior to the Effective Time (other than Canceled Shares and Dissenting Shares) shall be automatically canceled and converted into the right to receive, in accordance with the terms of this Agreement (A) $26.45 per share in cash, without interest, from Parent (such amount of cash, the 'Cash Consideration'), and (B) a number of validly issued, fully paid and nonassessable shares, par value EUR 0.59 per share, of Parent (the 'Parent Shares') equal to the Exchange Ratio.",
        "reference_section": "ARTICLE Article II EFFECT OF THE MERGER ON CAPITAL STOCK; EXCHANGE OF CERTIFICATES > Section 2.1 Effect on Securities > (a) > (ii)"
      }
    ],
    "cvr": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "cvr_exists",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "cvr_details",
        "answer": "NA",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "ticking_fees": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "ticking_fees_exists",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "ticking_fees_details",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "contingent_payments": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "contingent_payments_exists",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "contingent_payments_details",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "company_dividends": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "company_dividends_can_pay",
        "answer": false,
        "summary": "The company is prohibited from declaring or paying any dividends or other distributions with respect to its capital stock, except for cash dividends and distributions paid by wholly owned subsidiaries to the company or its wholly owned subsidiaries.",
        "confidence": 0.9,
        "reason": "The clause explicitly prohibits the company from declaring or paying dividends except under specific conditions.",
        "clause_text": "The Company shall not, and shall cause its Subsidiaries not to, directly or indirectly: (d) declare, set aside, authorize, make or pay any dividend or other distribution, payable in cash, stock, property or otherwise, with respect to the Company's or any of its Subsidiaries' capital stock or other equity interests, other than cash dividends and distributions paid by any direct or indirect wholly owned Subsidiary of the Company to the Company or any direct or indirect wholly owned Subsidiary of the Company;",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.1 – Conduct of Business by the Company Pending the Merger > (B) > (d)"
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "company_dividends_details",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "parent_dividends": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "parent_dividends_can_pay",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "parent_dividends_details",
        "answer": "Subject to applicable Law, there shall be paid to the holder of the Parent Shares issued in exchange for Certificates or Book-Entry Shares pursuant to Section 2.2(c), without interest, (i) at the time of delivery of such Parent Shares by the Exchange Agent pursuant to Section 2.2(c), the amount of dividends or other distributions, if any, with a record date after the Effective Time theretofore paid with respect to such Parent Shares, and (ii) at the appropriate payment date, the amount of dividends or other distributions, if any, with a record date after the Effective Time but prior to such delivery of such Parent Shares by the Exchange Agent pursuant to Section 2.2(c), and a payment date subsequent to such delivery of such Parent Shares by the Exchange Agent pursuant to Section 2.2(c), payable with respect to such Parent Shares.",
        "summary": "Dividends on Parent Shares issued in exchange for Company stock are paid without interest, based on record dates after the Effective Time, either at delivery or at the appropriate payment date.",
        "confidence": 0.9,
        "reason": "The clause specifies the timing and conditions for dividend payments on Parent Shares issued in the merger.",
        "clause_text": "Subject to applicable Law, there shall be paid to the holder of the Parent Shares issued in exchange for Certificates or Book-Entry Shares pursuant to Section 2.2(c), without interest, (i) at the time of delivery of such Parent Shares by the Exchange Agent pursuant to Section 2.2(c), the amount of dividends or other distributions, if any, with a record date after the Effective Time theretofore paid with respect to such Parent Shares, and (ii) at the appropriate payment date, the amount of dividends or other distributions, if any, with a record date after the Effective Time but prior to such delivery of such Parent Shares by the Exchange Agent pursuant to Section 2.2(c), and a payment date subsequent to such delivery of such Parent Shares by the Exchange Agent pursuant to Section 2.2(c), payable with respect to such Parent Shares.",
        "reference_section": "ARTICLE II – Effect of the Merger on Capital Stock; Exchange of Certificates > Section 2.2 – Exchange of Certificates > (d)"
      }
    ],
    "collar": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "collar_exists",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "collar_details",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "exchange_ratio_adjustment": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "exchange_ratio_adjustment_exists",
        "answer": true,
        "summary": "The agreement provides for an adjustment to the Exchange Ratio based on structural changes such as stock splits or stock dividends.",
        "confidence": 1.0,
        "reason": "The clause explicitly states that the Exchange Ratio will be adjusted for changes like stock splits or stock dividends.",
        "clause_text": "Without limiting the other provisions of this Agreement, if at any time during the period between the date of this Agreement and the Effective Time, any change in the number or type of outstanding Parent Shares or Company Common Stock shall occur as a result of a reclassification, recapitalization, exchange, stock split (including a reverse stock split), combination or readjustment of shares or any stock dividend or stock distribution with a record date during such period, the Merger Consideration, the Exchange Ratio and any other similarly dependent items, as the case may be, shall be appropriately adjusted to provide the same economic effect as contemplated by this Agreement prior to such event.",
        "reference_section": "ARTICLE II EFFECT OF THE MERGER ON CAPITAL STOCK; EXCHANGE OF CERTIFICATES > Section 2.1 Effect on Securities > (b)"
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "exchange_ratio_adjustment",
        "answer": "The exchange ratio adjustment mechanism includes adjustments for changes in the number or type of outstanding Parent Shares or Company Common Stock due to events like reclassification, recapitalization, exchange, stock split, combination, or stock dividend. The Exchange Ratio is set at 1.0340, and the Equity Award Exchange Ratio is calculated by dividing the Cash Consideration by the Parent Share Price and adding the Exchange Ratio.",
        "summary": "The exchange ratio is adjusted for changes in share numbers or types due to specific corporate events, with a fixed Exchange Ratio of 1.0340 and an Equity Award Exchange Ratio formula.",
        "confidence": 0.9,
        "reason": "The document specifies adjustments for corporate events and provides a formula for the Equity Award Exchange Ratio.",
        "clause_text": "if at any time during the period between the date of this Agreement and the Effective Time, any change in the number or type of outstanding Parent Shares or Company Common Stock shall occur as a result of a reclassification, recapitalization, exchange, stock split (including a reverse stock split), combination or readjustment of shares or any stock dividend or stock distribution with a record date during such period, the Merger Consideration, the Exchange Ratio and any other similarly dependent items, as the case may be, shall be appropriately adjusted to provide the same economic effect as contemplated by this Agreement prior to such event.",
        "reference_section": "ARTICLE Article II EFFECT OF THE MERGER ON CAPITAL STOCK; EXCHANGE OF CERTIFICATES > Section 2.1 Effect on Securities > (b)"
      }
    ],
    "fractional_shares_handling": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "fractional_shares_handling_exists",
        "answer": true,
        "summary": "The agreement includes provisions for handling fractional shares by providing cash in lieu of fractional Parent Shares.",
        "confidence": 0.95,
        "reason": "The agreement explicitly states that no fractional Parent Shares will be issued and cash will be paid in lieu of fractional shares.",
        "clause_text": "No certificate or scrip representing fractional Parent Shares shall be issued upon the cancelation and conversion of Company Common Stock pursuant to Section 2.1(a)(ii), and such fractional share interests shall not entitle the owner thereof to any Parent Shares or to vote or to any other rights of a holder of Parent Shares. All fractional shares that a single record holder of Company Common Stock would be otherwise entitled to receive shall be aggregated and calculations shall be rounded to four (4) decimal places. In lieu of any such fractional shares, each record holder of Company Common Stock who would otherwise be entitled to such fractional shares shall be entitled to an amount in cash, without interest, rounded down to the nearest cent, equal to the product of (i) the amount of the fractional share interest in a share of Parent Shares to which such holder would, but for this Section 2.1(c), be entitled under Section 2.1(a)(ii) and (ii) the Parent Share Price.",
        "reference_section": "ARTICLE Article II EFFECT OF THE MERGER ON CAPITAL STOCK; EXCHANGE OF CERTIFICATES > Section 2.1 Effect on Securities > (c)"
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "fractional_shares_handling",
        "answer": "cash in lieu",
        "summary": "Fractional shares are addressed by providing cash in lieu of fractional Parent Shares, rounded down to the nearest cent.",
        "confidence": 0.95,
        "reason": "The agreement specifies that no fractional Parent Shares will be issued, and instead, cash will be paid for fractional shares.",
        "clause_text": "No certificate or scrip representing fractional Parent Shares shall be issued upon the cancelation and conversion of Company Common Stock pursuant to Section 2.1(a)(ii), and such fractional share interests shall not entitle the owner thereof to any Parent Shares or to vote or to any other rights of a holder of Parent Shares. All fractional shares that a single record holder of Company Common Stock would be otherwise entitled to receive shall be aggregated and calculations shall be rounded to four (4) decimal places. In lieu of any such fractional shares, each record holder of Company Common Stock who would otherwise be entitled to such fractional shares shall be entitled to an amount in cash, without interest, rounded down to the nearest cent, equal to the product of (i) the amount of the fractional share interest in a share of Parent Shares to which such holder would, but for this Section 2.1(c), be entitled under Section 2.1(a)(ii) and (ii) the Parent Share Price.",
        "reference_section": "ARTICLE Article II EFFECT OF THE MERGER ON CAPITAL STOCK; EXCHANGE OF CERTIFICATES > Section 2.1 Effect on Securities > (c)"
      }
    ],
    "dividend_adjustment_mechanism": [
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "dividend_adjustment_mechanism_exists",
        "answer": true,
        "summary": "The merger consideration, including the Exchange Ratio, is adjusted to reflect stock dividends or stock distributions with a record date during the period between the date of the Agreement and the Effective Time.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that the Merger Consideration and Exchange Ratio will be adjusted for any stock dividend or stock distribution with a record date during the specified period.",
        "clause_text": "if at any time during the period between the date of this Agreement and the Effective Time, any change in the number or type of outstanding Parent Shares or Company Common Stock shall occur as a result of a reclassification, recapitalization, exchange, stock split (including a reverse stock split), combination or readjustment of shares or any stock dividend or stock distribution with a record date during such period, the Merger Consideration, the Exchange Ratio and any other similarly dependent items, as the case may be, shall be appropriately adjusted to provide the same economic effect as contemplated by this Agreement prior to such event.",
        "reference_section": "ARTICLE Article II EFFECT OF THE MERGER ON CAPITAL STOCK; EXCHANGE OF CERTIFICATES > Section 2.1 Effect on Securities > (b)"
      },
      {
        "section": "complex_consideration_and_dividends",
        "field_name": "dividend_adjustment_mechanism",
        "answer": "$26.45 per share in cash, without interest, from Parent",
        "summary": "The merger consideration will be adjusted to provide the same economic effect if any stock dividend or stock distribution occurs before the closing.",
        "confidence": 0.9,
        "reason": "The clause specifies that the merger consideration will be adjusted for stock dividends or distributions to maintain the same economic effect.",
        "clause_text": "if at any time during the period between the date of this Agreement and the Effective Time, any change in the number or type of outstanding Parent Shares or Company Common Stock shall occur as a result of a reclassification, recapitalization, exchange, stock split (including a reverse stock split), combination or readjustment of shares or any stock dividend or stock distribution with a record date during such period, the Merger Consideration, the Exchange Ratio and any other similarly dependent items, as the case may be, shall be appropriately adjusted to provide the same economic effect as contemplated by this Agreement prior to such event.",
        "reference_section": "ARTICLE Article II EFFECT OF THE MERGER ON CAPITAL STOCK; EXCHANGE OF CERTIFICATES > Section 2.1 Effect on Securities > (b)"
      }
    ]
  },
  "law_and_jurisdiction": {
    "governing_law": [
      {
        "section": "law_and_jurisdiction",
        "field_name": "governing_law_exists",
        "answer": true,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "law_and_jurisdiction",
        "field_name": "governing_law_jurisdiction",
        "answer": "Delaware",
        "summary": "The agreement specifies that it shall be governed by the laws of the State of Delaware.",
        "confidence": 1.0,
        "reason": "The governing law clause explicitly states that the agreement is governed by Delaware law.",
        "clause_text": "This Agreement and all Proceedings (whether based in contract, tort or otherwise) arising out of or relating to this Agreement or the actions of Parent, Merger Sub or the Company in the negotiation, administration, performance and enforcement hereof, shall be governed by, and construed in accordance with, the Laws of the State of Delaware, without giving effect to any choice or conflict of laws provision or rule (whether of the State of Delaware or any other jurisdiction) that would cause the application of the Laws of any jurisdiction other than the State of Delaware.",
        "reference_section": "ARTICLE Article VIII GENERAL PROVISIONS > Section 8.10 Governing Law"
      }
    ],
    "mae_interpretation_jurisdiction": [
      {
        "section": "law_and_jurisdiction",
        "field_name": "mae_interpretation_jurisdiction_exists",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "law_and_jurisdiction",
        "field_name": "mae_interpretation_jurisdiction",
        "answer": "State of Delaware",
        "summary": "The jurisdiction for MAE interpretation is governed by the laws of the State of Delaware.",
        "confidence": 0.9,
        "reason": "The governing law clause specifies that the agreement and related proceedings are governed by Delaware law.",
        "clause_text": "This Agreement and all Proceedings (whether based in contract, tort or otherwise) arising out of or relating to this Agreement or the actions of Parent, Merger Sub or the Company in the negotiation, administration, performance and enforcement hereof, shall be governed by, and construed in accordance with, the Laws of the State of Delaware, without giving effect to any choice or conflict of laws provision or rule (whether of the State of Delaware or any other jurisdiction) that would cause the application of the Laws of any jurisdiction other than the State of Delaware...",
        "reference_section": "ARTICLE Article VIII GENERAL PROVISIONS > Section 8.10 Governing Law"
      }
    ],
    "financing_jurisdiction": [
      {
        "section": "law_and_jurisdiction",
        "field_name": "financing_jurisdiction_exists",
        "answer": true,
        "summary": "The agreement specifies that disputes related to the Financing or the performance thereof must be brought in any state or Federal court sitting in the county of New York.",
        "confidence": 0.9,
        "reason": "The agreement explicitly states that disputes relating to the Financing must be brought in New York courts.",
        "clause_text": "Notwithstanding anything to the contrary in this Agreement, each party agrees that it will not bring or support any action, cause of action, claim, cross-claim or third-party claim of any kind or description, whether in law or in equity, whether in contract or in tort or otherwise, against the Financing Source Parties in any way relating to this Agreement or any of the transactions contemplated by this Agreement, including any dispute arising out of or relating in any way to the Financing or the performance thereof, in any forum other than any state or Federal court sitting in the county of New York.",
        "reference_section": "ARTICLE Article VIII GENERAL PROVISIONS > Section 8.12 Consent to Jurisdiction > (c)"
      },
      {
        "section": "law_and_jurisdiction",
        "field_name": "financing_jurisdiction",
        "answer": "New York",
        "summary": "All matters relating to any action or claim against any Financing Source Party, and all matters relating to the interpretation, construction, validity and enforcement against any of the Financing Source Parties relating to the Debt Letters or the performance thereof or the Financing, shall be exclusively governed by the Laws of the State of New York.",
        "confidence": 0.9,
        "reason": "The document explicitly states that matters related to the Financing Source Parties and the Financing are governed by New York law.",
        "clause_text": "all matters relating to any action or claim against any Financing Source Party, and all matters relating to the interpretation, construction, validity and enforcement (whether at law, in equity, in contract, in tort, or otherwise) against any of the Financing Source Parties in anyway relating to the Debt Letters or the performance thereof or the Financing, shall be exclusively governed by, and construed in accordance with, the Laws of the State of New York.",
        "reference_section": "ARTICLE Article VIII GENERAL PROVISIONS > Section 8.10 Governing Law"
      }
    ],
    "exclusive_forum_clause": [
      {
        "section": "law_and_jurisdiction",
        "field_name": "exclusive_forum_clause_exists",
        "answer": true,
        "summary": "The agreement includes an exclusive forum clause specifying that any legal claim or proceeding arising out of the agreement must be brought in the Delaware Court of Chancery or, if it declines jurisdiction, any state or federal court within Delaware.",
        "confidence": 0.95,
        "reason": "The clause explicitly states that parties submit to the exclusive jurisdiction of Delaware courts for disputes related to the agreement.",
        "clause_text": "(a) Each of the parties hereto hereby, with respect to any legal claim or Proceeding arising out of this Agreement or the transactions contemplated by this Agreement, (i) expressly and irrevocably submits, for itself and with respect to its property, generally and unconditionally, to the exclusive jurisdiction of the Delaware Court of Chancery and any appellate court therefrom within the State of Delaware (or, if the Delaware Court of Chancery declines to accept jurisdiction over a particular matter, any state or federal court within the State of Delaware), (ii) agrees that it will not attempt to deny or defeat such personal jurisdiction by motion or other request for leave from any such courts, (iii) agrees that it will not bring any claim or Proceeding relating to this Agreement or the transactions contemplated by this Agreement except in such courts...",
        "reference_section": "ARTICLE Article VIII GENERAL PROVISIONS > Section 8.12 Consent to Jurisdiction > (a)"
      },
      {
        "section": "law_and_jurisdiction",
        "field_name": "exclusive_forum_clause",
        "answer": "Delaware Court of Chancery",
        "summary": "The parties agree to submit to the exclusive jurisdiction of the Delaware Court of Chancery for any legal claims or proceedings arising out of the agreement.",
        "confidence": 1.0,
        "reason": "The clause explicitly states the exclusive jurisdiction of the Delaware Court of Chancery for disputes related to the agreement.",
        "clause_text": "(a) Each of the parties hereto hereby, with respect to any legal claim or Proceeding arising out of this Agreement or the transactions contemplated by this Agreement, (i) expressly and irrevocably submits, for itself and with respect to its property, generally and unconditionally, to the exclusive jurisdiction of the Delaware Court of Chancery and any appellate court therefrom within the State of Delaware (or, if the Delaware Court of Chancery declines to accept jurisdiction over a particular matter, any state or federal court within the State of Delaware),",
        "reference_section": "ARTICLE Article VIII GENERAL PROVISIONS > Section 8.12 Consent to Jurisdiction > (a)"
      }
    ],
    "financing_commitment_enforcement_venue": [
      {
        "section": "law_and_jurisdiction",
        "field_name": "financing_commitment_enforcement_venue_exists",
        "answer": true,
        "summary": "The agreement specifies that any legal claim or proceeding related to the financing commitments must be brought in state or federal courts sitting in the county of New York.",
        "confidence": 1.0,
        "reason": "The agreement explicitly states the jurisdiction for enforcing financing commitments.",
        "clause_text": "Notwithstanding anything to the contrary in this Agreement, each party agrees that it will not bring or support any action, cause of action, claim, cross-claim or third-party claim of any kind or description, whether in law or in equity, whether in contract or in tort or otherwise, against the Financing Source Parties in any way relating to this Agreement or any of the transactions contemplated by this Agreement, including any dispute arising out of or relating in any way to the Financing or the performance thereof, in any forum other than any state or Federal court sitting in the county of New York.",
        "reference_section": "ARTICLE Article VIII GENERAL PROVISIONS > Section 8.12 Consent to Jurisdiction > (c)"
      },
      {
        "section": "law_and_jurisdiction",
        "field_name": "financing_commitment_enforcement_venue",
        "answer": "any state or Federal court sitting in the county of New York",
        "summary": "The enforcement venue for actions against the Financing Source Parties is exclusively any state or Federal court sitting in the county of New York.",
        "confidence": 0.9,
        "reason": "The clause specifies that actions related to the Financing against the Financing Source Parties must be brought in New York courts.",
        "clause_text": "(c) Notwithstanding anything to the contrary in this Agreement, each party agrees that it will not bring or support any action, cause of action, claim, cross-claim or third-party claim of any kind or description, whether in law or in equity, whether in contract or in tort or otherwise, against the Financing Source Parties in any way relating to this Agreement or any of the transactions contemplated by this Agreement, including any dispute arising out of or relating in any way to the Financing or the performance thereof, in any forum other than any state or Federal court sitting in the county of New York.",
        "reference_section": "ARTICLE Article VIII GENERAL PROVISIONS > Section 8.12 Consent to Jurisdiction > (c)"
      }
    ],
    "split_venue_clause": [
      {
        "section": "law_and_jurisdiction",
        "field_name": "split_venue_clause_exists",
        "answer": true,
        "summary": "The agreement splits disputes into different jurisdictions, with general claims under Delaware jurisdiction and financing-related claims under New York jurisdiction.",
        "confidence": 0.95,
        "reason": "The agreement specifies that general claims are subject to Delaware jurisdiction, while claims related to financing are subject to New York jurisdiction.",
        "clause_text": "Notwithstanding anything to the contrary in this Agreement, each party agrees that it will not bring or support any action, cause of action, claim, cross-claim or third-party claim of any kind or description, whether in law or in equity, whether in contract or in tort or otherwise, against the Financing Source Parties in any way relating to this Agreement or any of the transactions contemplated by this Agreement, including any dispute arising out of or relating in any way to the Financing or the performance thereof, in any forum other than any state or Federal court sitting in the county of New York.",
        "reference_section": "ARTICLE Article VIII GENERAL PROVISIONS > Section 8.12 Consent to Jurisdiction > (c)"
      },
      {
        "section": "law_and_jurisdiction",
        "field_name": "split_venue_clause",
        "answer": "general in Delaware, financing in New York",
        "summary": "The agreement specifies that general legal claims are subject to Delaware jurisdiction, while claims related to financing are subject to New York jurisdiction.",
        "confidence": 0.95,
        "reason": "The agreement explicitly states that general claims are under Delaware jurisdiction and financing-related claims are under New York jurisdiction.",
        "clause_text": "(a) Each of the parties hereto hereby, with respect to any legal claim or Proceeding arising out of this Agreement or the transactions contemplated by this Agreement, (i) expressly and irrevocably submits, for itself and with respect to its property, generally and unconditionally, to the exclusive jurisdiction of the Delaware Court of Chancery... (c) Notwithstanding anything to the contrary in this Agreement, each party agrees that it will not bring or support any action... against the Financing Source Parties... in any forum other than any state or Federal court sitting in the county of New York.",
        "reference_section": "ARTICLE Article VIII GENERAL PROVISIONS > Section 8.12 Consent to Jurisdiction > (a), (c)"
      }
    ],
    "jury_trial_waiver": [
      {
        "section": "law_and_jurisdiction",
        "field_name": "jury_trial_waiver_exists",
        "answer": true,
        "summary": "The agreement contains a waiver of jury trial rights by Parent, Merger Sub, and the Company for any action, proceeding, or counterclaim arising out of or relating to the agreement.",
        "confidence": 1.0,
        "reason": "The clause explicitly states that all parties irrevocably waive their right to a trial by jury.",
        "clause_text": "EACH OF PARENT, MERGER SUB AND THE COMPANY HEREBY IRREVOCABLY WAIVES ALL RIGHT TO TRIAL BY JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM (WHETHER BASED IN CONTRACT, TORT OR OTHERWISE) BETWEEN THEM ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE ACTIONS OF PARENT, MERGER SUB OR THE COMPANY IN THE NEGOTIATION, ADMINISTRATION, PERFORMANCE AND ENFORCEMENT HEREOF (INCLUDING ANY ACTION OR PROCEEDING AGAINST THE FINANCING SOURCE PARTIES ARISING OUT OF OR RELATED TO THE TRANSACTIONS CONTEMPLATED HEREBY, THE FINANCING OR THE PERFORMANCE OF SERVICES WITH RESPECT THERETO).",
        "reference_section": "ARTICLE Article VIII GENERAL PROVISIONS > Section 8.14 WAIVER OF JURY TRIAL"
      },
      {
        "section": "law_and_jurisdiction",
        "field_name": "jury_trial_waiver",
        "answer": "EACH OF PARENT, MERGER SUB AND THE COMPANY HEREBY IRREVOCABLY WAIVES ALL RIGHT TO TRIAL BY JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM (WHETHER BASED IN CONTRACT, TORT OR OTHERWISE) BETWEEN THEM ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE ACTIONS OF PARENT, MERGER SUB OR THE COMPANY IN THE NEGOTIATION, ADMINISTRATION, PERFORMANCE AND ENFORCEMENT HEREOF (INCLUDING ANY ACTION OR PROCEEDING AGAINST THE FINANCING SOURCE PARTIES ARISING OUT OF OR RELATED TO THE TRANSACTIONS CONTEMPLATED HEREBY, THE FINANCING OR THE PERFORMANCE OF SERVICES WITH RESPECT THERETO).",
        "summary": "The parties irrevocably waive their right to a jury trial for any disputes arising from or related to the agreement.",
        "confidence": 1.0,
        "reason": "The clause explicitly states the waiver of the right to a jury trial for actions related to the agreement.",
        "clause_text": "EACH OF PARENT, MERGER SUB AND THE COMPANY HEREBY IRREVOCABLY WAIVES ALL RIGHT TO TRIAL BY JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM (WHETHER BASED IN CONTRACT, TORT OR OTHERWISE) BETWEEN THEM ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE ACTIONS OF PARENT, MERGER SUB OR THE COMPANY IN THE NEGOTIATION, ADMINISTRATION, PERFORMANCE AND ENFORCEMENT HEREOF (INCLUDING ANY ACTION OR PROCEEDING AGAINST THE FINANCING SOURCE PARTIES ARISING OUT OF OR RELATED TO THE TRANSACTIONS CONTEMPLATED HEREBY, THE FINANCING OR THE PERFORMANCE OF SERVICES WITH RESPECT THERETO).",
        "reference_section": "ARTICLE Article VIII GENERAL PROVISIONS > Section 8.14 WAIVER OF JURY TRIAL"
      }
    ],
    "arbitration_clause": [
      {
        "section": "law_and_jurisdiction",
        "field_name": "arbitration_clause_exists",
        "answer": false,
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      },
      {
        "section": "law_and_jurisdiction",
        "field_name": "arbitration_clause",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "ancillary_agreement_governing_law": [
      {
        "section": "law_and_jurisdiction",
        "field_name": "ancillary_agreement_governing_law_exists",
        "answer": true,
        "summary": "The ancillary agreements specify a different governing law from the main agreement, with matters relating to the Financing Source Parties governed by New York law, while the main agreement is governed by Delaware law.",
        "confidence": 0.9,
        "reason": "The document specifies that all matters relating to the Financing Source Parties are governed by New York law, differing from the main agreement's Delaware law.",
        "clause_text": "This Agreement and all Proceedings (whether based in contract, tort or otherwise) arising out of or relating to this Agreement or the actions of Parent, Merger Sub or the Company in the negotiation, administration, performance and enforcement hereof, shall be governed by, and construed in accordance with, the Laws of the State of Delaware... all matters relating to any action or claim against any Financing Source Party... shall be exclusively governed by, and construed in accordance with, the Laws of the State of New York.",
        "reference_section": "ARTICLE Article VIII GENERAL PROVISIONS > Section 8.10 Governing Law"
      },
      {
        "section": "law_and_jurisdiction",
        "field_name": "ancillary_agreement_governing_law",
        "answer": "New York",
        "summary": "The governing law for matters relating to the Financing Source Parties and the Financing is exclusively governed by the laws of the State of New York.",
        "confidence": 0.9,
        "reason": "The clause explicitly states that all matters relating to the Financing Source Parties and the Financing are governed by New York law.",
        "clause_text": "all matters relating to any action or claim against any Financing Source Party, and all matters relating to the interpretation, construction, validity and enforcement (whether at law, in equity, in contract, in tort, or otherwise) against any of the Financing Source Parties in anyway relating to the Debt Letters or the performance thereof or the Financing, shall be exclusively governed by, and construed in accordance with, the Laws of the State of New York.",
        "reference_section": "ARTICLE Article VIII GENERAL PROVISIONS > Section 8.10 Governing Law"
      }
    ]
  },
  "financing": {
    "committed_financing": [
      {
        "section": "financing",
        "field_name": "committed_financing_present",
        "answer": true,
        "summary": "The agreement mentions committed financing through a debt commitment letter involving JH North America Holdings Inc., Bank of America, N.A., and Jeffries Finance LLC.",
        "confidence": 0.95,
        "reason": "The document explicitly references a commitment letter and related fee letters, indicating committed financing.",
        "clause_text": "Parent has delivered to the Company true and complete fully executed copies of (a) the commitment letter, dated as of the date hereof, among JH North America Holdings Inc., a Delaware corporation and a wholly owned indirect Subsidiary of Parent (the \"Borrower\"), and Bank of America, N.A. and Jeffries Finance LLC (together, the \"Initial Lenders\") and (b) the fee letters related thereto...",
        "reference_section": "ARTICLE Article IV REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB > Section 4.25 Financing"
      },
      {
        "section": "financing",
        "field_name": "committed_financing_summary",
        "answer": "JH North America Holdings Inc., a wholly owned indirect Subsidiary of Parent, has secured committed debt financing from Bank of America, N.A. and Jeffries Finance LLC, who are the Initial Lenders.",
        "summary": "JH North America Holdings Inc., a wholly owned indirect Subsidiary of Parent, has secured committed debt financing from Bank of America, N.A. and Jeffries Finance LLC, who are the Initial Lenders.",
        "confidence": 0.9,
        "reason": "The clause explicitly mentions the commitment letter involving JH North America Holdings Inc. and the Initial Lenders, Bank of America, N.A. and Jeffries Finance LLC.",
        "clause_text": "Parent has delivered to the Company true and complete fully executed copies of (a) the commitment letter, dated as of the date hereof, among JH North America Holdings Inc., a Delaware corporation and a wholly owned indirect Subsidiary of Parent (the \"Borrower\"), and Bank of America, N.A. and Jeffries Finance LLC (together, the \"Initial Lenders\")...",
        "reference_section": "ARTICLE Article IV REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB > Section 4.25 Financing"
      }
    ],
    "cash_on_hand": [
      {
        "section": "financing",
        "field_name": "cash_on_hand_specified_present",
        "answer": true,
        "summary": "The agreement explicitly states that cash on hand will be used to fund part of the transaction.",
        "confidence": 0.9,
        "reason": "The clause explicitly mentions that cash on hand will be used along with other financing to consummate the merger.",
        "clause_text": "Parent shall, and shall cause its Subsidiaries (including the Borrower) to, use reasonable best efforts to take, or cause to be taken, all actions, and to do, or cause to be done, all things reasonably necessary to consummate the Financing in an amount sufficient, together with cash on hand and amounts available to be drawn on the Parent Credit Facilities, to consummate the Merger and the other transactions contemplated hereby no later than the Closing.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.15 – Financing and Financing Cooperation > (a)"
      },
      {
        "section": "financing",
        "field_name": "cash_on_hand_specified",
        "answer": "Parent shall use cash on hand as a funding source to consummate the Merger and other transactions.",
        "summary": "Parent will use cash on hand, along with other financial resources, to fund the Merger and related transactions.",
        "confidence": 0.9,
        "reason": "The clause specifies that cash on hand will be used in conjunction with other financing to complete the Merger.",
        "clause_text": "Parent shall, and shall cause its Subsidiaries (including the Borrower) to, use reasonable best efforts to take, or cause to be taken, all actions, and to do, or cause to be done, all things reasonably necessary to consummate the Financing in an amount sufficient, together with cash on hand and amounts available to be drawn on the Parent Credit Facilities, to consummate the Merger and the other transactions contemplated hereby no later than the Closing.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.15 Financing and Financing Cooperation > (a)"
      }
    ],
    "financing_efforts_summary": [
      {
        "section": "financing",
        "field_name": "financing_efforts_summary",
        "answer": "Parent is obligated to use reasonable best efforts to consummate the Financing, including maintaining the Debt Letters, entering into definitive agreements, and satisfying conditions to the Financing. Parent must also keep the Company informed of the status and any material adverse impacts on the Financing.",
        "summary": "Parent must use reasonable best efforts to secure financing, maintain agreements, and satisfy conditions, while keeping the Company informed of any material changes.",
        "confidence": 0.9,
        "reason": "The language specifies 'reasonable best efforts' and details actions required to secure financing, implying a strong obligation.",
        "clause_text": "Parent shall, and shall cause its Subsidiaries (including the Borrower) to, use reasonable best efforts to take, or cause to be taken, all actions, and to do, or cause to be done, all things reasonably necessary to consummate the Financing in an amount sufficient, together with cash on hand and amounts available to be drawn on the Parent Credit Facilities, to consummate the Merger and the other transactions contemplated hereby no later than the Closing, including, to the extent necessary to consummate the Merger and such other transactions, using reasonable best efforts to (i) (A) maintain in effect the Debt Letters and in all material respects comply with all of their respective obligations thereunder and (B) negotiate, enter into and deliver definitive agreements with respect to the Financing reflecting the terms contained in the Debt Letters (or with other terms agreed by Parent and the Financing Parties, subject to the restrictions on amendments of the Debt Letters set forth below), so that such agreements are in effect no later than the Closing, and (ii) satisfy on a timely basis all the conditions to the Financing and the definitive agreements related thereto that are in Parent's (or its Subsidiaries' (including the Borrower's)) control.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.15 – Financing and Financing Cooperation > (a)"
      }
    ],
    "substitute_financing_notice_and_efforts": [
      {
        "section": "financing",
        "field_name": "substitute_financing_notice_and_efforts",
        "answer": "The acquirer is required to notify the company if financing becomes unavailable and must use reasonable best efforts to obtain substitute financing.",
        "summary": "The acquirer must notify the company in writing if financing becomes unavailable and use reasonable best efforts to obtain substitute financing on terms not materially less favorable.",
        "confidence": 0.9,
        "reason": "The clause explicitly states the requirement to notify and seek substitute financing.",
        "clause_text": "If funds in the amounts set forth in the Debt Letters, or any portion thereof, become unavailable, Parent shall, and shall cause its Subsidiaries to, as promptly as practicable following the occurrence of such event (x) notify the Company in writing thereof and (y) use reasonable best efforts to obtain substitute financing...",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.15 – Financing and Financing Cooperation > (b)"
      }
    ]
  },
  "proxy_statement": {
    "proxy_statement_filing_timing": [
      {
        "section": "proxy_statement",
        "field_name": "proxy_statement_filing_timing",
        "answer": "As promptly as reasonably practicable after the execution of this Agreement",
        "summary": "The proxy statement and Form F-4 must be filed with the SEC as promptly as reasonably practicable after the execution of the agreement.",
        "confidence": 0.9,
        "reason": "The clause specifies the timing for filing the proxy statement and Form F-4 as 'as promptly as reasonably practicable after the execution of this Agreement.'",
        "clause_text": "(a) As promptly as reasonably practicable after the execution of this Agreement, (i) the Company (with Parent's reasonable cooperation) shall prepare and file with the SEC the Proxy Statement in preliminary form and (ii) Parent (with the Company's reasonable cooperation) shall prepare and file with the SEC a registration statement on Form F-4, in which the Proxy Statement will be included as a prospectus, in connection with the registration under the Securities Act of the Parent Shares to be issued in the Merger;",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.3 – Preparation of the Form F-4 and the Proxy Statement; Company Stockholders’ Meeting > (a)"
      }
    ],
    "f4_effectiveness": [
      {
        "section": "proxy_statement",
        "field_name": "f4_effectiveness_efforts",
        "answer": "reasonable best efforts",
        "summary": "The parties must use their reasonable best efforts to make the Form F-4 effective as promptly as reasonably practicable.",
        "confidence": 0.9,
        "reason": "The clause explicitly states the standard of 'reasonable best efforts' for the parties to achieve the effectiveness of the Form F-4.",
        "clause_text": "Subject to the terms and conditions of this Agreement, the parties hereto will cooperate with each other and use (and will cause their respective Subsidiaries to use) their respective reasonable best efforts to consummate the transactions contemplated by this Agreement and to cause the conditions to the Merger set forth in Article VI to be satisfied as promptly as reasonably practicable, including using reasonable best efforts to accomplish the following as promptly as reasonably practicable...",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (a)"
      },
      {
        "section": "proxy_statement",
        "field_name": "f4_effectiveness_target_date",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "shareholder_meeting": [
      {
        "section": "proxy_statement",
        "field_name": "shareholder_meeting_timing",
        "answer": "within fifty (50) days of the effectiveness of the Form F-4",
        "summary": "The shareholder meeting is expected to be held within fifty (50) days following the effectiveness of the Form F-4.",
        "confidence": 0.9,
        "reason": "The document specifies that the Company Stockholders' Meeting will be held within fifty (50) days of the Form F-4 becoming effective.",
        "clause_text": "Subject to the earlier termination of this Agreement in accordance with Section 7.1, the Company shall, as soon as reasonably practicable following the effectiveness of the Form F-4, duly call, give notice of, convene (on a date selected by the Company in consultation with Parent, which date shall be within, subject to adjournment or postponement as provided below, fifty (50) days of the effectiveness of the Form F-4) and hold a meeting of its stockholders (the \"Company Stockholders' Meeting\") for the purpose of seeking the Company Stockholder Approval.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.3 – Preparation of the Form F-4 and the Proxy Statement; Company Stockholders’ Meeting > (b)"
      },
      {
        "section": "proxy_statement",
        "field_name": "shareholder_meeting_deadline",
        "answer": "within fifty (50) days of the effectiveness of the Form F-4",
        "summary": "The shareholder meeting must be held within fifty (50) days of the effectiveness of the Form F-4.",
        "confidence": 0.9,
        "reason": "The document specifies a deadline for holding the shareholder meeting within fifty days after the Form F-4 becomes effective.",
        "clause_text": "Subject to the earlier termination of this Agreement in accordance with Section 7.1, the Company shall, as soon as reasonably practicable following the effectiveness of the Form F-4, duly call, give notice of, convene (on a date selected by the Company in consultation with Parent, which date shall be within, subject to adjournment or postponement as provided below, fifty (50) days of the effectiveness of the Form F-4) and hold a meeting of its stockholders (the 'Company Stockholders' Meeting') for the purpose of seeking the Company Stockholder Approval...",
        "reference_section": "ARTICLE Article V COVENANTS AND AGREEMENTS > Section 5.3 Preparation of the Form F-4 and the Proxy Statement; Company Stockholders’ Meeting > (b)"
      },
      {
        "section": "proxy_statement",
        "field_name": "shareholder_vote_efforts",
        "answer": "The company is required to use its reasonable best efforts to solicit proxies in favor of the adoption of the agreement and take all other action necessary or advisable to secure the Company Stockholder Approval.",
        "summary": "The company must use its reasonable best efforts to solicit proxies and take necessary actions to secure shareholder approval.",
        "confidence": 0.9,
        "reason": "The clause explicitly states the company's obligation to use reasonable best efforts to solicit proxies and secure approval.",
        "clause_text": "If the Company Board has not made an Adverse Recommendation Change in accordance with Section 5.6, the Company shall, through the Company Board, make the Company Recommendation, and shall include such Company Recommendation in the Proxy Statement, and use its reasonable best efforts to (A) solicit from its stockholders proxies in favor of the adoption of this Agreement and (B) take all other action necessary or advisable to secure the Company Stockholder Approval.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.3 – Preparation of the Form F-4 and the Proxy Statement; Company Stockholders’ Meeting > (b)"
      }
    ],
    "quorum_or_vote_failure": [
      {
        "section": "proxy_statement",
        "field_name": "quorum_or_vote_failure_handling",
        "answer": "If there are not sufficient affirmative votes to constitute a quorum or obtain shareholder approval, the Company may adjourn or postpone the meeting for up to 25 business days to allow additional time for solicitation of proxies.",
        "summary": "If quorum or shareholder approval is not met, the Company may adjourn or postpone the meeting for up to 25 business days to solicit more proxies.",
        "confidence": 0.9,
        "reason": "The clause explicitly allows for adjournment or postponement if there are insufficient votes for quorum or approval.",
        "clause_text": "the Company may adjourn or postpone the Company Stockholders' Meeting (i) after consultation with Parent, to the extent necessary to ensure that any supplement or amendment to the Proxy Statement or Form F-4 required by Law is provided to the stockholders of the Company within a reasonable amount of time in advance of the Company Stockholders' Meeting or (ii) if there are not sufficient affirmative votes in person or by proxy at such meeting to constitute a quorum at the Company Stockholders' Meeting or to obtain the Company Stockholder Approval, to allow reasonable additional time for solicitation of proxies for purposes of obtaining a quorum or the Company Stockholder Approval; provided, however, that unless agreed to in writing by Parent, any such adjournments or postponements under this clause (ii) shall be for a period of no more than twenty-five (25) Business Days in the aggregate;",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.3 – Preparation of the Form F-4 and the Proxy Statement; Company Stockholders’ Meeting > (b)"
      },
      {
        "section": "proxy_statement",
        "field_name": "quorum_or_vote_failure_deadline",
        "answer": "twenty-five Business Days",
        "summary": "The Company may adjourn or postpone the Company Stockholders' Meeting for a period of no more than twenty-five Business Days in the aggregate to allow additional time for solicitation of proxies.",
        "confidence": 0.9,
        "reason": "The document specifies a maximum period for adjournments or postponements to obtain a quorum or stockholder approval.",
        "clause_text": "provided, however, that unless agreed to in writing by Parent, any such adjournments or postponements under this clause (ii) shall be for a period of no more than twenty-five (25) Business Days in the aggregate;",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.3 – Preparation of the Form F-4 and the Proxy Statement; Company Stockholders’ Meeting > (b)"
      }
    ],
    "proxy_summary_notes": [
      {
        "section": "proxy_statement",
        "field_name": "proxy_summary_notes",
        "answer": "The Company must call a stockholders' meeting within 50 days of the Form F-4's effectiveness, with possible adjournments or postponements under specific conditions, and requires a majority vote for approval.",
        "summary": "The Company is required to hold a stockholders' meeting within 50 days of the Form F-4's effectiveness, with potential adjournments or postponements allowed under certain conditions, and a majority vote is needed for approval.",
        "confidence": 0.9,
        "reason": "The agreement specifies a timeline for the stockholders' meeting and conditions for adjournment or postponement, indicating notable terms related to proxy or shareholder voting.",
        "clause_text": "the Company shall, as soon as reasonably practicable following the effectiveness of the Form F-4, duly call, give notice of, convene (on a date selected by the Company in consultation with Parent, which date shall be within, subject to adjournment or postponement as provided below, fifty (50) days of the effectiveness of the Form F-4) and hold a meeting of its stockholders (the \"Company Stockholders' Meeting\") for the purpose of seeking the Company Stockholder Approval...",
        "reference_section": "ARTICLE Article V COVENANTS AND AGREEMENTS > Section 5.3 Preparation of the Form F-4 and the Proxy Statement; Company Stockholders’ Meeting > (b)"
      }
    ]
  },
  "timeline": {
    "agreement_signing_date": [
      {
        "section": "timeline",
        "field_name": "agreement_signing_date",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "confidentiality_agreement_signing_date": [
      {
        "section": "timeline",
        "field_name": "confidentiality_agreement_signing_date",
        "answer": "January 23, 2025",
        "summary": "The confidentiality agreement related to the merger was signed on January 23, 2025, between Parent and the Company.",
        "confidence": 1.0,
        "reason": "The date is explicitly stated in the definition of the Confidentiality Agreement.",
        "clause_text": "Confidentiality Agreement shall mean the confidentiality agreement, dated January 23, 2025, between Parent and the Company.",
        "reference_section": "Definition > Confidentiality Agreement"
      }
    ],
    "announcement_date": [
      {
        "section": "timeline",
        "field_name": "announcement_date",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "proxy_filing_deadline": [
      {
        "section": "timeline",
        "field_name": "proxy_filing_deadline",
        "answer": "As promptly as reasonably practicable after the execution of this Agreement",
        "summary": "The preliminary proxy statement and/or registration statement on Form F-4 must be filed as promptly as reasonably practicable after the execution of the agreement.",
        "confidence": 0.9,
        "reason": "The clause specifies that the filing should occur 'as promptly as reasonably practicable' after the agreement's execution.",
        "clause_text": "As promptly as reasonably practicable after the execution of this Agreement, (i) the Company (with Parent's reasonable cooperation) shall prepare and file with the SEC the Proxy Statement in preliminary form and (ii) Parent (with the Company's reasonable cooperation) shall prepare and file with the SEC a registration statement on Form F-4, in which the Proxy Statement will be included as a prospectus, in connection with the registration under the Securities Act of the Parent Shares to be issued in the Merger;",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.3 – Preparation of the Form F-4 and the Proxy Statement; Company Stockholders’ Meeting > (a)"
      }
    ],
    "shareholder_vote_deadline": [
      {
        "section": "timeline",
        "field_name": "shareholder_vote_deadline",
        "answer": "within 50 days of the effectiveness of the Form F-4",
        "summary": "The shareholder vote must occur within 50 days of the effectiveness of the Form F-4, subject to possible adjournment or postponement.",
        "confidence": 0.9,
        "reason": "The document specifies a timeline for the shareholder vote relative to the Form F-4 effectiveness.",
        "clause_text": "Subject to the earlier termination of this Agreement in accordance with Section 7.1, the Company shall, as soon as reasonably practicable following the effectiveness of the Form F-4, duly call, give notice of, convene (on a date selected by the Company in consultation with Parent, which date shall be within, subject to adjournment or postponement as provided below, fifty (50) days of the effectiveness of the Form F-4) and hold a meeting of its stockholders (the 'Company Stockholders' Meeting') for the purpose of seeking the Company Stockholder Approval.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.3 – Preparation of the Form F-4 and the Proxy Statement; Company Stockholders’ Meeting > (b)"
      }
    ],
    "outside_date": [
      {
        "section": "timeline",
        "field_name": "outside_date",
        "answer": "5:00 p.m. (Chicago, Illinois, United States time) on the twelve (12)-month anniversary of the date of this Agreement",
        "summary": "The initial Outside Date is specified as 5:00 p.m. on the twelve-month anniversary of the date of the Agreement.",
        "confidence": 0.95,
        "reason": "The clause explicitly states the Outside Date as the twelve-month anniversary of the Agreement date.",
        "clause_text": "by either Parent or the Company, if: (i) the Merger shall not have been consummated on or before 5:00 p.m. (Chicago, Illinois, United States time) on the twelve (12)-month anniversary of the date of this Agreement (the \"Termination Date\");",
        "reference_section": "ARTICLE Article VII TERMINATION, AMENDMENT AND WAIVER > Section 7.1 Termination > (b) > (i)"
      },
      {
        "section": "timeline",
        "field_name": "outside_date_extension_list",
        "answer": [
          {
            "Extension Length": "3 months",
            "Who Grants the Extension": "automatic",
            "Conditions to Extend": "if any of the conditions to Closing set forth in Section 6.1(d) or Section 6.1(e) (if the Restraint is in respect of an Antitrust Law) shall not have been satisfied, but all other conditions set forth in Section 6.1 through Section 6.3 shall have been satisfied or waived",
            "Termination Restrictions Due to Breach": "Yes, the right to terminate is not available to any party if a material breach by such party has been the principal cause of or principally resulted in the failure of the Closing to have occurred on or before the Termination Date."
          }
        ],
        "summary": "The Termination Date may be automatically extended by 3 months if certain conditions related to Antitrust Law are not met, provided all other conditions are satisfied or waived. Termination rights are restricted if a party's material breach caused the failure to close.",
        "confidence": 0.95,
        "reason": "The clause specifies an automatic extension and conditions under which termination rights are restricted due to breach.",
        "clause_text": "provided that if, on the Termination Date, any of the conditions to Closing set forth in Section 6.1(d) or Section 6.1(e) (if the Restraint is in respect of an Antitrust Law) shall not have been satisfied, but all other conditions set forth in Section 6.1 through Section 6.3 shall have been satisfied or waived...the Termination Date shall automatically, without any action on the part of the parties hereto, be extended for three (3) months...the right to terminate this Agreement pursuant to this Section 7.1(b)(i) shall not be available to any party if a material breach by such party of any of its obligations under this Agreement has been the principal cause of or principally resulted in the failure of the Closing to have occurred on or before the Termination Date;",
        "reference_section": "ARTICLE Article VII TERMINATION, AMENDMENT AND WAIVER > Section 7.1 Termination > (b)(i)"
      }
    ],
    "hsr_filing_deadline": [
      {
        "section": "timeline",
        "field_name": "hsr_filing_deadline",
        "answer": "twenty-five Business Days following the date of this Agreement",
        "summary": "The parties are required to make their respective filings under the HSR Act no later than twenty-five Business Days following the date of the Agreement.",
        "confidence": 0.9,
        "reason": "The document explicitly states the deadline for HSR Act filings as twenty-five Business Days from the date of the Agreement.",
        "clause_text": "Each of the parties hereto shall, in consultation and cooperation with the other parties and as promptly as reasonably practicable, but in any event no later than twenty-five (25) Business Days following the date of this Agreement, make its respective filings under the HSR Act.",
        "reference_section": "ARTICLE V – Covenants and Agreements > Section 5.4 – Appropriate Action; Consents; Filings > (a)"
      }
    ],
    "second_request_deadline": [
      {
        "section": "timeline",
        "field_name": "second_request_deadline",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "cfius_filing_deadline": [
      {
        "section": "timeline",
        "field_name": "cfius_filing_deadline",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "regulatory_approval_outside_date": [
      {
        "section": "timeline",
        "field_name": "regulatory_approval_outside_date",
        "answer": "5:00 p.m. on the twelve (12)-month anniversary of the date of this Agreement, extendable by three (3) months if certain regulatory conditions are not met.",
        "summary": "The Termination Date for the merger is set for 5:00 p.m. on the twelve-month anniversary of the agreement date, with an automatic three-month extension if specific regulatory conditions related to Antitrust Law are not satisfied.",
        "confidence": 0.9,
        "reason": "The clause specifies the Termination Date and conditions for extension based on regulatory approval delays.",
        "clause_text": "the Merger shall not have been consummated on or before 5:00 p.m. (Chicago, Illinois, United States time) on the twelve (12)-month anniversary of the date of this Agreement (the \"Termination Date\"); provided that if, on the Termination Date, any of the conditions to Closing set forth in Section 6.1(d) or Section 6.1(e) (if the Restraint is in respect of an Antitrust Law) shall not have been satisfied, but all other conditions set forth in Section 6.1 through Section 6.3 shall have been satisfied or waived (other than those conditions that by their nature are to be satisfied at the Effective Time (if such conditions are capable of being satisfied were the Closing to occur at such time)), the Termination Date shall automatically, without any action on the part of the parties hereto, be extended for three (3) months, and such date as so extended shall be the \"Termination Date\" for all purposes hereunder;",
        "reference_section": "ARTICLE Article VII TERMINATION, AMENDMENT AND WAIVER > Section 7.1 Termination > (b)(i)"
      }
    ],
    "termination_rights_trigger_dates": [
      {
        "section": "timeline",
        "field_name": "termination_rights_trigger_dates",
        "answer": "5:00 p.m. (Chicago, Illinois, United States time) on the twelve (12)-month anniversary of the date of this Agreement",
        "summary": "The agreement may be terminated if the merger is not consummated by 5:00 p.m. on the twelve-month anniversary of the agreement date, with a possible three-month extension under certain conditions.",
        "confidence": 0.95,
        "reason": "The clause explicitly states the termination date as the twelve-month anniversary of the agreement date, with conditions for extension.",
        "clause_text": "by either Parent or the Company, if: (i) the Merger shall not have been consummated on or before 5:00 p.m. (Chicago, Illinois, United States time) on the twelve (12)-month anniversary of the date of this Agreement (the \"Termination Date\"); provided that if, on the Termination Date, any of the conditions to Closing set forth in Section 6.1(d) or Section 6.1(e) (if the Restraint is in respect of an Antitrust Law) shall not have been satisfied, but all other conditions set forth in Section 6.1 through Section 6.3 shall have been satisfied or waived (other than those conditions that by their nature are to be satisfied at the Effective Time (if such conditions are capable of being satisfied were the Closing to occur at such time)), the Termination Date shall automatically, without any action on the part of the parties hereto, be extended for three (3) months, and such date as so extended shall be the \"Termination Date\" for all purposes hereunder;",
        "reference_section": "ARTICLE Article VII TERMINATION, AMENDMENT AND WAIVER > Section 7.1 Termination > (b) > (i)"
      }
    ],
    "marketing_period_dates": [
      {
        "section": "timeline",
        "field_name": "marketing_period_dates",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "inside_date": [
      {
        "section": "timeline",
        "field_name": "inside_date",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ],
    "closing_date": [
      {
        "section": "timeline",
        "field_name": "closing_date",
        "answer": "third Business Day after the satisfaction or waiver of the conditions set forth in Article VI",
        "summary": "The closing of the Merger shall occur no later than the third Business Day after the satisfaction or waiver of the conditions set forth in Article VI.",
        "confidence": 0.95,
        "reason": "The clause explicitly states the closing date as the third Business Day after the satisfaction or waiver of specific conditions.",
        "clause_text": "Subject to the provisions of Article VI, the closing of the Merger (the \"Closing\") shall take place at 9:00 a.m. (Chicago, Illinois, United States time) on a date to be specified by the parties hereto, but no later than the third (3rd) Business Day after the satisfaction or waiver of the conditions set forth in Article VI (other than those conditions that by their terms are to be satisfied at the Closing, but subject to the satisfaction or waiver of such conditions), unless another time, date or place is agreed to in writing by the parties hereto (such date being the \"Closing Date\").",
        "reference_section": "ARTICLE Article I THE MERGER > Section 1.2 The Closing"
      }
    ],
    "conditions_satisfaction_end_date": [
      {
        "section": "timeline",
        "field_name": "conditions_satisfaction_end_date",
        "answer": "Not found",
        "summary": "",
        "confidence": 1.0,
        "reason": "",
        "clause_text": "",
        "reference_section": ""
      }
    ]
  }
}
